ssw04104 personal page - To The Moon

ssw04104

ssw04104

No personal profile

80Follow

14Followers

0Topic

0Badge

2023-09-02

I just want to collect point

2022-08-19

Hi

$100M College Whiz Who Scored As BBBY Squeezed Says He "Wasn't That Aware It Was A Meme"

2022-08-19

Goov

$100M College Whiz Who Scored As BBBY Squeezed Says He "Wasn't That Aware It Was A Meme"

2021-09-20

Hi

Toplines Before US Market Open on Monday

2021-09-15

//@ssw04104: Hi

Stock market opens slightly higher Wednesday, with Dow lagging peer benchmarks

2021-09-15

Hi

Stock market opens slightly higher Wednesday, with Dow lagging peer benchmarks

2021-09-13

Hi

Toplines Before US Market Open on Monday

2021-09-12

Hi

Cathie Wood's Latest Picks: 2 Stocks She Just Bought

2021-09-10

Hi

Sorry, the original content has been removed

2021-09-10

Hi

ContextLogic Should Really Perform Better Than It Has Been

2021-09-08

Hi

Sorry, the original content has been removed

2021-09-07

Like

Strategists Say the Stock Market Could Struggle This Fall. What to Buy Now?

2021-09-06

H

Sorry, the original content has been removed

2021-08-30

Hi//@ssw04104: Hi

Moderna, BioNTech Rally Stalls Ahead of CDC Meeting on Boosters

2021-08-30

Hi

Moderna, BioNTech Rally Stalls Ahead of CDC Meeting on Boosters

2021-08-27

Ok

Box: A Comfortable Investment At Tremendously Cheap Prices

2021-08-26

K

AMC Stock: Running Of The Bulls Knocks Short Sellers Down

2021-08-25

Great ariticle, would you like to share it?

Sorry, the original content has been removed

2021-08-25

H

Sorry, the original content has been removed

2021-08-24

Hi

MSCI CEO Dismisses Concern Chinese Stocks Are ‘Uninvestable’

Go to Tiger App to see more news

Invest in Global Markets with Tiger Brokers!

Open App

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3578668729356671","uuid":"3578668729356671","gmtCreate":1615577549078,"gmtModify":1660927803961,"name":"ssw04104","pinyin":"ssw04104","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","hatId":"ca_profile_frame_Mpy1eK","hatName":"","vip":1,"status":2,"fanSize":14,"headSize":80,"tweetSize":83,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.30%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":215436054118504,"gmtCreate":1693627397836,"gmtModify":1693627403462,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"I just want to collect point","listText":"I just want to collect point","text":"I just want to collect point","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/215436054118504","isVote":1,"tweetType":1,"viewCount":1465,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9998301172,"gmtCreate":1660925866399,"gmtModify":1676536424950,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9998301172","repostId":"1117983793","repostType":4,"repost":{"id":"1117983793","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1660918975,"share":"https://ttm.financial/m/news/1117983793?lang=&edition=full_marsco","pubTime":"2022-08-19 22:22","market":"us","language":"en","title":"$100M College Whiz Who Scored As BBBY Squeezed Says He \"Wasn't That Aware It Was A Meme\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1117983793","media":"Benzinga","summary":"ZINGER KEY POINTS“I wasn’t that aware it was a meme stock,” Jake Freeman told Benzinga.Investor focu","content":"<html><head></head><body><h2>ZINGER KEY POINTS</h2><ul><li>“I wasn’t that aware it was a meme stock,” Jake Freeman told Benzinga.</li><li>Investor focus now, however, is on MindMed, which was co-Founded by Jake&#39;s uncle.</li></ul><p><img src=\"https://static.tigerbbs.com/2254510fd8e5225fad6178e4e1680a38\" tg-width=\"5616\" tg-height=\"3744\" referrerpolicy=\"no-referrer\"/><b>Jake Freeman</b>, the 20-year-old college student who reportedly banked $100 million trading Bed Bath and Beyond stock, purchased 4.69 million shares of the retailer <b>Bed Bath &amp; Beyond Inc</b></p><p>BBBY in July at roughly $5.20 per share along with his uncle, Dr. <b>Scott Freeman.</b></p><p>That netted their Freeman Capital Management family fund a 6.21% passive stake in the meme stock.</p><p>“I wasn’t that aware it was a meme stock,” the University of Southern California student told Benzinga on Thursday.</p><p>“I approached it more from a mathematical side — looking at the balance sheet and the intersection of the debt side, the equity. I did not expect in any way the stock going up so fast.”</p><p><b>The Bed Bath &amp; Beyond Investor&#39;s Plan:</b> In a July 21letter to Bed Bath &amp; Beyond, the younger Freeman outlined Freeman Capital’s plan for the realignment of the retailer, which consisted of two crucial legs: cutting debt and raising capital.</p><p>Fast forward just four weeks later, coupled with a carefully orchestrated short squeeze by Reddit&#39;s WallStreetBets community known as the &#34;Apes,&#34; shares of Bed Bath rocketed to $28.60 at the highs on Tuesday — the same day Freeman Capital exited its entire stake in the company.</p><p>Curiously, on the same day, <b>GameStop Corp.</b> Chairman <b>Ryan Cohen</b>, who sparked the Bed Bath &amp; Beyond fanfare with the Apes, filed with the SEC saying he intended to sell as many as 9.45 million shares of the company beginning that day.</p><p>The Freeman Family Fund&#39;s sale was well-timed. It closed at more than $130 million after spending $25 million in the initial investment, netting around $105-$110 million, or between 420%-460%.</p><p><b>MindMed Shares Skyrocket:</b> Jake, who previously interned at Volaris Capital Management invests with his uncle Scott, who is the co-founder and former chief medical officer of <b>Mind Medicine (MindMed) Inc</b>. MindMed shares rocketed 77.4% from the previous day&#39;s highs on Thursday after the Bed Bath &amp; Beyond sale was disclosed.</p><p><i>Read more: EXCLUSIVE: Food Wholesaler Talks Crazy Chicken And Beef Prices — &#39;Fresh Meat Arbitrage&#39;</i></p><p>The investor focus is now on MindMed, which was originally a privately owned company, Savant, co-founded Scott.</p><p>The Freemans have built a 5.6% stake in the company and sent astrategic value enhancement planto MindMed, outlining the fund&#39;s interest in working &#34;hand-in-hand&#34; to cut the development time of MindMed&#39;s two original drugs and slash its annual cash-burn rate.</p><p>Analyzing the letter, which the younger Freeman confirmed to Benzinga, FCM is focusing on MindMed&#39;s core drugs, cutting cash burn and terminating MindMed&#39;s at-the-money equity offering.</p><p>“I’ve been in drug development since I was in high school,” Scott said in an Aug. 16 interview on the YouTube channel Psychedelic Invest.</p><p>“About 13 years ago I partnered with <b>Stephen Hurst</b> and we founded a company called Savant.It was a private company working on drugs to treat addiction.”</p><p>After MindMed bought Savant, where he was previously CMO, Scott became the company&#39;s first CMO. Heleft the organizationaround a year after he arrived, making him the first senior member of the team to do so.</p><p>Benzinga asked the younger Freeman why Scott left the company; he said he could not divulge the reason for Freeman’s departure due to a non-disclosure agreement.</p><p>“As a co-founder,” Scott said in the aforementioned interview. “I’ve been sitting on the sidelines watching, and one of the reasons why I want to go back is that I think there are things that I think need to be done differently.”</p><p>In the letter to MindMed, the pair call for an overhaul of the company, including cutting 11 of its 22 employees; the elimination of more than $21.8 million in non-core expenditures; and half of its cash burn rate over time.</p><p>It also calls for the immediate development of a proposal to approach the FDA to upgrade its MM-120 drug from a Phase 2 trial to a Phase 3 trial, which the Freemans said could bring the drug to market in four years rather than the expected seven to eight years.</p><p>The enhancement plan calls for a 50% reduction in executive compensation as well.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>$100M College Whiz Who Scored As BBBY Squeezed Says He \"Wasn't That Aware It Was A Meme\"</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n$100M College Whiz Who Scored As BBBY Squeezed Says He \"Wasn't That Aware It Was A Meme\"\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-08-19 22:22</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><h2>ZINGER KEY POINTS</h2><ul><li>“I wasn’t that aware it was a meme stock,” Jake Freeman told Benzinga.</li><li>Investor focus now, however, is on MindMed, which was co-Founded by Jake&#39;s uncle.</li></ul><p><img src=\"https://static.tigerbbs.com/2254510fd8e5225fad6178e4e1680a38\" tg-width=\"5616\" tg-height=\"3744\" referrerpolicy=\"no-referrer\"/><b>Jake Freeman</b>, the 20-year-old college student who reportedly banked $100 million trading Bed Bath and Beyond stock, purchased 4.69 million shares of the retailer <b>Bed Bath &amp; Beyond Inc</b></p><p>BBBY in July at roughly $5.20 per share along with his uncle, Dr. <b>Scott Freeman.</b></p><p>That netted their Freeman Capital Management family fund a 6.21% passive stake in the meme stock.</p><p>“I wasn’t that aware it was a meme stock,” the University of Southern California student told Benzinga on Thursday.</p><p>“I approached it more from a mathematical side — looking at the balance sheet and the intersection of the debt side, the equity. I did not expect in any way the stock going up so fast.”</p><p><b>The Bed Bath &amp; Beyond Investor&#39;s Plan:</b> In a July 21letter to Bed Bath &amp; Beyond, the younger Freeman outlined Freeman Capital’s plan for the realignment of the retailer, which consisted of two crucial legs: cutting debt and raising capital.</p><p>Fast forward just four weeks later, coupled with a carefully orchestrated short squeeze by Reddit&#39;s WallStreetBets community known as the &#34;Apes,&#34; shares of Bed Bath rocketed to $28.60 at the highs on Tuesday — the same day Freeman Capital exited its entire stake in the company.</p><p>Curiously, on the same day, <b>GameStop Corp.</b> Chairman <b>Ryan Cohen</b>, who sparked the Bed Bath &amp; Beyond fanfare with the Apes, filed with the SEC saying he intended to sell as many as 9.45 million shares of the company beginning that day.</p><p>The Freeman Family Fund&#39;s sale was well-timed. It closed at more than $130 million after spending $25 million in the initial investment, netting around $105-$110 million, or between 420%-460%.</p><p><b>MindMed Shares Skyrocket:</b> Jake, who previously interned at Volaris Capital Management invests with his uncle Scott, who is the co-founder and former chief medical officer of <b>Mind Medicine (MindMed) Inc</b>. MindMed shares rocketed 77.4% from the previous day&#39;s highs on Thursday after the Bed Bath &amp; Beyond sale was disclosed.</p><p><i>Read more: EXCLUSIVE: Food Wholesaler Talks Crazy Chicken And Beef Prices — &#39;Fresh Meat Arbitrage&#39;</i></p><p>The investor focus is now on MindMed, which was originally a privately owned company, Savant, co-founded Scott.</p><p>The Freemans have built a 5.6% stake in the company and sent astrategic value enhancement planto MindMed, outlining the fund&#39;s interest in working &#34;hand-in-hand&#34; to cut the development time of MindMed&#39;s two original drugs and slash its annual cash-burn rate.</p><p>Analyzing the letter, which the younger Freeman confirmed to Benzinga, FCM is focusing on MindMed&#39;s core drugs, cutting cash burn and terminating MindMed&#39;s at-the-money equity offering.</p><p>“I’ve been in drug development since I was in high school,” Scott said in an Aug. 16 interview on the YouTube channel Psychedelic Invest.</p><p>“About 13 years ago I partnered with <b>Stephen Hurst</b> and we founded a company called Savant.It was a private company working on drugs to treat addiction.”</p><p>After MindMed bought Savant, where he was previously CMO, Scott became the company&#39;s first CMO. Heleft the organizationaround a year after he arrived, making him the first senior member of the team to do so.</p><p>Benzinga asked the younger Freeman why Scott left the company; he said he could not divulge the reason for Freeman’s departure due to a non-disclosure agreement.</p><p>“As a co-founder,” Scott said in the aforementioned interview. “I’ve been sitting on the sidelines watching, and one of the reasons why I want to go back is that I think there are things that I think need to be done differently.”</p><p>In the letter to MindMed, the pair call for an overhaul of the company, including cutting 11 of its 22 employees; the elimination of more than $21.8 million in non-core expenditures; and half of its cash burn rate over time.</p><p>It also calls for the immediate development of a proposal to approach the FDA to upgrade its MM-120 drug from a Phase 2 trial to a Phase 3 trial, which the Freemans said could bring the drug to market in four years rather than the expected seven to eight years.</p><p>The enhancement plan calls for a 50% reduction in executive compensation as well.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MNMD":"Mind Medicine (MindMed) Inc.","BBBY":"3B家居"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117983793","content_text":"ZINGER KEY POINTS“I wasn’t that aware it was a meme stock,” Jake Freeman told Benzinga.Investor focus now, however, is on MindMed, which was co-Founded by Jake's uncle.Jake Freeman, the 20-year-old college student who reportedly banked $100 million trading Bed Bath and Beyond stock, purchased 4.69 million shares of the retailer Bed Bath & Beyond IncBBBY in July at roughly $5.20 per share along with his uncle, Dr. Scott Freeman.That netted their Freeman Capital Management family fund a 6.21% passive stake in the meme stock.“I wasn’t that aware it was a meme stock,” the University of Southern California student told Benzinga on Thursday.“I approached it more from a mathematical side — looking at the balance sheet and the intersection of the debt side, the equity. I did not expect in any way the stock going up so fast.”The Bed Bath & Beyond Investor's Plan: In a July 21letter to Bed Bath & Beyond, the younger Freeman outlined Freeman Capital’s plan for the realignment of the retailer, which consisted of two crucial legs: cutting debt and raising capital.Fast forward just four weeks later, coupled with a carefully orchestrated short squeeze by Reddit's WallStreetBets community known as the \"Apes,\" shares of Bed Bath rocketed to $28.60 at the highs on Tuesday — the same day Freeman Capital exited its entire stake in the company.Curiously, on the same day, GameStop Corp. Chairman Ryan Cohen, who sparked the Bed Bath & Beyond fanfare with the Apes, filed with the SEC saying he intended to sell as many as 9.45 million shares of the company beginning that day.The Freeman Family Fund's sale was well-timed. It closed at more than $130 million after spending $25 million in the initial investment, netting around $105-$110 million, or between 420%-460%.MindMed Shares Skyrocket: Jake, who previously interned at Volaris Capital Management invests with his uncle Scott, who is the co-founder and former chief medical officer of Mind Medicine (MindMed) Inc. MindMed shares rocketed 77.4% from the previous day's highs on Thursday after the Bed Bath & Beyond sale was disclosed.Read more: EXCLUSIVE: Food Wholesaler Talks Crazy Chicken And Beef Prices — 'Fresh Meat Arbitrage'The investor focus is now on MindMed, which was originally a privately owned company, Savant, co-founded Scott.The Freemans have built a 5.6% stake in the company and sent astrategic value enhancement planto MindMed, outlining the fund's interest in working \"hand-in-hand\" to cut the development time of MindMed's two original drugs and slash its annual cash-burn rate.Analyzing the letter, which the younger Freeman confirmed to Benzinga, FCM is focusing on MindMed's core drugs, cutting cash burn and terminating MindMed's at-the-money equity offering.“I’ve been in drug development since I was in high school,” Scott said in an Aug. 16 interview on the YouTube channel Psychedelic Invest.“About 13 years ago I partnered with Stephen Hurst and we founded a company called Savant.It was a private company working on drugs to treat addiction.”After MindMed bought Savant, where he was previously CMO, Scott became the company's first CMO. Heleft the organizationaround a year after he arrived, making him the first senior member of the team to do so.Benzinga asked the younger Freeman why Scott left the company; he said he could not divulge the reason for Freeman’s departure due to a non-disclosure agreement.“As a co-founder,” Scott said in the aforementioned interview. “I’ve been sitting on the sidelines watching, and one of the reasons why I want to go back is that I think there are things that I think need to be done differently.”In the letter to MindMed, the pair call for an overhaul of the company, including cutting 11 of its 22 employees; the elimination of more than $21.8 million in non-core expenditures; and half of its cash burn rate over time.It also calls for the immediate development of a proposal to approach the FDA to upgrade its MM-120 drug from a Phase 2 trial to a Phase 3 trial, which the Freemans said could bring the drug to market in four years rather than the expected seven to eight years.The enhancement plan calls for a 50% reduction in executive compensation as well.","news_type":1,"symbols_score_info":{"BBBY":0.9,"MNMD":0.9}},"isVote":1,"tweetType":1,"viewCount":1369,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9998303443,"gmtCreate":1660925763185,"gmtModify":1676536424934,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Goov","listText":"Goov","text":"Goov","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9998303443","repostId":"1117983793","repostType":4,"repost":{"id":"1117983793","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1660918975,"share":"https://ttm.financial/m/news/1117983793?lang=&edition=full_marsco","pubTime":"2022-08-19 22:22","market":"us","language":"en","title":"$100M College Whiz Who Scored As BBBY Squeezed Says He \"Wasn't That Aware It Was A Meme\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1117983793","media":"Benzinga","summary":"ZINGER KEY POINTS“I wasn’t that aware it was a meme stock,” Jake Freeman told Benzinga.Investor focu","content":"<html><head></head><body><h2>ZINGER KEY POINTS</h2><ul><li>“I wasn’t that aware it was a meme stock,” Jake Freeman told Benzinga.</li><li>Investor focus now, however, is on MindMed, which was co-Founded by Jake&#39;s uncle.</li></ul><p><img src=\"https://static.tigerbbs.com/2254510fd8e5225fad6178e4e1680a38\" tg-width=\"5616\" tg-height=\"3744\" referrerpolicy=\"no-referrer\"/><b>Jake Freeman</b>, the 20-year-old college student who reportedly banked $100 million trading Bed Bath and Beyond stock, purchased 4.69 million shares of the retailer <b>Bed Bath &amp; Beyond Inc</b></p><p>BBBY in July at roughly $5.20 per share along with his uncle, Dr. <b>Scott Freeman.</b></p><p>That netted their Freeman Capital Management family fund a 6.21% passive stake in the meme stock.</p><p>“I wasn’t that aware it was a meme stock,” the University of Southern California student told Benzinga on Thursday.</p><p>“I approached it more from a mathematical side — looking at the balance sheet and the intersection of the debt side, the equity. I did not expect in any way the stock going up so fast.”</p><p><b>The Bed Bath &amp; Beyond Investor&#39;s Plan:</b> In a July 21letter to Bed Bath &amp; Beyond, the younger Freeman outlined Freeman Capital’s plan for the realignment of the retailer, which consisted of two crucial legs: cutting debt and raising capital.</p><p>Fast forward just four weeks later, coupled with a carefully orchestrated short squeeze by Reddit&#39;s WallStreetBets community known as the &#34;Apes,&#34; shares of Bed Bath rocketed to $28.60 at the highs on Tuesday — the same day Freeman Capital exited its entire stake in the company.</p><p>Curiously, on the same day, <b>GameStop Corp.</b> Chairman <b>Ryan Cohen</b>, who sparked the Bed Bath &amp; Beyond fanfare with the Apes, filed with the SEC saying he intended to sell as many as 9.45 million shares of the company beginning that day.</p><p>The Freeman Family Fund&#39;s sale was well-timed. It closed at more than $130 million after spending $25 million in the initial investment, netting around $105-$110 million, or between 420%-460%.</p><p><b>MindMed Shares Skyrocket:</b> Jake, who previously interned at Volaris Capital Management invests with his uncle Scott, who is the co-founder and former chief medical officer of <b>Mind Medicine (MindMed) Inc</b>. MindMed shares rocketed 77.4% from the previous day&#39;s highs on Thursday after the Bed Bath &amp; Beyond sale was disclosed.</p><p><i>Read more: EXCLUSIVE: Food Wholesaler Talks Crazy Chicken And Beef Prices — &#39;Fresh Meat Arbitrage&#39;</i></p><p>The investor focus is now on MindMed, which was originally a privately owned company, Savant, co-founded Scott.</p><p>The Freemans have built a 5.6% stake in the company and sent astrategic value enhancement planto MindMed, outlining the fund&#39;s interest in working &#34;hand-in-hand&#34; to cut the development time of MindMed&#39;s two original drugs and slash its annual cash-burn rate.</p><p>Analyzing the letter, which the younger Freeman confirmed to Benzinga, FCM is focusing on MindMed&#39;s core drugs, cutting cash burn and terminating MindMed&#39;s at-the-money equity offering.</p><p>“I’ve been in drug development since I was in high school,” Scott said in an Aug. 16 interview on the YouTube channel Psychedelic Invest.</p><p>“About 13 years ago I partnered with <b>Stephen Hurst</b> and we founded a company called Savant.It was a private company working on drugs to treat addiction.”</p><p>After MindMed bought Savant, where he was previously CMO, Scott became the company&#39;s first CMO. Heleft the organizationaround a year after he arrived, making him the first senior member of the team to do so.</p><p>Benzinga asked the younger Freeman why Scott left the company; he said he could not divulge the reason for Freeman’s departure due to a non-disclosure agreement.</p><p>“As a co-founder,” Scott said in the aforementioned interview. “I’ve been sitting on the sidelines watching, and one of the reasons why I want to go back is that I think there are things that I think need to be done differently.”</p><p>In the letter to MindMed, the pair call for an overhaul of the company, including cutting 11 of its 22 employees; the elimination of more than $21.8 million in non-core expenditures; and half of its cash burn rate over time.</p><p>It also calls for the immediate development of a proposal to approach the FDA to upgrade its MM-120 drug from a Phase 2 trial to a Phase 3 trial, which the Freemans said could bring the drug to market in four years rather than the expected seven to eight years.</p><p>The enhancement plan calls for a 50% reduction in executive compensation as well.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>$100M College Whiz Who Scored As BBBY Squeezed Says He \"Wasn't That Aware It Was A Meme\"</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n$100M College Whiz Who Scored As BBBY Squeezed Says He \"Wasn't That Aware It Was A Meme\"\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2022-08-19 22:22</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><h2>ZINGER KEY POINTS</h2><ul><li>“I wasn’t that aware it was a meme stock,” Jake Freeman told Benzinga.</li><li>Investor focus now, however, is on MindMed, which was co-Founded by Jake&#39;s uncle.</li></ul><p><img src=\"https://static.tigerbbs.com/2254510fd8e5225fad6178e4e1680a38\" tg-width=\"5616\" tg-height=\"3744\" referrerpolicy=\"no-referrer\"/><b>Jake Freeman</b>, the 20-year-old college student who reportedly banked $100 million trading Bed Bath and Beyond stock, purchased 4.69 million shares of the retailer <b>Bed Bath &amp; Beyond Inc</b></p><p>BBBY in July at roughly $5.20 per share along with his uncle, Dr. <b>Scott Freeman.</b></p><p>That netted their Freeman Capital Management family fund a 6.21% passive stake in the meme stock.</p><p>“I wasn’t that aware it was a meme stock,” the University of Southern California student told Benzinga on Thursday.</p><p>“I approached it more from a mathematical side — looking at the balance sheet and the intersection of the debt side, the equity. I did not expect in any way the stock going up so fast.”</p><p><b>The Bed Bath &amp; Beyond Investor&#39;s Plan:</b> In a July 21letter to Bed Bath &amp; Beyond, the younger Freeman outlined Freeman Capital’s plan for the realignment of the retailer, which consisted of two crucial legs: cutting debt and raising capital.</p><p>Fast forward just four weeks later, coupled with a carefully orchestrated short squeeze by Reddit&#39;s WallStreetBets community known as the &#34;Apes,&#34; shares of Bed Bath rocketed to $28.60 at the highs on Tuesday — the same day Freeman Capital exited its entire stake in the company.</p><p>Curiously, on the same day, <b>GameStop Corp.</b> Chairman <b>Ryan Cohen</b>, who sparked the Bed Bath &amp; Beyond fanfare with the Apes, filed with the SEC saying he intended to sell as many as 9.45 million shares of the company beginning that day.</p><p>The Freeman Family Fund&#39;s sale was well-timed. It closed at more than $130 million after spending $25 million in the initial investment, netting around $105-$110 million, or between 420%-460%.</p><p><b>MindMed Shares Skyrocket:</b> Jake, who previously interned at Volaris Capital Management invests with his uncle Scott, who is the co-founder and former chief medical officer of <b>Mind Medicine (MindMed) Inc</b>. MindMed shares rocketed 77.4% from the previous day&#39;s highs on Thursday after the Bed Bath &amp; Beyond sale was disclosed.</p><p><i>Read more: EXCLUSIVE: Food Wholesaler Talks Crazy Chicken And Beef Prices — &#39;Fresh Meat Arbitrage&#39;</i></p><p>The investor focus is now on MindMed, which was originally a privately owned company, Savant, co-founded Scott.</p><p>The Freemans have built a 5.6% stake in the company and sent astrategic value enhancement planto MindMed, outlining the fund&#39;s interest in working &#34;hand-in-hand&#34; to cut the development time of MindMed&#39;s two original drugs and slash its annual cash-burn rate.</p><p>Analyzing the letter, which the younger Freeman confirmed to Benzinga, FCM is focusing on MindMed&#39;s core drugs, cutting cash burn and terminating MindMed&#39;s at-the-money equity offering.</p><p>“I’ve been in drug development since I was in high school,” Scott said in an Aug. 16 interview on the YouTube channel Psychedelic Invest.</p><p>“About 13 years ago I partnered with <b>Stephen Hurst</b> and we founded a company called Savant.It was a private company working on drugs to treat addiction.”</p><p>After MindMed bought Savant, where he was previously CMO, Scott became the company&#39;s first CMO. Heleft the organizationaround a year after he arrived, making him the first senior member of the team to do so.</p><p>Benzinga asked the younger Freeman why Scott left the company; he said he could not divulge the reason for Freeman’s departure due to a non-disclosure agreement.</p><p>“As a co-founder,” Scott said in the aforementioned interview. “I’ve been sitting on the sidelines watching, and one of the reasons why I want to go back is that I think there are things that I think need to be done differently.”</p><p>In the letter to MindMed, the pair call for an overhaul of the company, including cutting 11 of its 22 employees; the elimination of more than $21.8 million in non-core expenditures; and half of its cash burn rate over time.</p><p>It also calls for the immediate development of a proposal to approach the FDA to upgrade its MM-120 drug from a Phase 2 trial to a Phase 3 trial, which the Freemans said could bring the drug to market in four years rather than the expected seven to eight years.</p><p>The enhancement plan calls for a 50% reduction in executive compensation as well.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MNMD":"Mind Medicine (MindMed) Inc.","BBBY":"3B家居"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117983793","content_text":"ZINGER KEY POINTS“I wasn’t that aware it was a meme stock,” Jake Freeman told Benzinga.Investor focus now, however, is on MindMed, which was co-Founded by Jake's uncle.Jake Freeman, the 20-year-old college student who reportedly banked $100 million trading Bed Bath and Beyond stock, purchased 4.69 million shares of the retailer Bed Bath & Beyond IncBBBY in July at roughly $5.20 per share along with his uncle, Dr. Scott Freeman.That netted their Freeman Capital Management family fund a 6.21% passive stake in the meme stock.“I wasn’t that aware it was a meme stock,” the University of Southern California student told Benzinga on Thursday.“I approached it more from a mathematical side — looking at the balance sheet and the intersection of the debt side, the equity. I did not expect in any way the stock going up so fast.”The Bed Bath & Beyond Investor's Plan: In a July 21letter to Bed Bath & Beyond, the younger Freeman outlined Freeman Capital’s plan for the realignment of the retailer, which consisted of two crucial legs: cutting debt and raising capital.Fast forward just four weeks later, coupled with a carefully orchestrated short squeeze by Reddit's WallStreetBets community known as the \"Apes,\" shares of Bed Bath rocketed to $28.60 at the highs on Tuesday — the same day Freeman Capital exited its entire stake in the company.Curiously, on the same day, GameStop Corp. Chairman Ryan Cohen, who sparked the Bed Bath & Beyond fanfare with the Apes, filed with the SEC saying he intended to sell as many as 9.45 million shares of the company beginning that day.The Freeman Family Fund's sale was well-timed. It closed at more than $130 million after spending $25 million in the initial investment, netting around $105-$110 million, or between 420%-460%.MindMed Shares Skyrocket: Jake, who previously interned at Volaris Capital Management invests with his uncle Scott, who is the co-founder and former chief medical officer of Mind Medicine (MindMed) Inc. MindMed shares rocketed 77.4% from the previous day's highs on Thursday after the Bed Bath & Beyond sale was disclosed.Read more: EXCLUSIVE: Food Wholesaler Talks Crazy Chicken And Beef Prices — 'Fresh Meat Arbitrage'The investor focus is now on MindMed, which was originally a privately owned company, Savant, co-founded Scott.The Freemans have built a 5.6% stake in the company and sent astrategic value enhancement planto MindMed, outlining the fund's interest in working \"hand-in-hand\" to cut the development time of MindMed's two original drugs and slash its annual cash-burn rate.Analyzing the letter, which the younger Freeman confirmed to Benzinga, FCM is focusing on MindMed's core drugs, cutting cash burn and terminating MindMed's at-the-money equity offering.“I’ve been in drug development since I was in high school,” Scott said in an Aug. 16 interview on the YouTube channel Psychedelic Invest.“About 13 years ago I partnered with Stephen Hurst and we founded a company called Savant.It was a private company working on drugs to treat addiction.”After MindMed bought Savant, where he was previously CMO, Scott became the company's first CMO. Heleft the organizationaround a year after he arrived, making him the first senior member of the team to do so.Benzinga asked the younger Freeman why Scott left the company; he said he could not divulge the reason for Freeman’s departure due to a non-disclosure agreement.“As a co-founder,” Scott said in the aforementioned interview. “I’ve been sitting on the sidelines watching, and one of the reasons why I want to go back is that I think there are things that I think need to be done differently.”In the letter to MindMed, the pair call for an overhaul of the company, including cutting 11 of its 22 employees; the elimination of more than $21.8 million in non-core expenditures; and half of its cash burn rate over time.It also calls for the immediate development of a proposal to approach the FDA to upgrade its MM-120 drug from a Phase 2 trial to a Phase 3 trial, which the Freemans said could bring the drug to market in four years rather than the expected seven to eight years.The enhancement plan calls for a 50% reduction in executive compensation as well.","news_type":1,"symbols_score_info":{"BBBY":0.9,"MNMD":0.9}},"isVote":1,"tweetType":1,"viewCount":1310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860341377,"gmtCreate":1632141101899,"gmtModify":1676530708683,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/860341377","repostId":"1130418583","repostType":4,"repost":{"id":"1130418583","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632138209,"share":"https://ttm.financial/m/news/1130418583?lang=&edition=full_marsco","pubTime":"2021-09-20 19:43","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1130418583","media":"Tiger Newspress","summary":"(Sept 20) U.S. stock futures sold off Monday morning, tracking declines in overseas equities as inve","content":"<p>(Sept 20)&nbsp;U.S. stock futures sold off Monday morning, tracking declines in overseas equities as investors nervously eyed the potential ripple effects of the default of a major Chinese real estate company and ongoing debates over the debt limit in Washington.</p>\n<p>At 07:47 a.m. ET,&nbsp;Dow futures sank by more than 600 points, or 1.79%, in early trading. S&amp;P 500 futures also dropped by more than 1%, adding to losses from last week. The CBOE Volatility Index, or Vix (^VIX), jumped by more than 30% as a confluence of concerns roiled markets.</p>\n<p><img src=\"https://static.tigerbbs.com/b8c25019026526b24ae7ba8fd17ac289\" tg-width=\"1242\" tg-height=\"503\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Stocks making the biggest moves premarket</b></p>\n<p>1)&nbsp;China Evergrande Group—&nbsp;Chinese property giant&nbsp;Evergrande tumbled more than 10% on Hong Kong Stock Exchange, spooking Asian markets.&nbsp;The company has been scrambling to pay its suppliers, and warned investors twice in as many weeks that it could default on its debts. Last week Evergrande said its property sales will likely continue to drop significantly in September after declining for months.</p>\n<p><b>2)&nbsp;<a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b> — The pharmaceutical giantsaid Mondaythat trials showed its Covid vaccine was safe and effective when used in children ages 5 to 11. Pfizer and partner BioNTech said they would submit the results for approval “as soon as possible.” Shares of Pfizer were down about 1% in premarket trading.</p>\n<p><b>3)&nbsp;<a href=\"https://laohu8.com/S/LPI\">Laredo</a> ,<a href=\"https://laohu8.com/S/OXY\">Occidental</a></b> — Oil and energy stocks dipped in premarket trading on Monday. The SPDR S&amp;P Oil &amp; Gas Exploration ETF is down more than 3% in early trading, on pace for its 3rd straight negative session. Laredo Petroleum is down more than 8%, Callon Petroleum is down roughly 6%, and Occidental Petroleum is down nearly 5%. The losses came as crude oil fell on fears of a global economic slowdown tied to the China property market.</p>\n<p><b>4)&nbsp;<a href=\"https://laohu8.com/S/CL\">Colgate-Palmolive</a></b> — The consumer staples stock wasupgradedto buy from hold by Deutsche Bank on Sunday. The investment firm said that Colgate’s difficulties with inflation and in some international markets was already priced in to its stock.</p>\n<p>5)&nbsp;JPMorgan,&nbsp;Bank of America— Bank stocks slid in unison amid a decline in bond yields on slowdown fears. Investors flocked to Treasurys for safety as the stock market is set for its biggest sell-off in months. Big bank stocks took a hit as the falling rates may crimp profits. Bank of America and JPMorgan Chase were each down more than 2% in premarket trading. Citizens Financial Group dropped 3%, while Citigroup declined 2.5%.</p>\n<p><b>6)&nbsp;<a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a></b> — The United Kingdom-based pharmaceutical company announced on Monday that its breast cancer drug Enhertu showed positive results in a phase-three trial. Shares of the company were up more than 1% in premarket trading.</p>\n<p><b>7)&nbsp;<a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a> </b>— Cathie Wood’s ARK Innovation ETF is down 2.75% in the premarket, on pace to snap a 3-day winning streak. Compugen, DraftKings, Coinbase and Square are so of the ETF’s biggest losers this morning.</p>\n<p>Some investors believe this is just normal market action that can occur in September.</p>\n<p>“The reasons for drop this morning are the same as last week: China concerns (Evergrande, regulation, COVID), Fed tapering and possible tax hikes, but nothing new occurred this weekend to justify this mornings’ declines,” Tom Essaye, founder of Sevens Report, said in a note.</p>\n<p>Other risky assets declined on Monday.Bitcoinlost 8% tobelow $44,000.</p>\n<p>Most commodities were in the red.Goldwas among the few assets in the green, adding 0.5% to $1,760.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-20 19:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Sept 20)&nbsp;U.S. stock futures sold off Monday morning, tracking declines in overseas equities as investors nervously eyed the potential ripple effects of the default of a major Chinese real estate company and ongoing debates over the debt limit in Washington.</p>\n<p>At 07:47 a.m. ET,&nbsp;Dow futures sank by more than 600 points, or 1.79%, in early trading. S&amp;P 500 futures also dropped by more than 1%, adding to losses from last week. The CBOE Volatility Index, or Vix (^VIX), jumped by more than 30% as a confluence of concerns roiled markets.</p>\n<p><img src=\"https://static.tigerbbs.com/b8c25019026526b24ae7ba8fd17ac289\" tg-width=\"1242\" tg-height=\"503\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Stocks making the biggest moves premarket</b></p>\n<p>1)&nbsp;China Evergrande Group—&nbsp;Chinese property giant&nbsp;Evergrande tumbled more than 10% on Hong Kong Stock Exchange, spooking Asian markets.&nbsp;The company has been scrambling to pay its suppliers, and warned investors twice in as many weeks that it could default on its debts. Last week Evergrande said its property sales will likely continue to drop significantly in September after declining for months.</p>\n<p><b>2)&nbsp;<a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b> — The pharmaceutical giantsaid Mondaythat trials showed its Covid vaccine was safe and effective when used in children ages 5 to 11. Pfizer and partner BioNTech said they would submit the results for approval “as soon as possible.” Shares of Pfizer were down about 1% in premarket trading.</p>\n<p><b>3)&nbsp;<a href=\"https://laohu8.com/S/LPI\">Laredo</a> ,<a href=\"https://laohu8.com/S/OXY\">Occidental</a></b> — Oil and energy stocks dipped in premarket trading on Monday. The SPDR S&amp;P Oil &amp; Gas Exploration ETF is down more than 3% in early trading, on pace for its 3rd straight negative session. Laredo Petroleum is down more than 8%, Callon Petroleum is down roughly 6%, and Occidental Petroleum is down nearly 5%. The losses came as crude oil fell on fears of a global economic slowdown tied to the China property market.</p>\n<p><b>4)&nbsp;<a href=\"https://laohu8.com/S/CL\">Colgate-Palmolive</a></b> — The consumer staples stock wasupgradedto buy from hold by Deutsche Bank on Sunday. The investment firm said that Colgate’s difficulties with inflation and in some international markets was already priced in to its stock.</p>\n<p>5)&nbsp;JPMorgan,&nbsp;Bank of America— Bank stocks slid in unison amid a decline in bond yields on slowdown fears. Investors flocked to Treasurys for safety as the stock market is set for its biggest sell-off in months. Big bank stocks took a hit as the falling rates may crimp profits. Bank of America and JPMorgan Chase were each down more than 2% in premarket trading. Citizens Financial Group dropped 3%, while Citigroup declined 2.5%.</p>\n<p><b>6)&nbsp;<a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a></b> — The United Kingdom-based pharmaceutical company announced on Monday that its breast cancer drug Enhertu showed positive results in a phase-three trial. Shares of the company were up more than 1% in premarket trading.</p>\n<p><b>7)&nbsp;<a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a> </b>— Cathie Wood’s ARK Innovation ETF is down 2.75% in the premarket, on pace to snap a 3-day winning streak. Compugen, DraftKings, Coinbase and Square are so of the ETF’s biggest losers this morning.</p>\n<p>Some investors believe this is just normal market action that can occur in September.</p>\n<p>“The reasons for drop this morning are the same as last week: China concerns (Evergrande, regulation, COVID), Fed tapering and possible tax hikes, but nothing new occurred this weekend to justify this mornings’ declines,” Tom Essaye, founder of Sevens Report, said in a note.</p>\n<p>Other risky assets declined on Monday.Bitcoinlost 8% tobelow $44,000.</p>\n<p>Most commodities were in the red.Goldwas among the few assets in the green, adding 0.5% to $1,760.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯","SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130418583","content_text":"(Sept 20) U.S. stock futures sold off Monday morning, tracking declines in overseas equities as investors nervously eyed the potential ripple effects of the default of a major Chinese real estate company and ongoing debates over the debt limit in Washington.\nAt 07:47 a.m. ET, Dow futures sank by more than 600 points, or 1.79%, in early trading. S&P 500 futures also dropped by more than 1%, adding to losses from last week. The CBOE Volatility Index, or Vix (^VIX), jumped by more than 30% as a confluence of concerns roiled markets.\n\nStocks making the biggest moves premarket\n1) China Evergrande Group— Chinese property giant Evergrande tumbled more than 10% on Hong Kong Stock Exchange, spooking Asian markets. The company has been scrambling to pay its suppliers, and warned investors twice in as many weeks that it could default on its debts. Last week Evergrande said its property sales will likely continue to drop significantly in September after declining for months.\n2) Pfizer — The pharmaceutical giantsaid Mondaythat trials showed its Covid vaccine was safe and effective when used in children ages 5 to 11. Pfizer and partner BioNTech said they would submit the results for approval “as soon as possible.” Shares of Pfizer were down about 1% in premarket trading.\n3) Laredo ,Occidental — Oil and energy stocks dipped in premarket trading on Monday. The SPDR S&P Oil & Gas Exploration ETF is down more than 3% in early trading, on pace for its 3rd straight negative session. Laredo Petroleum is down more than 8%, Callon Petroleum is down roughly 6%, and Occidental Petroleum is down nearly 5%. The losses came as crude oil fell on fears of a global economic slowdown tied to the China property market.\n4) Colgate-Palmolive — The consumer staples stock wasupgradedto buy from hold by Deutsche Bank on Sunday. The investment firm said that Colgate’s difficulties with inflation and in some international markets was already priced in to its stock.\n5) JPMorgan, Bank of America— Bank stocks slid in unison amid a decline in bond yields on slowdown fears. Investors flocked to Treasurys for safety as the stock market is set for its biggest sell-off in months. Big bank stocks took a hit as the falling rates may crimp profits. Bank of America and JPMorgan Chase were each down more than 2% in premarket trading. Citizens Financial Group dropped 3%, while Citigroup declined 2.5%.\n6) AstraZeneca Plc — The United Kingdom-based pharmaceutical company announced on Monday that its breast cancer drug Enhertu showed positive results in a phase-three trial. Shares of the company were up more than 1% in premarket trading.\n7) ARK Innovation ETF — Cathie Wood’s ARK Innovation ETF is down 2.75% in the premarket, on pace to snap a 3-day winning streak. Compugen, DraftKings, Coinbase and Square are so of the ETF’s biggest losers this morning.\nSome investors believe this is just normal market action that can occur in September.\n“The reasons for drop this morning are the same as last week: China concerns (Evergrande, regulation, COVID), Fed tapering and possible tax hikes, but nothing new occurred this weekend to justify this mornings’ declines,” Tom Essaye, founder of Sevens Report, said in a note.\nOther risky assets declined on Monday.Bitcoinlost 8% tobelow $44,000.\nMost commodities were in the red.Goldwas among the few assets in the green, adding 0.5% to $1,760.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":1870,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882456885,"gmtCreate":1631716409847,"gmtModify":1676530617288,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"//<a href=\"https://laohu8.com/U/3578668729356671\">@ssw04104</a>: Hi","listText":"//<a href=\"https://laohu8.com/U/3578668729356671\">@ssw04104</a>: Hi","text":"//@ssw04104: Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/882456885","repostId":"1195655593","repostType":4,"repost":{"id":"1195655593","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631712759,"share":"https://ttm.financial/m/news/1195655593?lang=&edition=full_marsco","pubTime":"2021-09-15 21:32","market":"us","language":"en","title":"Stock market opens slightly higher Wednesday, with Dow lagging peer benchmarks","url":"https://stock-news.laohu8.com/highlight/detail?id=1195655593","media":"Tiger Newspress","summary":"The S&P 500 rebounded slightly Wednesday after the stock average closed Tuesday at the lowest level since Aug. 20, the latest in a string of negative trading sessions this September.The major index traded ticked up 0.2%. The Dow Jones Industrial Average traded near the flatline. The Nasdaq Composite inched 0.2% higher.Some bullish economic news released before the bell Wednesday helped sooth investor sentiment. The NY Fed's Empire Index, a measure of manufacturing in the region came in at 34.3 f","content":"<p>The S&amp;P 500 rebounded slightly Wednesday after the stock average closed Tuesday at the lowest level since Aug. 20, the latest in a string of negative trading sessions this September.</p>\n<p>The major index traded ticked up 0.2%. The Dow Jones Industrial Average traded near the flatline. The Nasdaq Composite inched 0.2% higher.</p>\n<p><img src=\"https://static.tigerbbs.com/14cfdae0b249c0e62fb230f3b2b5b05d\" tg-width=\"1061\" tg-height=\"419\" referrerpolicy=\"no-referrer\"></p>\n<p>Some bullish economic news released before the bell Wednesday helped sooth investor sentiment. The NY Fed's Empire Index, a measure of manufacturing in the region came in at 34.3 for September, way ahead of the 18 consensus estimate from FactSet and an acceleration from August.</p>\n<p>Markets have been in a funk so far this month amid rising investor worries about the delta variant derailing the economic recovery, along with hand-wringing over the next action by the Federal Reserve.</p>\n<p>Tuesday marked the fifth straight day of losses for the Nasdaq. The Dow, S&amp;P 500 and the small-cap Russell 2000 index have been in the red for six of the last seven days.</p>\n<p>\"Despite concerns about the recent downshift in economic and business cycle momentum, we remain confident that strong growth lies ahead and activity is bound to re-accelerate,\" wrote JPMorgan strategist Dubravko Lakos-Bujas, in a note Wednesday. \"We remain positive on the equity outlook, and expect S&amp;P 500 to reach 4,700 by end of this year and surpass 5,000 next year on better than expected earnings.\"</p>\n<p>Microsoft shares gained more than 1% in premarket trading after announcing a dividend increase and a sizable $60 billion share repurchase program.</p>\n<p>Energy stocks, which have been popular bets among investors banking on a big economic recovery, gained&nbsp;as WTI crude topped $71. Exxon added about 1%.</p>\n<p>Apple shares rebounded slightly&nbsp;after the shares fell Tuesday after the&nbsp;unveiling of a new iPhone and other products.</p>\n<p>Casino stocks like Las Vegas Sands and Wynn Resorts traded in the red again. Those names took a big hit Tuesday as the government of Macau looks to increase regulatory scrutiny over casinos and Chinese health authorities reported a Covid-19 outbreak.</p>\n<p>In regular trading Tuesday, the Dow fell 292.06 points, or 0.8%, to 34,577.57, retreating after it snapped a five-day losing streak on Monday. The S&amp;P 500 lost 0.6% to finish at 4,443.05 and the Nasdaq Composite slipped 0.5% to 15,037.76.</p>\n<p>September hashistorically been a down monthfor the markets, which have seen an average decline of 0.56% in the month since 1945, according to CFRA. And after eight months of straight gains, strategists say a major pullback could be imminent.</p>\n<p>For September, the Dow is off by more than 2% and the S&amp;P 500 is off 1.8%. The S&amp;P 500 is on track to see its worth monthly performance since October 2020.</p>\n<p>The S&amp;P 500 has continued to move higher throughout the year, dipping below the 50-day moving average only once, according to Fundstrat. Mike Wilson, chief investment officer at Morgan Stanley, told CNBC’s “Fast Money” that could be just the beginning.</p>\n<p>“The midcycle transition always ends with a correction in the index,” he said of the S&amp;P 500. “Maybe it’ll be this week, maybe a month from now. I don’t think we’ll get done with this year, however, with that 50-day moving average holding up throughout the year because that’s the pattern we typically see in this part of the recovery phase.”</p>\n<p>On Tuesday the Labor Department released data before the bell&nbsp;showing a smaller-than-expected rise in U.S. inflation&nbsp;for the month of August. Consumer prices rose 5.3% from a year ago and 0.3% from July. Stripping out food and energy, the consumer price index was up just 0.1% for the month.</p>\n<p>Initially, markets rallied but turned back down after the market open as uncertainty about the timing of the Federal Reserve’s tapering of asset purchases settled in.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock market opens slightly higher Wednesday, with Dow lagging peer benchmarks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock market opens slightly higher Wednesday, with Dow lagging peer benchmarks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-15 21:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The S&amp;P 500 rebounded slightly Wednesday after the stock average closed Tuesday at the lowest level since Aug. 20, the latest in a string of negative trading sessions this September.</p>\n<p>The major index traded ticked up 0.2%. The Dow Jones Industrial Average traded near the flatline. The Nasdaq Composite inched 0.2% higher.</p>\n<p><img src=\"https://static.tigerbbs.com/14cfdae0b249c0e62fb230f3b2b5b05d\" tg-width=\"1061\" tg-height=\"419\" referrerpolicy=\"no-referrer\"></p>\n<p>Some bullish economic news released before the bell Wednesday helped sooth investor sentiment. The NY Fed's Empire Index, a measure of manufacturing in the region came in at 34.3 for September, way ahead of the 18 consensus estimate from FactSet and an acceleration from August.</p>\n<p>Markets have been in a funk so far this month amid rising investor worries about the delta variant derailing the economic recovery, along with hand-wringing over the next action by the Federal Reserve.</p>\n<p>Tuesday marked the fifth straight day of losses for the Nasdaq. The Dow, S&amp;P 500 and the small-cap Russell 2000 index have been in the red for six of the last seven days.</p>\n<p>\"Despite concerns about the recent downshift in economic and business cycle momentum, we remain confident that strong growth lies ahead and activity is bound to re-accelerate,\" wrote JPMorgan strategist Dubravko Lakos-Bujas, in a note Wednesday. \"We remain positive on the equity outlook, and expect S&amp;P 500 to reach 4,700 by end of this year and surpass 5,000 next year on better than expected earnings.\"</p>\n<p>Microsoft shares gained more than 1% in premarket trading after announcing a dividend increase and a sizable $60 billion share repurchase program.</p>\n<p>Energy stocks, which have been popular bets among investors banking on a big economic recovery, gained&nbsp;as WTI crude topped $71. Exxon added about 1%.</p>\n<p>Apple shares rebounded slightly&nbsp;after the shares fell Tuesday after the&nbsp;unveiling of a new iPhone and other products.</p>\n<p>Casino stocks like Las Vegas Sands and Wynn Resorts traded in the red again. Those names took a big hit Tuesday as the government of Macau looks to increase regulatory scrutiny over casinos and Chinese health authorities reported a Covid-19 outbreak.</p>\n<p>In regular trading Tuesday, the Dow fell 292.06 points, or 0.8%, to 34,577.57, retreating after it snapped a five-day losing streak on Monday. The S&amp;P 500 lost 0.6% to finish at 4,443.05 and the Nasdaq Composite slipped 0.5% to 15,037.76.</p>\n<p>September hashistorically been a down monthfor the markets, which have seen an average decline of 0.56% in the month since 1945, according to CFRA. And after eight months of straight gains, strategists say a major pullback could be imminent.</p>\n<p>For September, the Dow is off by more than 2% and the S&amp;P 500 is off 1.8%. The S&amp;P 500 is on track to see its worth monthly performance since October 2020.</p>\n<p>The S&amp;P 500 has continued to move higher throughout the year, dipping below the 50-day moving average only once, according to Fundstrat. Mike Wilson, chief investment officer at Morgan Stanley, told CNBC’s “Fast Money” that could be just the beginning.</p>\n<p>“The midcycle transition always ends with a correction in the index,” he said of the S&amp;P 500. “Maybe it’ll be this week, maybe a month from now. I don’t think we’ll get done with this year, however, with that 50-day moving average holding up throughout the year because that’s the pattern we typically see in this part of the recovery phase.”</p>\n<p>On Tuesday the Labor Department released data before the bell&nbsp;showing a smaller-than-expected rise in U.S. inflation&nbsp;for the month of August. Consumer prices rose 5.3% from a year ago and 0.3% from July. Stripping out food and energy, the consumer price index was up just 0.1% for the month.</p>\n<p>Initially, markets rallied but turned back down after the market open as uncertainty about the timing of the Federal Reserve’s tapering of asset purchases settled in.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195655593","content_text":"The S&P 500 rebounded slightly Wednesday after the stock average closed Tuesday at the lowest level since Aug. 20, the latest in a string of negative trading sessions this September.\nThe major index traded ticked up 0.2%. The Dow Jones Industrial Average traded near the flatline. The Nasdaq Composite inched 0.2% higher.\n\nSome bullish economic news released before the bell Wednesday helped sooth investor sentiment. The NY Fed's Empire Index, a measure of manufacturing in the region came in at 34.3 for September, way ahead of the 18 consensus estimate from FactSet and an acceleration from August.\nMarkets have been in a funk so far this month amid rising investor worries about the delta variant derailing the economic recovery, along with hand-wringing over the next action by the Federal Reserve.\nTuesday marked the fifth straight day of losses for the Nasdaq. The Dow, S&P 500 and the small-cap Russell 2000 index have been in the red for six of the last seven days.\n\"Despite concerns about the recent downshift in economic and business cycle momentum, we remain confident that strong growth lies ahead and activity is bound to re-accelerate,\" wrote JPMorgan strategist Dubravko Lakos-Bujas, in a note Wednesday. \"We remain positive on the equity outlook, and expect S&P 500 to reach 4,700 by end of this year and surpass 5,000 next year on better than expected earnings.\"\nMicrosoft shares gained more than 1% in premarket trading after announcing a dividend increase and a sizable $60 billion share repurchase program.\nEnergy stocks, which have been popular bets among investors banking on a big economic recovery, gained as WTI crude topped $71. Exxon added about 1%.\nApple shares rebounded slightly after the shares fell Tuesday after the unveiling of a new iPhone and other products.\nCasino stocks like Las Vegas Sands and Wynn Resorts traded in the red again. Those names took a big hit Tuesday as the government of Macau looks to increase regulatory scrutiny over casinos and Chinese health authorities reported a Covid-19 outbreak.\nIn regular trading Tuesday, the Dow fell 292.06 points, or 0.8%, to 34,577.57, retreating after it snapped a five-day losing streak on Monday. The S&P 500 lost 0.6% to finish at 4,443.05 and the Nasdaq Composite slipped 0.5% to 15,037.76.\nSeptember hashistorically been a down monthfor the markets, which have seen an average decline of 0.56% in the month since 1945, according to CFRA. And after eight months of straight gains, strategists say a major pullback could be imminent.\nFor September, the Dow is off by more than 2% and the S&P 500 is off 1.8%. The S&P 500 is on track to see its worth monthly performance since October 2020.\nThe S&P 500 has continued to move higher throughout the year, dipping below the 50-day moving average only once, according to Fundstrat. Mike Wilson, chief investment officer at Morgan Stanley, told CNBC’s “Fast Money” that could be just the beginning.\n“The midcycle transition always ends with a correction in the index,” he said of the S&P 500. “Maybe it’ll be this week, maybe a month from now. I don’t think we’ll get done with this year, however, with that 50-day moving average holding up throughout the year because that’s the pattern we typically see in this part of the recovery phase.”\nOn Tuesday the Labor Department released data before the bell showing a smaller-than-expected rise in U.S. inflation for the month of August. Consumer prices rose 5.3% from a year ago and 0.3% from July. Stripping out food and energy, the consumer price index was up just 0.1% for the month.\nInitially, markets rallied but turned back down after the market open as uncertainty about the timing of the Federal Reserve’s tapering of asset purchases settled in.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":1238,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":882456974,"gmtCreate":1631716396598,"gmtModify":1676530617288,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/882456974","repostId":"1195655593","repostType":4,"repost":{"id":"1195655593","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631712759,"share":"https://ttm.financial/m/news/1195655593?lang=&edition=full_marsco","pubTime":"2021-09-15 21:32","market":"us","language":"en","title":"Stock market opens slightly higher Wednesday, with Dow lagging peer benchmarks","url":"https://stock-news.laohu8.com/highlight/detail?id=1195655593","media":"Tiger Newspress","summary":"The S&P 500 rebounded slightly Wednesday after the stock average closed Tuesday at the lowest level since Aug. 20, the latest in a string of negative trading sessions this September.The major index traded ticked up 0.2%. The Dow Jones Industrial Average traded near the flatline. The Nasdaq Composite inched 0.2% higher.Some bullish economic news released before the bell Wednesday helped sooth investor sentiment. The NY Fed's Empire Index, a measure of manufacturing in the region came in at 34.3 f","content":"<p>The S&amp;P 500 rebounded slightly Wednesday after the stock average closed Tuesday at the lowest level since Aug. 20, the latest in a string of negative trading sessions this September.</p>\n<p>The major index traded ticked up 0.2%. The Dow Jones Industrial Average traded near the flatline. The Nasdaq Composite inched 0.2% higher.</p>\n<p><img src=\"https://static.tigerbbs.com/14cfdae0b249c0e62fb230f3b2b5b05d\" tg-width=\"1061\" tg-height=\"419\" referrerpolicy=\"no-referrer\"></p>\n<p>Some bullish economic news released before the bell Wednesday helped sooth investor sentiment. The NY Fed's Empire Index, a measure of manufacturing in the region came in at 34.3 for September, way ahead of the 18 consensus estimate from FactSet and an acceleration from August.</p>\n<p>Markets have been in a funk so far this month amid rising investor worries about the delta variant derailing the economic recovery, along with hand-wringing over the next action by the Federal Reserve.</p>\n<p>Tuesday marked the fifth straight day of losses for the Nasdaq. The Dow, S&amp;P 500 and the small-cap Russell 2000 index have been in the red for six of the last seven days.</p>\n<p>\"Despite concerns about the recent downshift in economic and business cycle momentum, we remain confident that strong growth lies ahead and activity is bound to re-accelerate,\" wrote JPMorgan strategist Dubravko Lakos-Bujas, in a note Wednesday. \"We remain positive on the equity outlook, and expect S&amp;P 500 to reach 4,700 by end of this year and surpass 5,000 next year on better than expected earnings.\"</p>\n<p>Microsoft shares gained more than 1% in premarket trading after announcing a dividend increase and a sizable $60 billion share repurchase program.</p>\n<p>Energy stocks, which have been popular bets among investors banking on a big economic recovery, gained&nbsp;as WTI crude topped $71. Exxon added about 1%.</p>\n<p>Apple shares rebounded slightly&nbsp;after the shares fell Tuesday after the&nbsp;unveiling of a new iPhone and other products.</p>\n<p>Casino stocks like Las Vegas Sands and Wynn Resorts traded in the red again. Those names took a big hit Tuesday as the government of Macau looks to increase regulatory scrutiny over casinos and Chinese health authorities reported a Covid-19 outbreak.</p>\n<p>In regular trading Tuesday, the Dow fell 292.06 points, or 0.8%, to 34,577.57, retreating after it snapped a five-day losing streak on Monday. The S&amp;P 500 lost 0.6% to finish at 4,443.05 and the Nasdaq Composite slipped 0.5% to 15,037.76.</p>\n<p>September hashistorically been a down monthfor the markets, which have seen an average decline of 0.56% in the month since 1945, according to CFRA. And after eight months of straight gains, strategists say a major pullback could be imminent.</p>\n<p>For September, the Dow is off by more than 2% and the S&amp;P 500 is off 1.8%. The S&amp;P 500 is on track to see its worth monthly performance since October 2020.</p>\n<p>The S&amp;P 500 has continued to move higher throughout the year, dipping below the 50-day moving average only once, according to Fundstrat. Mike Wilson, chief investment officer at Morgan Stanley, told CNBC’s “Fast Money” that could be just the beginning.</p>\n<p>“The midcycle transition always ends with a correction in the index,” he said of the S&amp;P 500. “Maybe it’ll be this week, maybe a month from now. I don’t think we’ll get done with this year, however, with that 50-day moving average holding up throughout the year because that’s the pattern we typically see in this part of the recovery phase.”</p>\n<p>On Tuesday the Labor Department released data before the bell&nbsp;showing a smaller-than-expected rise in U.S. inflation&nbsp;for the month of August. Consumer prices rose 5.3% from a year ago and 0.3% from July. Stripping out food and energy, the consumer price index was up just 0.1% for the month.</p>\n<p>Initially, markets rallied but turned back down after the market open as uncertainty about the timing of the Federal Reserve’s tapering of asset purchases settled in.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock market opens slightly higher Wednesday, with Dow lagging peer benchmarks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock market opens slightly higher Wednesday, with Dow lagging peer benchmarks\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-15 21:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>The S&amp;P 500 rebounded slightly Wednesday after the stock average closed Tuesday at the lowest level since Aug. 20, the latest in a string of negative trading sessions this September.</p>\n<p>The major index traded ticked up 0.2%. The Dow Jones Industrial Average traded near the flatline. The Nasdaq Composite inched 0.2% higher.</p>\n<p><img src=\"https://static.tigerbbs.com/14cfdae0b249c0e62fb230f3b2b5b05d\" tg-width=\"1061\" tg-height=\"419\" referrerpolicy=\"no-referrer\"></p>\n<p>Some bullish economic news released before the bell Wednesday helped sooth investor sentiment. The NY Fed's Empire Index, a measure of manufacturing in the region came in at 34.3 for September, way ahead of the 18 consensus estimate from FactSet and an acceleration from August.</p>\n<p>Markets have been in a funk so far this month amid rising investor worries about the delta variant derailing the economic recovery, along with hand-wringing over the next action by the Federal Reserve.</p>\n<p>Tuesday marked the fifth straight day of losses for the Nasdaq. The Dow, S&amp;P 500 and the small-cap Russell 2000 index have been in the red for six of the last seven days.</p>\n<p>\"Despite concerns about the recent downshift in economic and business cycle momentum, we remain confident that strong growth lies ahead and activity is bound to re-accelerate,\" wrote JPMorgan strategist Dubravko Lakos-Bujas, in a note Wednesday. \"We remain positive on the equity outlook, and expect S&amp;P 500 to reach 4,700 by end of this year and surpass 5,000 next year on better than expected earnings.\"</p>\n<p>Microsoft shares gained more than 1% in premarket trading after announcing a dividend increase and a sizable $60 billion share repurchase program.</p>\n<p>Energy stocks, which have been popular bets among investors banking on a big economic recovery, gained&nbsp;as WTI crude topped $71. Exxon added about 1%.</p>\n<p>Apple shares rebounded slightly&nbsp;after the shares fell Tuesday after the&nbsp;unveiling of a new iPhone and other products.</p>\n<p>Casino stocks like Las Vegas Sands and Wynn Resorts traded in the red again. Those names took a big hit Tuesday as the government of Macau looks to increase regulatory scrutiny over casinos and Chinese health authorities reported a Covid-19 outbreak.</p>\n<p>In regular trading Tuesday, the Dow fell 292.06 points, or 0.8%, to 34,577.57, retreating after it snapped a five-day losing streak on Monday. The S&amp;P 500 lost 0.6% to finish at 4,443.05 and the Nasdaq Composite slipped 0.5% to 15,037.76.</p>\n<p>September hashistorically been a down monthfor the markets, which have seen an average decline of 0.56% in the month since 1945, according to CFRA. And after eight months of straight gains, strategists say a major pullback could be imminent.</p>\n<p>For September, the Dow is off by more than 2% and the S&amp;P 500 is off 1.8%. The S&amp;P 500 is on track to see its worth monthly performance since October 2020.</p>\n<p>The S&amp;P 500 has continued to move higher throughout the year, dipping below the 50-day moving average only once, according to Fundstrat. Mike Wilson, chief investment officer at Morgan Stanley, told CNBC’s “Fast Money” that could be just the beginning.</p>\n<p>“The midcycle transition always ends with a correction in the index,” he said of the S&amp;P 500. “Maybe it’ll be this week, maybe a month from now. I don’t think we’ll get done with this year, however, with that 50-day moving average holding up throughout the year because that’s the pattern we typically see in this part of the recovery phase.”</p>\n<p>On Tuesday the Labor Department released data before the bell&nbsp;showing a smaller-than-expected rise in U.S. inflation&nbsp;for the month of August. Consumer prices rose 5.3% from a year ago and 0.3% from July. Stripping out food and energy, the consumer price index was up just 0.1% for the month.</p>\n<p>Initially, markets rallied but turned back down after the market open as uncertainty about the timing of the Federal Reserve’s tapering of asset purchases settled in.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195655593","content_text":"The S&P 500 rebounded slightly Wednesday after the stock average closed Tuesday at the lowest level since Aug. 20, the latest in a string of negative trading sessions this September.\nThe major index traded ticked up 0.2%. The Dow Jones Industrial Average traded near the flatline. The Nasdaq Composite inched 0.2% higher.\n\nSome bullish economic news released before the bell Wednesday helped sooth investor sentiment. The NY Fed's Empire Index, a measure of manufacturing in the region came in at 34.3 for September, way ahead of the 18 consensus estimate from FactSet and an acceleration from August.\nMarkets have been in a funk so far this month amid rising investor worries about the delta variant derailing the economic recovery, along with hand-wringing over the next action by the Federal Reserve.\nTuesday marked the fifth straight day of losses for the Nasdaq. The Dow, S&P 500 and the small-cap Russell 2000 index have been in the red for six of the last seven days.\n\"Despite concerns about the recent downshift in economic and business cycle momentum, we remain confident that strong growth lies ahead and activity is bound to re-accelerate,\" wrote JPMorgan strategist Dubravko Lakos-Bujas, in a note Wednesday. \"We remain positive on the equity outlook, and expect S&P 500 to reach 4,700 by end of this year and surpass 5,000 next year on better than expected earnings.\"\nMicrosoft shares gained more than 1% in premarket trading after announcing a dividend increase and a sizable $60 billion share repurchase program.\nEnergy stocks, which have been popular bets among investors banking on a big economic recovery, gained as WTI crude topped $71. Exxon added about 1%.\nApple shares rebounded slightly after the shares fell Tuesday after the unveiling of a new iPhone and other products.\nCasino stocks like Las Vegas Sands and Wynn Resorts traded in the red again. Those names took a big hit Tuesday as the government of Macau looks to increase regulatory scrutiny over casinos and Chinese health authorities reported a Covid-19 outbreak.\nIn regular trading Tuesday, the Dow fell 292.06 points, or 0.8%, to 34,577.57, retreating after it snapped a five-day losing streak on Monday. The S&P 500 lost 0.6% to finish at 4,443.05 and the Nasdaq Composite slipped 0.5% to 15,037.76.\nSeptember hashistorically been a down monthfor the markets, which have seen an average decline of 0.56% in the month since 1945, according to CFRA. And after eight months of straight gains, strategists say a major pullback could be imminent.\nFor September, the Dow is off by more than 2% and the S&P 500 is off 1.8%. The S&P 500 is on track to see its worth monthly performance since October 2020.\nThe S&P 500 has continued to move higher throughout the year, dipping below the 50-day moving average only once, according to Fundstrat. Mike Wilson, chief investment officer at Morgan Stanley, told CNBC’s “Fast Money” that could be just the beginning.\n“The midcycle transition always ends with a correction in the index,” he said of the S&P 500. “Maybe it’ll be this week, maybe a month from now. I don’t think we’ll get done with this year, however, with that 50-day moving average holding up throughout the year because that’s the pattern we typically see in this part of the recovery phase.”\nOn Tuesday the Labor Department released data before the bell showing a smaller-than-expected rise in U.S. inflation for the month of August. Consumer prices rose 5.3% from a year ago and 0.3% from July. Stripping out food and energy, the consumer price index was up just 0.1% for the month.\nInitially, markets rallied but turned back down after the market open as uncertainty about the timing of the Federal Reserve’s tapering of asset purchases settled in.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":1867,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":886038032,"gmtCreate":1631536981126,"gmtModify":1676530568891,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/886038032","repostId":"1129341543","repostType":4,"repost":{"id":"1129341543","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631534652,"share":"https://ttm.financial/m/news/1129341543?lang=&edition=full_marsco","pubTime":"2021-09-13 20:04","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1129341543","media":"Tiger Newspress","summary":"U.S. stock index futures rose on Monday after the S&P 500 logged its worst week in more than two mon","content":"<p>U.S. stock index futures rose on Monday after the S&amp;P 500 logged its worst week in more than two months, with investors keeping a close eye on inflation as well as monetary and tax policies.</p>\n<p>S&amp;P 500 E-minis were up 23.25 points, or 0.52% at 08:00 am ET. Dow E-minis were up 183 points, or 0.53%, while Nasdaq 100 E-minis were up 75 points, or 0.49%.</p>\n<p><img src=\"https://static.tigerbbs.com/2d51dd22d532e1b98f0ecae05c1f7a3e\" tg-width=\"1080\" tg-height=\"416\" width=\"100%\" height=\"auto\"></p>\n<p>Apple Inc rose 0.9% in premarket trading after a mixed court ruling in Epic Games’ antitrust case against the iPhone maker knocked nearly $90 billion off its market value on Friday.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Virgin Galactic(SPCE)</b> – Virgin Galactic is delaying its first commercial research space mission after a third-party supplier warned of a potential defect in a component of the flight control system. Virgin Galactic shares slid 3.3% in the premarket.</p>\n<p><b>Dell Technologies(DELL) </b>– Dell added 1.9% in premarket action after Goldman Sachs added the computer maker’s stock to its “Conviction Buy” list. Goldman cited strong cash flow generation and debt paydown plans, among other factors.</p>\n<p><b>TransUnion(TRU)</b> – TransUnion announced a deal to buy closely held information services company Neustar for $3.1 billion in cash. The credit reporting agency expects the deal to close during the fourth quarter.</p>\n<p><b>Viacom(VIAC) </b>– Viacom is planning a revamp of its Paramount Pictures unit, according to people familiar with the matter who spoke to The Wall Street Journal. The revamp, which would separate the TV and film operations, could be announced as soon as today. Viacom rose 1% in the premarket.</p>\n<p><b>Kansas City Southern(KSU)</b> – Kansas City Southern said&nbsp;the latest takeover bid&nbsp;from&nbsp;Canadian Pacific Railway(CP) is superior to the one it previously agreed to with&nbsp;Canadian National Railway(CNI). Canadian National now has five days to improve its offer, should it choose to do so. Canadian Pacific rallied 0.9% in premarket trading.</p>\n<p><b>Walt Disney(DIS)</b> – Disney will show the remainder of its 2021 movie releases exclusively in theaters, rather than making them simultaneously available on its Disney+ streaming service. Disney’s “Shang-Chi and the Legend of the 10 Rings” topped the weekend box office once again following its record Labor Day weekend performance, with that movie showing exclusively in theaters.</p>\n<p><b>Alibaba(BABA)</b> – Alibaba fell 1.7% in premarket action.</p>\n<p><b>Apple(AAPL)</b> – Epic Games will appeal Friday’s ruling that Apple’s app store was not an illegal monopoly. Epic did win a partial victory in the case, with the judge ruling that Apple must allow developers to include external payment links.</p>\n<p><b>Carlyle Group(CG)</b> – Carlyle is considering a $6 billion sale or initial public offering for packaging company Novolex, according to a Bloomberg report. The private-equity firm bought Novolex for an undisclosed amount in November 2016.</p>\n<p><b>MGM Resorts(MGM)</b> – MGM rose 1.5% in the premarket after Bernstein upgraded the resort operator’s stock to “outperform” from “market perform,” citing its strong presence in the gaming and sports betting industry as well as moves to divest the company’s real estate portfolio.</p>\n<p><b>Pfizer(PFE) </b>– Pfizer’s Covid-19 vaccine – developed in conjunction with German partner&nbsp;BioNTech(BNTX) – could be authorized for use in children aged 5-11 as soon as next month, according to two sources familiar with the situation who spoke to Reuters. Pfizer is expected to have enough study data by then to submit an application for emergency use authorization to the Food and Drug Administration. BioNTech added 1.1% in premarket trading.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-13 20:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures rose on Monday after the S&amp;P 500 logged its worst week in more than two months, with investors keeping a close eye on inflation as well as monetary and tax policies.</p>\n<p>S&amp;P 500 E-minis were up 23.25 points, or 0.52% at 08:00 am ET. Dow E-minis were up 183 points, or 0.53%, while Nasdaq 100 E-minis were up 75 points, or 0.49%.</p>\n<p><img src=\"https://static.tigerbbs.com/2d51dd22d532e1b98f0ecae05c1f7a3e\" tg-width=\"1080\" tg-height=\"416\" width=\"100%\" height=\"auto\"></p>\n<p>Apple Inc rose 0.9% in premarket trading after a mixed court ruling in Epic Games’ antitrust case against the iPhone maker knocked nearly $90 billion off its market value on Friday.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Virgin Galactic(SPCE)</b> – Virgin Galactic is delaying its first commercial research space mission after a third-party supplier warned of a potential defect in a component of the flight control system. Virgin Galactic shares slid 3.3% in the premarket.</p>\n<p><b>Dell Technologies(DELL) </b>– Dell added 1.9% in premarket action after Goldman Sachs added the computer maker’s stock to its “Conviction Buy” list. Goldman cited strong cash flow generation and debt paydown plans, among other factors.</p>\n<p><b>TransUnion(TRU)</b> – TransUnion announced a deal to buy closely held information services company Neustar for $3.1 billion in cash. The credit reporting agency expects the deal to close during the fourth quarter.</p>\n<p><b>Viacom(VIAC) </b>– Viacom is planning a revamp of its Paramount Pictures unit, according to people familiar with the matter who spoke to The Wall Street Journal. The revamp, which would separate the TV and film operations, could be announced as soon as today. Viacom rose 1% in the premarket.</p>\n<p><b>Kansas City Southern(KSU)</b> – Kansas City Southern said&nbsp;the latest takeover bid&nbsp;from&nbsp;Canadian Pacific Railway(CP) is superior to the one it previously agreed to with&nbsp;Canadian National Railway(CNI). Canadian National now has five days to improve its offer, should it choose to do so. Canadian Pacific rallied 0.9% in premarket trading.</p>\n<p><b>Walt Disney(DIS)</b> – Disney will show the remainder of its 2021 movie releases exclusively in theaters, rather than making them simultaneously available on its Disney+ streaming service. Disney’s “Shang-Chi and the Legend of the 10 Rings” topped the weekend box office once again following its record Labor Day weekend performance, with that movie showing exclusively in theaters.</p>\n<p><b>Alibaba(BABA)</b> – Alibaba fell 1.7% in premarket action.</p>\n<p><b>Apple(AAPL)</b> – Epic Games will appeal Friday’s ruling that Apple’s app store was not an illegal monopoly. Epic did win a partial victory in the case, with the judge ruling that Apple must allow developers to include external payment links.</p>\n<p><b>Carlyle Group(CG)</b> – Carlyle is considering a $6 billion sale or initial public offering for packaging company Novolex, according to a Bloomberg report. The private-equity firm bought Novolex for an undisclosed amount in November 2016.</p>\n<p><b>MGM Resorts(MGM)</b> – MGM rose 1.5% in the premarket after Bernstein upgraded the resort operator’s stock to “outperform” from “market perform,” citing its strong presence in the gaming and sports betting industry as well as moves to divest the company’s real estate portfolio.</p>\n<p><b>Pfizer(PFE) </b>– Pfizer’s Covid-19 vaccine – developed in conjunction with German partner&nbsp;BioNTech(BNTX) – could be authorized for use in children aged 5-11 as soon as next month, according to two sources familiar with the situation who spoke to Reuters. Pfizer is expected to have enough study data by then to submit an application for emergency use authorization to the Food and Drug Administration. BioNTech added 1.1% in premarket trading.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","DIS":"迪士尼","AAPL":"苹果",".IXIC":"NASDAQ Composite","BABA":"阿里巴巴","MGM":"美高梅","CG":"凯雷","TRU":"TransUnion","PFE":"辉瑞",".SPX":"S&P 500 Index",".DJI":"道琼斯","KSU":"堪萨斯南方铁路","DELL":"戴尔","SPCE":"维珍银河"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129341543","content_text":"U.S. stock index futures rose on Monday after the S&P 500 logged its worst week in more than two months, with investors keeping a close eye on inflation as well as monetary and tax policies.\nS&P 500 E-minis were up 23.25 points, or 0.52% at 08:00 am ET. Dow E-minis were up 183 points, or 0.53%, while Nasdaq 100 E-minis were up 75 points, or 0.49%.\n\nApple Inc rose 0.9% in premarket trading after a mixed court ruling in Epic Games’ antitrust case against the iPhone maker knocked nearly $90 billion off its market value on Friday.\nStocks making the biggest moves in the premarket:\nVirgin Galactic(SPCE) – Virgin Galactic is delaying its first commercial research space mission after a third-party supplier warned of a potential defect in a component of the flight control system. Virgin Galactic shares slid 3.3% in the premarket.\nDell Technologies(DELL) – Dell added 1.9% in premarket action after Goldman Sachs added the computer maker’s stock to its “Conviction Buy” list. Goldman cited strong cash flow generation and debt paydown plans, among other factors.\nTransUnion(TRU) – TransUnion announced a deal to buy closely held information services company Neustar for $3.1 billion in cash. The credit reporting agency expects the deal to close during the fourth quarter.\nViacom(VIAC) – Viacom is planning a revamp of its Paramount Pictures unit, according to people familiar with the matter who spoke to The Wall Street Journal. The revamp, which would separate the TV and film operations, could be announced as soon as today. Viacom rose 1% in the premarket.\nKansas City Southern(KSU) – Kansas City Southern said the latest takeover bid from Canadian Pacific Railway(CP) is superior to the one it previously agreed to with Canadian National Railway(CNI). Canadian National now has five days to improve its offer, should it choose to do so. Canadian Pacific rallied 0.9% in premarket trading.\nWalt Disney(DIS) – Disney will show the remainder of its 2021 movie releases exclusively in theaters, rather than making them simultaneously available on its Disney+ streaming service. Disney’s “Shang-Chi and the Legend of the 10 Rings” topped the weekend box office once again following its record Labor Day weekend performance, with that movie showing exclusively in theaters.\nAlibaba(BABA) – Alibaba fell 1.7% in premarket action.\nApple(AAPL) – Epic Games will appeal Friday’s ruling that Apple’s app store was not an illegal monopoly. Epic did win a partial victory in the case, with the judge ruling that Apple must allow developers to include external payment links.\nCarlyle Group(CG) – Carlyle is considering a $6 billion sale or initial public offering for packaging company Novolex, according to a Bloomberg report. The private-equity firm bought Novolex for an undisclosed amount in November 2016.\nMGM Resorts(MGM) – MGM rose 1.5% in the premarket after Bernstein upgraded the resort operator’s stock to “outperform” from “market perform,” citing its strong presence in the gaming and sports betting industry as well as moves to divest the company’s real estate portfolio.\nPfizer(PFE) – Pfizer’s Covid-19 vaccine – developed in conjunction with German partner BioNTech(BNTX) – could be authorized for use in children aged 5-11 as soon as next month, according to two sources familiar with the situation who spoke to Reuters. Pfizer is expected to have enough study data by then to submit an application for emergency use authorization to the Food and Drug Administration. BioNTech added 1.1% in premarket trading.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AAPL":0.9,"BABA":0.9,"BNTX":0.9,"CG":0.9,"DELL":0.9,"DIS":0.9,"ESmain":0.9,"NQmain":0.9,"YMmain":0.9,"KSU":0.9,"MGM":0.9,"PFE":0.9,"SPCE":0.9,"TRU":0.9,"VIAC":0.9}},"isVote":1,"tweetType":1,"viewCount":1611,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888142430,"gmtCreate":1631463678720,"gmtModify":1676530551941,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/888142430","repostId":"1147481023","repostType":4,"repost":{"id":"1147481023","kind":"news","pubTimestamp":1631408592,"share":"https://ttm.financial/m/news/1147481023?lang=&edition=full_marsco","pubTime":"2021-09-12 09:03","market":"us","language":"en","title":"Cathie Wood's Latest Picks: 2 Stocks She Just Bought","url":"https://stock-news.laohu8.com/highlight/detail?id=1147481023","media":"Motley Fool","summary":"Wood is doubling down on these innovative tech companies.","content":"<p><b>Key Points</b></p>\n<ul>\n <li>The ARK Innovation ETF has beaten the market over the past one, three, and five years.</li>\n</ul>\n<p></p>\n<p>Fund manager Cathie Wood, the founder and CEO of ARK Invest, has earned a reputation as one of Wall Street's best stock pickers. And that reputation is well deserved. Over the past one, three, and five years, ARK's flagship&nbsp;<b>Innovation ETF</b>&nbsp;has crushed the broader market.</p>\n<p>Given that impressive track record, smart investors may want to keep tabs on what Wood is buying and selling. Recently, she added shares of&nbsp;<b>PagerDuty</b>(NYSE:PD)&nbsp;and&nbsp;<b>UiPath</b>(NYSE:PATH)&nbsp;to ARK's flagship ETF. Here's what you should know about these tech stocks.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e31513ae84b50946bda3a4867cf9aacc\" tg-width=\"2000\" tg-height=\"1087\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p>\n<p><b>1. PagerDuty</b></p>\n<p>PagerDuty is the central nervous system for the modern enterprise. Its platform sits at the center of a company's digital ecosystem, collecting data from virtually all systems and devices. Then, by blending those signals with artificial intelligence, PagerDuty helps its clients predict and prevent the downtime of critical services and technologies.</p>\n<p>For example, the PagerDuty platform captures data from application performance-monitoring tools such as&nbsp;<b>Datadog</b>, IT operations hubs such as&nbsp;<b>ServiceNow</b>, public clouds such as&nbsp;<b>Microsoft</b>Azure, customer service software such as&nbsp;<b>Salesforce.com</b>, and communications platforms such as&nbsp;<b>Zoom</b>. And when issues are identified, PagerDuty either triggers automatic remediation or alerts the appropriate people, helping them quickly resolve incidents such as website outages or system failures.</p>\n<p>As a pioneer in this industry, PagerDuty has 12 years' worth of data and more than 14,100 customers, both of which make the company's artificial-intelligence models more effective. And as new clients join the platform, PagerDuty's data repository will continue to grow, further reinforcing this advantage.</p>\n<p>Financially, the company has posted solid top-line growth over the past two years. Trailing-12-month revenue has increased from $142.7 million in the second quarter of 2020 to $244.2 million in Q2 of 2022, which ended July 31, with a compound annual growth rate (CAGR) of 31%.</p>\n<p>Investors should note that PagerDuty is still not profitable on a&nbsp;GAAP basis, and the company generated negative free cash flow of $6.4 million over the past 12 months. However, PagerDuty is still in the early stages of growing its business, and management believes the company has captured less than 1%&nbsp;of its market opportunity.</p>\n<p>Here's the bottom line: In an increasingly digital world, delivering a high-quality customer experience is not an option -- it's a necessity. And PagerDuty capitalizes on that fact, helping clients keep their digital ecosystems up and running at all times. Given Wood's focus on innovative technologies such as artificial intelligence, I'm not surprised to see her adding shares of this tech stock to ARK's portfolio.</p>\n<p><b>2. UiPath</b></p>\n<p>UiPath is on a mission to bring automation to every enterprise. To that end, its platform combines three cutting-edge technologies -- artificial intelligence, low-code development, and robotic process automation -- helping clients build, deploy, and manage software bots capable of automating various processes in place of human employees.</p>\n<p>To do this, UiPath's bots rely on several types of artificial intelligence, including computer vision, natural language processing, and machine learning. Together, these technologies infuse the bots with the ability to read and understand language, emulate human behavior, and make decisions. In turn, that allows them to automate both simple and complex tasks, such as reviewing emails, completing forms, and extracting data from documents.</p>\n<p>One of UiPath's greatest advantages is its partner ecosystem. The company provides prebuilt integrations with hundreds of popular technologies, including&nbsp;<b>Amazon</b>&nbsp;Web Services, Microsoft 365, and Salesforce, meaning clients can quickly automate workflows on these platforms.</p>\n<p>Because of the scope of the company's mission and its value proposition to clients, UiPath has grown its top line at an impressive pace. Its trailing-12-month revenue has grown from $451.2 million in the second quarter of 2021 to $736.9 million in Q2 of 2022, which ended July 31, for a CAGR of 63%.</p>\n<p>Like PagerDuty, UiPath is currently unprofitable on a GAAP basis and is free cash flow negative. But the company has established itself as the industry leader, according to&nbsp;<b>Forrester Research</b>, and it makes sense to reinforce that advantage by investing aggressively in growth. That's exactly what management is doing.</p>\n<p>Here's the bottom line: Automation drives efficiency and productivity by freeing human employees to spend their time on more important tasks, something that would benefit virtually every enterprise in the world. And UiPath has the best product on the market. That's why I'm not surprised to see Wood doubling down on this&nbsp;tech stock.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood's Latest Picks: 2 Stocks She Just Bought</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood's Latest Picks: 2 Stocks She Just Bought\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-12 09:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/11/cathie-woods-lastest-picks-2-hot-stocks-she-bought/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nThe ARK Innovation ETF has beaten the market over the past one, three, and five years.\n\n\nFund manager Cathie Wood, the founder and CEO of ARK Invest, has earned a reputation as one of Wall...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/11/cathie-woods-lastest-picks-2-hot-stocks-she-bought/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKG":"ARK Genomic Revolution ETF","ARKW":"ARK Next Generation Internet ETF","PD":"PagerDuty, Inc.","PATH":"UiPath","ARKK":"ARK Innovation ETF"},"source_url":"https://www.fool.com/investing/2021/09/11/cathie-woods-lastest-picks-2-hot-stocks-she-bought/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147481023","content_text":"Key Points\n\nThe ARK Innovation ETF has beaten the market over the past one, three, and five years.\n\n\nFund manager Cathie Wood, the founder and CEO of ARK Invest, has earned a reputation as one of Wall Street's best stock pickers. And that reputation is well deserved. Over the past one, three, and five years, ARK's flagship Innovation ETF has crushed the broader market.\nGiven that impressive track record, smart investors may want to keep tabs on what Wood is buying and selling. Recently, she added shares of PagerDuty(NYSE:PD) and UiPath(NYSE:PATH) to ARK's flagship ETF. Here's what you should know about these tech stocks.\nIMAGE SOURCE: GETTY IMAGES.\n1. PagerDuty\nPagerDuty is the central nervous system for the modern enterprise. Its platform sits at the center of a company's digital ecosystem, collecting data from virtually all systems and devices. Then, by blending those signals with artificial intelligence, PagerDuty helps its clients predict and prevent the downtime of critical services and technologies.\nFor example, the PagerDuty platform captures data from application performance-monitoring tools such as Datadog, IT operations hubs such as ServiceNow, public clouds such as MicrosoftAzure, customer service software such as Salesforce.com, and communications platforms such as Zoom. And when issues are identified, PagerDuty either triggers automatic remediation or alerts the appropriate people, helping them quickly resolve incidents such as website outages or system failures.\nAs a pioneer in this industry, PagerDuty has 12 years' worth of data and more than 14,100 customers, both of which make the company's artificial-intelligence models more effective. And as new clients join the platform, PagerDuty's data repository will continue to grow, further reinforcing this advantage.\nFinancially, the company has posted solid top-line growth over the past two years. Trailing-12-month revenue has increased from $142.7 million in the second quarter of 2020 to $244.2 million in Q2 of 2022, which ended July 31, with a compound annual growth rate (CAGR) of 31%.\nInvestors should note that PagerDuty is still not profitable on a GAAP basis, and the company generated negative free cash flow of $6.4 million over the past 12 months. However, PagerDuty is still in the early stages of growing its business, and management believes the company has captured less than 1% of its market opportunity.\nHere's the bottom line: In an increasingly digital world, delivering a high-quality customer experience is not an option -- it's a necessity. And PagerDuty capitalizes on that fact, helping clients keep their digital ecosystems up and running at all times. Given Wood's focus on innovative technologies such as artificial intelligence, I'm not surprised to see her adding shares of this tech stock to ARK's portfolio.\n2. UiPath\nUiPath is on a mission to bring automation to every enterprise. To that end, its platform combines three cutting-edge technologies -- artificial intelligence, low-code development, and robotic process automation -- helping clients build, deploy, and manage software bots capable of automating various processes in place of human employees.\nTo do this, UiPath's bots rely on several types of artificial intelligence, including computer vision, natural language processing, and machine learning. Together, these technologies infuse the bots with the ability to read and understand language, emulate human behavior, and make decisions. In turn, that allows them to automate both simple and complex tasks, such as reviewing emails, completing forms, and extracting data from documents.\nOne of UiPath's greatest advantages is its partner ecosystem. The company provides prebuilt integrations with hundreds of popular technologies, including Amazon Web Services, Microsoft 365, and Salesforce, meaning clients can quickly automate workflows on these platforms.\nBecause of the scope of the company's mission and its value proposition to clients, UiPath has grown its top line at an impressive pace. Its trailing-12-month revenue has grown from $451.2 million in the second quarter of 2021 to $736.9 million in Q2 of 2022, which ended July 31, for a CAGR of 63%.\nLike PagerDuty, UiPath is currently unprofitable on a GAAP basis and is free cash flow negative. But the company has established itself as the industry leader, according to Forrester Research, and it makes sense to reinforce that advantage by investing aggressively in growth. That's exactly what management is doing.\nHere's the bottom line: Automation drives efficiency and productivity by freeing human employees to spend their time on more important tasks, something that would benefit virtually every enterprise in the world. And UiPath has the best product on the market. That's why I'm not surprised to see Wood doubling down on this tech stock.","news_type":1,"symbols_score_info":{"ARKG":0.9,"ARKK":0.9,"ARKW":0.9,"PATH":0.9,"PD":0.9}},"isVote":1,"tweetType":1,"viewCount":1621,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881007403,"gmtCreate":1631279497902,"gmtModify":1676530517067,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/881007403","repostId":"1160544799","repostType":4,"isVote":1,"tweetType":1,"viewCount":1602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881007638,"gmtCreate":1631279475724,"gmtModify":1676530517059,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/881007638","repostId":"1197281775","repostType":4,"repost":{"id":"1197281775","kind":"news","pubTimestamp":1631276910,"share":"https://ttm.financial/m/news/1197281775?lang=&edition=full_marsco","pubTime":"2021-09-10 20:28","market":"us","language":"en","title":"ContextLogic Should Really Perform Better Than It Has Been","url":"https://stock-news.laohu8.com/highlight/detail?id=1197281775","media":"InvestorPlace","summary":"It’s time for questions before buying WISH stock.\n\nWhile the novel coronavirus pandemic imposed seve","content":"<blockquote>\n <b>It’s time for questions before buying WISH stock.</b>\n</blockquote>\n<p>While the novel coronavirus pandemic imposed severe economic damage across the globe, some segments certainly fared better than others. In particular, services that offer online transactions saw a significant boost, which is why&nbsp;<b><a href=\"https://laohu8.com/S/WISH\">ContextLogic Inc.</a></b> stock is so perplexing.</p>\n<p>Rather than screaming higher, WISH stock is down 62% for the year.</p>\n<p>An e-commerce platform that facilitates sales between individual buyers and sellers, ContextLogic in theory should enjoy robust user growth and engagement. Since the start of the pandemic,&nbsp;online sales as a percentage of total retail transactions&nbsp;averaged approximately 13.6% on a quarterly basis since the first three months of 2020.</p>\n<p>Right there, that should be a reason to acquire WISH stock.</p>\n<p>For context, in the fourth quarter of 2019, the above metric measured “only” 11.4%. Put another way, e-commerce has been a burgeoning segment since the advent of the internet. But the pandemic lit a fire under online merchant places. So, why the disappointment in WISH stock?</p>\n<p>As my<i>InvestorPlace</i>colleague Muslim Farooque stated – and rather bluntly, I might add – ContextLogic suffered a&nbsp;disastrous outing for its Q2 2021 earnings report.</p>\n<p>Specifically, he wrote that:</p>\n<blockquote>\n Long-term growth drivers are in place, but its troubling fundamentals and business risks have me concerned about the stock’s potential. There’s no sugarcoating this: ContextLogic’s second-quarter earnings card was bad. Its revenues fell 6% on ayear-over-year basis to $656 million, missing over $60 million estimates.\n</blockquote>\n<p>Additionally, Farooque added that “Its net loss increased&nbsp;from $11 million to $111 million&nbsp;and missed estimates by considerable margins.”</p>\n<p>In my opinion, the glaring vulnerability is that “the company’s monthly active users (MAUs) dropped 22% from the prior-year period to $90 million in the quarter. Quarterly active buyers tanked 44% to 17 million as well.”</p>\n<p><b>Trying to Explain Things Makes WISH Stock Look Worse</b></p>\n<p>Of course, everything nowadays revolves around the pandemic. Although ContextLogic’s business may have benefited from the initial volley of infections, the gradual acclimatization to the new normal apparently placed pressure on WISH stock.</p>\n<p>That’s not my take but rather the company’s leadership team. According to ContextLogic’s Form 10-Q filed with the Securities and Exchange Commission, management&nbsp;explained the reduction in active users and engagement&nbsp;as follows:</p>\n<blockquote>\n MAUs decreased approximately 22% and 16% from the three and six months ended June 30, 2020 to the three and six months ended June 30, 2021, respectively, which we believe was primarily driven by a decrease in overall mobile usage as stay-at-home restrictions eased around the world and lower marketing efficiency as the costs to advertise on key digital platforms increased.\n</blockquote>\n<p>I grabbed the above quote from page 21 if you’d like to follow along. On the surface, this sounds like a reasonable explanation. But just a few paragraphs earlier, ContextLogic explains that its “model relies on cost-effectively adding new users, converting those users into buyers and improving engagement and monetization of those buyers on Wish over time as well as adding new merchants, delivering economic success for those merchants, and having those merchants use more of our end-to-end platform.”</p>\n<p>To me, this sounds like an admission that the company’s core business model isn’t working. Naturally, this will raise concerns about the upcoming Q3 earnings report. Additionally, ContextLogic really ought to be improving sales, not going backward.</p>\n<p>Yes, I understand that the comparison to Q2 2020 isn’t favorable because 2021 is the year of initiating the recovery. But so what? A return to normal implies that our economic circumstances will normalize as well. Therefore, why would that be a negative for WISH stock? It really should be a positive.</p>\n<p><b>Don’t Take the Trap of Low Expectations</b></p>\n<p>My colleague is concerned about how ContextLogic will fare in the next quarterly report and I’m right there with him. I concede that the company now has to compete with the brick and mortars for users but again, so what? E-commerce overall has been a thorn on physical retailers’ side for decades.</p>\n<p>And it’s not like the industry of people buying stuff from each other online is about to fade into irrelevance. No, if anything, it’s only getting<i>more</i>relevant. That being the case, ContextLogic’s poor earnings report seems to suggest that without a gun to customers’ heads – the gun being the coronavirus in this analogy – they will gravitate toward superior alternatives.</p>\n<p>Now, it’s not all bad news. ContextLogic plies its trade in a viable ecosystem which entails that the company has an execution problem. Those challenges are easier resolved than being in the wrong industry altogether. But unless you envision management turning things around right quick, I’d be extra cautious about WISH stock.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ContextLogic Should Really Perform Better Than It Has Been</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nContextLogic Should Really Perform Better Than It Has Been\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-10 20:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/09/wish-stock-explanation-should-perform-better/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s time for questions before buying WISH stock.\n\nWhile the novel coronavirus pandemic imposed severe economic damage across the globe, some segments certainly fared better than others. In particular...</p>\n\n<a href=\"https://investorplace.com/2021/09/wish-stock-explanation-should-perform-better/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/09/wish-stock-explanation-should-perform-better/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197281775","content_text":"It’s time for questions before buying WISH stock.\n\nWhile the novel coronavirus pandemic imposed severe economic damage across the globe, some segments certainly fared better than others. In particular, services that offer online transactions saw a significant boost, which is why ContextLogic Inc. stock is so perplexing.\nRather than screaming higher, WISH stock is down 62% for the year.\nAn e-commerce platform that facilitates sales between individual buyers and sellers, ContextLogic in theory should enjoy robust user growth and engagement. Since the start of the pandemic, online sales as a percentage of total retail transactions averaged approximately 13.6% on a quarterly basis since the first three months of 2020.\nRight there, that should be a reason to acquire WISH stock.\nFor context, in the fourth quarter of 2019, the above metric measured “only” 11.4%. Put another way, e-commerce has been a burgeoning segment since the advent of the internet. But the pandemic lit a fire under online merchant places. So, why the disappointment in WISH stock?\nAs myInvestorPlacecolleague Muslim Farooque stated – and rather bluntly, I might add – ContextLogic suffered a disastrous outing for its Q2 2021 earnings report.\nSpecifically, he wrote that:\n\n Long-term growth drivers are in place, but its troubling fundamentals and business risks have me concerned about the stock’s potential. There’s no sugarcoating this: ContextLogic’s second-quarter earnings card was bad. Its revenues fell 6% on ayear-over-year basis to $656 million, missing over $60 million estimates.\n\nAdditionally, Farooque added that “Its net loss increased from $11 million to $111 million and missed estimates by considerable margins.”\nIn my opinion, the glaring vulnerability is that “the company’s monthly active users (MAUs) dropped 22% from the prior-year period to $90 million in the quarter. Quarterly active buyers tanked 44% to 17 million as well.”\nTrying to Explain Things Makes WISH Stock Look Worse\nOf course, everything nowadays revolves around the pandemic. Although ContextLogic’s business may have benefited from the initial volley of infections, the gradual acclimatization to the new normal apparently placed pressure on WISH stock.\nThat’s not my take but rather the company’s leadership team. According to ContextLogic’s Form 10-Q filed with the Securities and Exchange Commission, management explained the reduction in active users and engagement as follows:\n\n MAUs decreased approximately 22% and 16% from the three and six months ended June 30, 2020 to the three and six months ended June 30, 2021, respectively, which we believe was primarily driven by a decrease in overall mobile usage as stay-at-home restrictions eased around the world and lower marketing efficiency as the costs to advertise on key digital platforms increased.\n\nI grabbed the above quote from page 21 if you’d like to follow along. On the surface, this sounds like a reasonable explanation. But just a few paragraphs earlier, ContextLogic explains that its “model relies on cost-effectively adding new users, converting those users into buyers and improving engagement and monetization of those buyers on Wish over time as well as adding new merchants, delivering economic success for those merchants, and having those merchants use more of our end-to-end platform.”\nTo me, this sounds like an admission that the company’s core business model isn’t working. Naturally, this will raise concerns about the upcoming Q3 earnings report. Additionally, ContextLogic really ought to be improving sales, not going backward.\nYes, I understand that the comparison to Q2 2020 isn’t favorable because 2021 is the year of initiating the recovery. But so what? A return to normal implies that our economic circumstances will normalize as well. Therefore, why would that be a negative for WISH stock? It really should be a positive.\nDon’t Take the Trap of Low Expectations\nMy colleague is concerned about how ContextLogic will fare in the next quarterly report and I’m right there with him. I concede that the company now has to compete with the brick and mortars for users but again, so what? E-commerce overall has been a thorn on physical retailers’ side for decades.\nAnd it’s not like the industry of people buying stuff from each other online is about to fade into irrelevance. No, if anything, it’s only gettingmorerelevant. That being the case, ContextLogic’s poor earnings report seems to suggest that without a gun to customers’ heads – the gun being the coronavirus in this analogy – they will gravitate toward superior alternatives.\nNow, it’s not all bad news. ContextLogic plies its trade in a viable ecosystem which entails that the company has an execution problem. Those challenges are easier resolved than being in the wrong industry altogether. But unless you envision management turning things around right quick, I’d be extra cautious about WISH stock.","news_type":1,"symbols_score_info":{"WISH":0.9}},"isVote":1,"tweetType":1,"viewCount":928,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":889377541,"gmtCreate":1631112205483,"gmtModify":1676530472091,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/889377541","repostId":"2165999773","repostType":4,"isVote":1,"tweetType":1,"viewCount":422,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":880302223,"gmtCreate":1631016776762,"gmtModify":1676530442898,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/880302223","repostId":"1130130857","repostType":4,"repost":{"id":"1130130857","kind":"news","pubTimestamp":1631007146,"share":"https://ttm.financial/m/news/1130130857?lang=&edition=full_marsco","pubTime":"2021-09-07 17:32","market":"us","language":"en","title":"Strategists Say the Stock Market Could Struggle This Fall. What to Buy Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=1130130857","media":"Barron's","summary":"What a year this has been for the markets!Fueled by a torrent of monetary and fiscal stimulus, economic and earnings growth, and  a mostly receding pandemic, theS&P 500stock index has rallied 20%, notching seven straight months of gains and more than 50 highs along the way. And that’s on top of last year’s 68% rebound from the market’s March 2020 lows.Tailwinds remain in place, but headwinds now loom that could slow stocks’ advance. Stimulus spending has peaked, and economic and corporate-earnin","content":"<p>What a year this has been for the markets! Fueled by a torrent of monetary and fiscal stimulus, economic and earnings growth, and (until recently) a mostly receding pandemic, theS&amp;P 500stock index has rallied 20%, notching seven straight months of gains and more than 50 highs along the way. And that’s on top of last year’s 68% rebound from the market’s March 2020 lows.</p>\n<p>Tailwinds remain in place, but headwinds now loom that could slow stocks’ advance. Stimulus spending has peaked, and economic and corporate-earnings growth are likely to decelerate through the end of the year. What’s more, theFederal Reserve has all but promised to start tapering its bond buyingin coming months, and the Biden administration has proposed hiking corporate and personal tax rates. None of this is apt to sit well with holders of increasingly pricey shares.</p>\n<p>In other words,brace for a volatile fallin which conflicting forces buffet stocks, bonds, and investors. “The everything rally is behind us,” says Saira Malik, chief investment officer of global equities at Nuveen. “It’s not going to be a sharply rising economic tide that lifts all boats from here.”</p>\n<p>That’s the general consensus among the six market strategists and chief investment officers whom<i>Barron’s</i>recently consulted. All see the S&amp;P 500 ending the year near Thursday’s close of 4536. Their average target: 4585.</p>\n<p>Next year’s gains look muted, as well, relative to recent trends. The group expects the S&amp;P 500 to tack on another 6% in 2022, rising to about 4800.</p>\n<p><img src=\"https://static.tigerbbs.com/eb61c7b74b9b0f18a019afb4ac44ad59\" tg-width=\"300\" tg-height=\"645\" referrerpolicy=\"no-referrer\">With stocks trading for about 21 times the coming year’s expected earnings,bonds yielding little, and cash yielding less than nothing after accounting for inflation, investors face tough asset-allocation decisions. In place of the “everything rally,” which lifted fast-growing tech stocks, no-growth meme stocks, and the Dogecoins of the digital world, our market watchers recommend focusing on “quality” investments. In equities, that means shares of businesses with solid balance sheets, expanding profit margins, and ample and recurring free cash flow. Even if the averages do little in coming months, these stocks are likely to shine.</p>\n<p>The stock market’s massive rally in the past year was a gift of sorts from the Federal Reserve, which flooded the financial system with money to stave off theeconomic damage wrought by the Covid pandemic. Since March 2020, the U.S. central bank has been buying a combined $120 billion a month of U.S. Treasuries and mortgage-backed securities, while keeping its benchmark federal-funds rate target at 0% to 0.25%. These moves have depressed bond yields and pushed investors into riskier assets, including stocks.</p>\n<p>Fed Chairman Jerome <a href=\"https://laohu8.com/S/POWL\">Powell</a> has said that the central bank might begin to wind down, or taper, its emergency asset purchases sometime in the coming quarters, a move that could roil risk assets of all sorts. “For us, it’s very simple: Tapering is tightening,” says Mike Wilson, chief investment officer and chief U.S. equity strategist atMorgan Stanley.“It’s the first step away from maximum accommodation [by the Fed]. They’re being very calculated about it this time, but the bottom line is that it should have a negative effect on equity valuations.”</p>\n<p>The government’s stimulus spending, too, has peaked, the strategists note. Supplemental federal unemployment benefits of $300 a week expire as of Sept. 6. Although Congress seems likely to pass a bipartisan infrastructure bill this fall, the near-term economic impact will pale in comparison to the multiple rounds of stimulus introduced since March 2020.</p>\n<p><img src=\"https://static.tigerbbs.com/c2cb76c498c1c4c980139e3d0514c261\" tg-width=\"300\" tg-height=\"645\" referrerpolicy=\"no-referrer\">The bill includes about $550 billion in new spending—a fraction of the trillions authorized by previous laws—and it will be spread out over many years. The short-term boost that infrastructure stimulus will give to consumer spending, which accounts for almost 70% of U.S. growth domestic product, won’t come close to what the economy saw after millions of Americans received checks from the government this past year.</p>\n<p>A budget bill approved by Democrats only should follow the infrastructure bill, and include spending to support Medicare expansion, child-care funding, free community-college tuition, public housing, and climate-related measures, among other party priorities. Congress could vote to lift taxes on corporations and high-earning individuals to offset that spending—another near-term risk to the market.</p>\n<p><img src=\"https://static.tigerbbs.com/6693da658db16059fc99e08a7531675f\" tg-width=\"300\" tg-height=\"645\" referrerpolicy=\"no-referrer\">Other politically charged issues likewise could derail equities this fall. Congress needs to pass a debt-ceiling increase to fund the government, and a stop-gap spending bill later this month to avoid a <a href=\"https://laohu8.com/S/WASH\">Washington</a> shutdown in October.</p>\n<p>For now, our market experts are relatively sanguine about the economic impact of the Delta variant of Covid-19. As long as vaccines remain effective in minimizing severe infections that lead to hospitalizations and deaths, the negative effects of the current Covid wave will be limited largely to the travel industry and movie theaters, they say. Wall Street’s base case for the market doesn’t include a renewed wave of lockdowns that would undermine economic growth.</p>\n<p>Inflation has been a hot topic at the Fed and among investors, partly because it has been running so hot of late. The U.S. consumer price index rose at an annualized 5.4% in both June and July—a spike the Fed calls transitory, although others aren’t so sure. The strategists are taking Powell’s side of the argument; they expect inflation to fall significantly next year. Their forecasts fall between 2.5% and 3.5%, which they consider manageable for consumers and companies, and an acceptable side effect of rapid economic growth. An inflation rate above 2.5%, however, combined with Fed tapering, would mean that now ultralow bond yields should rise.</p>\n<p>“We think inflation will continue to run hotter than it has since the financial crisis, but it’s hard for us to see inflation much over 2.5% once many of the reopening-related pressures start to dissipate,” says Michael Fredericks, head of income investing for theBlackRockMulti-Asset Strategies Group. “So bond yields do need to move up, but that will happen gradually.”</p>\n<p>The strategists see the yield on the 10-year U.S. Treasury note climbing to around 1.65% by year end. That’s about 35 basis points—or hundredths of a percentage point—above current levels, but below the 1.75% that the yield reached at its March 2021 highs. By next year, the 10-year Treasury could yield 2%, the group says. Those aren’t big moves in absolute terms, but they’re meaningful for&nbsp;the bond market—and could be even more so for stocks.</p>\n<p>Rising yields tend to weigh on stock valuations for two reasons. Higher-yielding bonds offer competition to stocks, and companies’ future earnings are worthless in the present when discounting them at a higher rate. Still, a 10-year yield around 2% won’t be enough to knock stock valuations down to pre-Covid levels. Even if yields climb, market strategists see the price/earnings multiple of the S&amp;P 500 holding well above its 30-year average of 16 times forward earnings. The index’s forward P/E topped 23 last fall.</p>\n<p><img src=\"https://static.tigerbbs.com/e08d24cb421d7cc13debd76a9c6fea01\" tg-width=\"660\" tg-height=\"434\" referrerpolicy=\"no-referrer\"></p>\n<p>As long as 10-year Treasury yields stay in the 2% range, the S&amp;P 500 should be able to command a forward P/E in the high teens, strategists say. A return to the 16-times long-term average isn’t in the cards until there is more pressure from much higher yields—or something else that causes stocks to fall.</p>\n<p>If yields surge past 2% or 2.25%, investors could start to question equity valuations more seriously, says&nbsp;<a href=\"https://laohu8.com/S/STT\">State</a> Street’schief portfolio strategist, Gaurav Mallik: “We haven’t seen [the 10-year yield] above 2% for some time now, so that’s an important sentiment level for investors.”</p>\n<p><img src=\"https://static.tigerbbs.com/93ff6490069ab5dc1b4057f1ff7966f3\" tg-width=\"664\" tg-height=\"441\" referrerpolicy=\"no-referrer\"></p>\n<p>Wilson is more concerned, noting that the stock market’s valuation risk is asymmetric: “It’s very unlikely that multiples are going to go up, and there’s a good chance that they go down more than 10% given the deceleration in growth and where we are in the cycle,” he says</p>\n<p>If 16 to 23 times forward earnings is the range, he adds, “you’re already at the very high end of that. There’s more potential risk than reward.”</p>\n<p>Some P/E-multiple compression is baked into all six strategists’ forecasts, heaping greater importance on the path of profit growth. On average, the strategists expect S&amp;P 500 earnings to jump 46% this year, to about $204, after last year’s earnings depression. That could be followed by a more normalized gain of 9% in 2022, to about $222.50.</p>\n<p>A potential headwind would be a higher federal corporate-tax rate in 2022. The details of Democrats’ spending and taxation plans will be worked out in the coming weeks, and investors can expect to hear a lot more about potential tax increases. Several strategists see a 25% federal rate on corporate profits as a likely compromise figure, above the 21% in place since 2018, but below the 28% sought by the Biden administration.</p>\n<p>An increase of that magnitude would shave about 5% off S&amp;P 500 earnings next year. The index could drop by a similar amount as the passage of the Democrats’ reconciliation bill nears this fall, but the impact should be limited to that initial correction. As with the tax cuts in December 2017, the change should be a <a href=\"https://laohu8.com/S/AONE.U\">one</a>-time event for the market, some strategists predict.</p>\n<p>These concerns aside, investors shouldn’t miss the bigger picture: The U.S. economy is in good shape and growing robustly. The strategists expect gross domestic product to rise 6.3% this year and about 4% in 2022. “The cyclical uplift and above-trend growth will continue at least through 2022, and we want to be biased toward assets that have that exposure,” says Mallik.</p>\n<blockquote>\n “We’re going to have a hot economy this year and next. When GDP growth is above average, value beats growth and cyclicals beat defensives.”— Lori Calvasina, RBC Capital Markets\n</blockquote>\n<p>The State Street strategist recommends overweighting materials, financials, and technology in investment portfolios. That approach includes both economically sensitive companies, such as banks and miners, and steady growers in the tech sector.</p>\n<p>RBC Capital Markets’ head of U.S. equity strategy, Lori Calvasina, likewise takes a barbell approach, with both cyclical and growth exposure. Her preferred sectors are energy, financials, and technology.</p>\n<p>“Valuations are still a lot more attractive in financials and energy than growth [sectors such as technology or consumer discretionary,]” Calvasina says. “The catalyst in the near term is getting out of the current Covid wave... We’re going to have a hot economy this year and next, and traditionally when GDP growth is above average, value beats growth and cyclicals beat defensives.”</p>\n<p>But the focus on quality will be pivotal, especially moving into the second half of 2022. That’s when the Fed is likely to hike interest rates for the first time in this cycle. By 2023, the economy could return to pre-Covid growth on the order of 2%.</p>\n<p>“The historical playbook is that coming out of a recession, you tend to see low-quality outperformance that lasts about a year, then leadership flips back to high quality,” Calvasina says. “But that transition from low quality back to high quality tends to be very bumpy.”</p>\n<p><b>A Shopping List for Fall</b></p>\n<p>Most strategists favor a combination of economically sensitive stocks and steady growers, including tech shares. Financials should do well, particularly if bond yields rise.</p>\n<p><img src=\"https://static.tigerbbs.com/a54c4bd114c1a5f7f700d1fc14d30d8e\" tg-width=\"970\" tg-height=\"230\" referrerpolicy=\"no-referrer\"></p>\n<p>Although stocks with quality attributes have outperformed the market this summer, according to a <a href=\"https://laohu8.com/S/BLK\">BlackRock</a> analysis, the quality factor has lagged since positive vaccine news was first reported last November.</p>\n<p>“We’re moving into a mid-cycle environment, when underlying economic growth remains strong but momentum begins to decelerate,” BlackRock’s Fredericks says. “Our research shows that quality stocks perform particularly well in such a period.”</p>\n<p>He recommends overweighting profitable technology companies; financials, including banks, and consumer staples and industrials with those quality characteristics.</p>\n<p>For <a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a>’s head of equity strategy, Christopher Harvey, a mix of post-pandemic beneficiaries and defensive exposure is the way to go. He constructed a basket of stocks with lower-than-average volatility—which should outperform during periods of market uncertainty or stress this fall—and high “Covid beta,” or sensitivity to good or bad news about the pandemic. One requirement; The stocks had to be rated the equivalent of Buy by Wells Fargo’s equity analysts.</p>\n<p>“There’s near-term economic uncertainty, interest-rate uncertainty, and Covid risk, and generally we’re in a seasonally weaker part of the year around September,” says Harvey. “If we can balance low vol and high Covid beta, we can mitigate a lot of the upcoming uncertainty and volatility around timing of several of those catalysts. Longer-term, though, we still want to have that [reopening exposure.]”</p>\n<p>Harvey’s list of low-volatility stocks with high Covid beta includesApple(AAPL),<a href=\"https://laohu8.com/S/BAC\">Bank of America</a>(BAC),<a href=\"https://laohu8.com/S/NTRSP\">Northern</a> Trust(NTRS),Lowe’s(LOW),<a href=\"https://laohu8.com/S/IQV\">IQVIA</a> Holdings(IQV), andMasco(MAS).</p>\n<p>Overall, banks are the most frequently recommended group for the months ahead. TheInvesco KBW Bankexchange-traded fund (KBWB) provides broad exposure to the sector in the U.S.</p>\n<p>“We like the valuations [and] credit quality; they are now allowed to buy back shares and increase dividends, and there’s higher Covid beta,” says Harvey.</p>\n<p>Cheaper valuations mean less potential downside in a market correction. And, contrary to much of the rest of the stock market, higher interest rates would be a tailwind for the banks, which could then charge more for loans.</p>\n<p><a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> stocks also have some fans. “<a href=\"https://laohu8.com/S/HR\">Healthcare</a> has both defensive and growth attributes to it,” Wilson says. “You’re paying a lot less per unit of growth in healthcare today than you are in other sectors. So we think it provides good balance in this market when we’re worried about valuation.” Health insurerHumana(HUM) makes Wilson’s “Fresh Money Buy List” of stocks Buy-rated by <a href=\"https://laohu8.com/S/MS\">Morgan Stanley</a> analysts and fitting his macro views.</p>\n<p>Nuveen’s Malik is also looking toward health care for relatively underpriced growth exposure, namely in the pharmaceuticals and biotechnology groups. She points toSeagen(SGEN), which is focused on oncology drugs and could be an attractive acquisition target for a pharma giant.</p>\n<p>Malik also likesAbbVie(ABBV) which trades at an undemanding eight times forward earnings and sports a 4.7% dividend yield. The coming expiration of patents on its blockbuster anti-inflammatory drug Humira has kept some investors away, but Malik is confident that management can limit the damage and sees promising drugs in development at the $200 billion company.</p>\n<p>Both stocks have had a tough time in recent days. Seagen fell more than 8% last week, to around $152, on news that its co-founder and CEO sold a large number of shares recently. AndAbbVietanked 7% Wednesday, to $112.27, after the Food and Drug Administration required new warning labels for JAK inhibitors, a type of anti-rheumatoid drug that includes one of <a href=\"https://laohu8.com/S/ABBV\">AbbVie</a>’s most promising post-Humira products.</p>\n<p><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>(PFE),<a href=\"https://laohu8.com/S/AXP\">American Express</a>(AXP),Johnson &amp; Johnson(JNJ), andCisco Systems(CSCO) are other S&amp;P 500 members that pass a<i>Barron’s</i>screen for quality attributes.</p>\n<p>After a year of steady gains, investors might be reminded this fall that stocks can also decline, as growth momentum and policy support begin to fade. But underlying economic strength supports buying the dip, should the market drop from its highs. <a href=\"https://laohu8.com/S/JE\">Just</a> be more selective. And go with quality.</p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Strategists Say the Stock Market Could Struggle This Fall. What to Buy Now?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStrategists Say the Stock Market Could Struggle This Fall. What to Buy Now?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 17:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/stocks-could-struggle-this-fall-market-strategists-say-stick-with-quality-companies-51630699840?siteid=yhoof2><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What a year this has been for the markets! Fueled by a torrent of monetary and fiscal stimulus, economic and earnings growth, and (until recently) a mostly receding pandemic, theS&P 500stock index has...</p>\n\n<a href=\"https://www.barrons.com/articles/stocks-could-struggle-this-fall-market-strategists-say-stick-with-quality-companies-51630699840?siteid=yhoof2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://www.barrons.com/articles/stocks-could-struggle-this-fall-market-strategists-say-stick-with-quality-companies-51630699840?siteid=yhoof2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130130857","content_text":"What a year this has been for the markets! Fueled by a torrent of monetary and fiscal stimulus, economic and earnings growth, and (until recently) a mostly receding pandemic, theS&P 500stock index has rallied 20%, notching seven straight months of gains and more than 50 highs along the way. And that’s on top of last year’s 68% rebound from the market’s March 2020 lows.\nTailwinds remain in place, but headwinds now loom that could slow stocks’ advance. Stimulus spending has peaked, and economic and corporate-earnings growth are likely to decelerate through the end of the year. What’s more, theFederal Reserve has all but promised to start tapering its bond buyingin coming months, and the Biden administration has proposed hiking corporate and personal tax rates. None of this is apt to sit well with holders of increasingly pricey shares.\nIn other words,brace for a volatile fallin which conflicting forces buffet stocks, bonds, and investors. “The everything rally is behind us,” says Saira Malik, chief investment officer of global equities at Nuveen. “It’s not going to be a sharply rising economic tide that lifts all boats from here.”\nThat’s the general consensus among the six market strategists and chief investment officers whomBarron’srecently consulted. All see the S&P 500 ending the year near Thursday’s close of 4536. Their average target: 4585.\nNext year’s gains look muted, as well, relative to recent trends. The group expects the S&P 500 to tack on another 6% in 2022, rising to about 4800.\nWith stocks trading for about 21 times the coming year’s expected earnings,bonds yielding little, and cash yielding less than nothing after accounting for inflation, investors face tough asset-allocation decisions. In place of the “everything rally,” which lifted fast-growing tech stocks, no-growth meme stocks, and the Dogecoins of the digital world, our market watchers recommend focusing on “quality” investments. In equities, that means shares of businesses with solid balance sheets, expanding profit margins, and ample and recurring free cash flow. Even if the averages do little in coming months, these stocks are likely to shine.\nThe stock market’s massive rally in the past year was a gift of sorts from the Federal Reserve, which flooded the financial system with money to stave off theeconomic damage wrought by the Covid pandemic. Since March 2020, the U.S. central bank has been buying a combined $120 billion a month of U.S. Treasuries and mortgage-backed securities, while keeping its benchmark federal-funds rate target at 0% to 0.25%. These moves have depressed bond yields and pushed investors into riskier assets, including stocks.\nFed Chairman Jerome Powell has said that the central bank might begin to wind down, or taper, its emergency asset purchases sometime in the coming quarters, a move that could roil risk assets of all sorts. “For us, it’s very simple: Tapering is tightening,” says Mike Wilson, chief investment officer and chief U.S. equity strategist atMorgan Stanley.“It’s the first step away from maximum accommodation [by the Fed]. They’re being very calculated about it this time, but the bottom line is that it should have a negative effect on equity valuations.”\nThe government’s stimulus spending, too, has peaked, the strategists note. Supplemental federal unemployment benefits of $300 a week expire as of Sept. 6. Although Congress seems likely to pass a bipartisan infrastructure bill this fall, the near-term economic impact will pale in comparison to the multiple rounds of stimulus introduced since March 2020.\nThe bill includes about $550 billion in new spending—a fraction of the trillions authorized by previous laws—and it will be spread out over many years. The short-term boost that infrastructure stimulus will give to consumer spending, which accounts for almost 70% of U.S. growth domestic product, won’t come close to what the economy saw after millions of Americans received checks from the government this past year.\nA budget bill approved by Democrats only should follow the infrastructure bill, and include spending to support Medicare expansion, child-care funding, free community-college tuition, public housing, and climate-related measures, among other party priorities. Congress could vote to lift taxes on corporations and high-earning individuals to offset that spending—another near-term risk to the market.\nOther politically charged issues likewise could derail equities this fall. Congress needs to pass a debt-ceiling increase to fund the government, and a stop-gap spending bill later this month to avoid a Washington shutdown in October.\nFor now, our market experts are relatively sanguine about the economic impact of the Delta variant of Covid-19. As long as vaccines remain effective in minimizing severe infections that lead to hospitalizations and deaths, the negative effects of the current Covid wave will be limited largely to the travel industry and movie theaters, they say. Wall Street’s base case for the market doesn’t include a renewed wave of lockdowns that would undermine economic growth.\nInflation has been a hot topic at the Fed and among investors, partly because it has been running so hot of late. The U.S. consumer price index rose at an annualized 5.4% in both June and July—a spike the Fed calls transitory, although others aren’t so sure. The strategists are taking Powell’s side of the argument; they expect inflation to fall significantly next year. Their forecasts fall between 2.5% and 3.5%, which they consider manageable for consumers and companies, and an acceptable side effect of rapid economic growth. An inflation rate above 2.5%, however, combined with Fed tapering, would mean that now ultralow bond yields should rise.\n“We think inflation will continue to run hotter than it has since the financial crisis, but it’s hard for us to see inflation much over 2.5% once many of the reopening-related pressures start to dissipate,” says Michael Fredericks, head of income investing for theBlackRockMulti-Asset Strategies Group. “So bond yields do need to move up, but that will happen gradually.”\nThe strategists see the yield on the 10-year U.S. Treasury note climbing to around 1.65% by year end. That’s about 35 basis points—or hundredths of a percentage point—above current levels, but below the 1.75% that the yield reached at its March 2021 highs. By next year, the 10-year Treasury could yield 2%, the group says. Those aren’t big moves in absolute terms, but they’re meaningful for the bond market—and could be even more so for stocks.\nRising yields tend to weigh on stock valuations for two reasons. Higher-yielding bonds offer competition to stocks, and companies’ future earnings are worthless in the present when discounting them at a higher rate. Still, a 10-year yield around 2% won’t be enough to knock stock valuations down to pre-Covid levels. Even if yields climb, market strategists see the price/earnings multiple of the S&P 500 holding well above its 30-year average of 16 times forward earnings. The index’s forward P/E topped 23 last fall.\n\nAs long as 10-year Treasury yields stay in the 2% range, the S&P 500 should be able to command a forward P/E in the high teens, strategists say. A return to the 16-times long-term average isn’t in the cards until there is more pressure from much higher yields—or something else that causes stocks to fall.\nIf yields surge past 2% or 2.25%, investors could start to question equity valuations more seriously, says State Street’schief portfolio strategist, Gaurav Mallik: “We haven’t seen [the 10-year yield] above 2% for some time now, so that’s an important sentiment level for investors.”\n\nWilson is more concerned, noting that the stock market’s valuation risk is asymmetric: “It’s very unlikely that multiples are going to go up, and there’s a good chance that they go down more than 10% given the deceleration in growth and where we are in the cycle,” he says\nIf 16 to 23 times forward earnings is the range, he adds, “you’re already at the very high end of that. There’s more potential risk than reward.”\nSome P/E-multiple compression is baked into all six strategists’ forecasts, heaping greater importance on the path of profit growth. On average, the strategists expect S&P 500 earnings to jump 46% this year, to about $204, after last year’s earnings depression. That could be followed by a more normalized gain of 9% in 2022, to about $222.50.\nA potential headwind would be a higher federal corporate-tax rate in 2022. The details of Democrats’ spending and taxation plans will be worked out in the coming weeks, and investors can expect to hear a lot more about potential tax increases. Several strategists see a 25% federal rate on corporate profits as a likely compromise figure, above the 21% in place since 2018, but below the 28% sought by the Biden administration.\nAn increase of that magnitude would shave about 5% off S&P 500 earnings next year. The index could drop by a similar amount as the passage of the Democrats’ reconciliation bill nears this fall, but the impact should be limited to that initial correction. As with the tax cuts in December 2017, the change should be a one-time event for the market, some strategists predict.\nThese concerns aside, investors shouldn’t miss the bigger picture: The U.S. economy is in good shape and growing robustly. The strategists expect gross domestic product to rise 6.3% this year and about 4% in 2022. “The cyclical uplift and above-trend growth will continue at least through 2022, and we want to be biased toward assets that have that exposure,” says Mallik.\n\n “We’re going to have a hot economy this year and next. When GDP growth is above average, value beats growth and cyclicals beat defensives.”— Lori Calvasina, RBC Capital Markets\n\nThe State Street strategist recommends overweighting materials, financials, and technology in investment portfolios. That approach includes both economically sensitive companies, such as banks and miners, and steady growers in the tech sector.\nRBC Capital Markets’ head of U.S. equity strategy, Lori Calvasina, likewise takes a barbell approach, with both cyclical and growth exposure. Her preferred sectors are energy, financials, and technology.\n“Valuations are still a lot more attractive in financials and energy than growth [sectors such as technology or consumer discretionary,]” Calvasina says. “The catalyst in the near term is getting out of the current Covid wave... We’re going to have a hot economy this year and next, and traditionally when GDP growth is above average, value beats growth and cyclicals beat defensives.”\nBut the focus on quality will be pivotal, especially moving into the second half of 2022. That’s when the Fed is likely to hike interest rates for the first time in this cycle. By 2023, the economy could return to pre-Covid growth on the order of 2%.\n“The historical playbook is that coming out of a recession, you tend to see low-quality outperformance that lasts about a year, then leadership flips back to high quality,” Calvasina says. “But that transition from low quality back to high quality tends to be very bumpy.”\nA Shopping List for Fall\nMost strategists favor a combination of economically sensitive stocks and steady growers, including tech shares. Financials should do well, particularly if bond yields rise.\n\nAlthough stocks with quality attributes have outperformed the market this summer, according to a BlackRock analysis, the quality factor has lagged since positive vaccine news was first reported last November.\n“We’re moving into a mid-cycle environment, when underlying economic growth remains strong but momentum begins to decelerate,” BlackRock’s Fredericks says. “Our research shows that quality stocks perform particularly well in such a period.”\nHe recommends overweighting profitable technology companies; financials, including banks, and consumer staples and industrials with those quality characteristics.\nFor Wells Fargo’s head of equity strategy, Christopher Harvey, a mix of post-pandemic beneficiaries and defensive exposure is the way to go. He constructed a basket of stocks with lower-than-average volatility—which should outperform during periods of market uncertainty or stress this fall—and high “Covid beta,” or sensitivity to good or bad news about the pandemic. One requirement; The stocks had to be rated the equivalent of Buy by Wells Fargo’s equity analysts.\n“There’s near-term economic uncertainty, interest-rate uncertainty, and Covid risk, and generally we’re in a seasonally weaker part of the year around September,” says Harvey. “If we can balance low vol and high Covid beta, we can mitigate a lot of the upcoming uncertainty and volatility around timing of several of those catalysts. Longer-term, though, we still want to have that [reopening exposure.]”\nHarvey’s list of low-volatility stocks with high Covid beta includesApple(AAPL),Bank of America(BAC),Northern Trust(NTRS),Lowe’s(LOW),IQVIA Holdings(IQV), andMasco(MAS).\nOverall, banks are the most frequently recommended group for the months ahead. TheInvesco KBW Bankexchange-traded fund (KBWB) provides broad exposure to the sector in the U.S.\n“We like the valuations [and] credit quality; they are now allowed to buy back shares and increase dividends, and there’s higher Covid beta,” says Harvey.\nCheaper valuations mean less potential downside in a market correction. And, contrary to much of the rest of the stock market, higher interest rates would be a tailwind for the banks, which could then charge more for loans.\nHealthcare stocks also have some fans. “Healthcare has both defensive and growth attributes to it,” Wilson says. “You’re paying a lot less per unit of growth in healthcare today than you are in other sectors. So we think it provides good balance in this market when we’re worried about valuation.” Health insurerHumana(HUM) makes Wilson’s “Fresh Money Buy List” of stocks Buy-rated by Morgan Stanley analysts and fitting his macro views.\nNuveen’s Malik is also looking toward health care for relatively underpriced growth exposure, namely in the pharmaceuticals and biotechnology groups. She points toSeagen(SGEN), which is focused on oncology drugs and could be an attractive acquisition target for a pharma giant.\nMalik also likesAbbVie(ABBV) which trades at an undemanding eight times forward earnings and sports a 4.7% dividend yield. The coming expiration of patents on its blockbuster anti-inflammatory drug Humira has kept some investors away, but Malik is confident that management can limit the damage and sees promising drugs in development at the $200 billion company.\nBoth stocks have had a tough time in recent days. Seagen fell more than 8% last week, to around $152, on news that its co-founder and CEO sold a large number of shares recently. AndAbbVietanked 7% Wednesday, to $112.27, after the Food and Drug Administration required new warning labels for JAK inhibitors, a type of anti-rheumatoid drug that includes one of AbbVie’s most promising post-Humira products.\nPfizer(PFE),American Express(AXP),Johnson & Johnson(JNJ), andCisco Systems(CSCO) are other S&P 500 members that pass aBarron’sscreen for quality attributes.\nAfter a year of steady gains, investors might be reminded this fall that stocks can also decline, as growth momentum and policy support begin to fade. But underlying economic strength supports buying the dip, should the market drop from its highs. Just be more selective. And go with quality.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":613,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":817891795,"gmtCreate":1630927930617,"gmtModify":1676530422304,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/817891795","repostId":"2165233386","repostType":4,"isVote":1,"tweetType":1,"viewCount":446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":811530841,"gmtCreate":1630331251783,"gmtModify":1676530271526,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi//<a href=\"https://laohu8.com/U/3578668729356671\">@ssw04104</a>: Hi","listText":"Hi//<a href=\"https://laohu8.com/U/3578668729356671\">@ssw04104</a>: Hi","text":"Hi//@ssw04104: Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/811530841","repostId":"2163885784","repostType":4,"repost":{"id":"2163885784","kind":"news","pubTimestamp":1630329604,"share":"https://ttm.financial/m/news/2163885784?lang=&edition=full_marsco","pubTime":"2021-08-30 21:20","market":"us","language":"en","title":"Moderna, BioNTech Rally Stalls Ahead of CDC Meeting on Boosters","url":"https://stock-news.laohu8.com/highlight/detail?id=2163885784","media":"Bloomberg","summary":"(Bloomberg) -- The huge rally for Covid-19 vaccine makers has stalled as Wall Street waits for the U","content":"<p>(Bloomberg) -- The huge rally for Covid-19 vaccine makers has stalled as Wall Street waits for the U.S Centers for Disease Control and Prevention to weigh in on whether Americans should get a third shot.</p>\n<p>On Monday, a meeting of outside advisers to the agency could finally give investors a sense of clarity.</p>\n<p>Moderna Inc., which became the best performer in the S&amp;P 500 Index after its stock price more than tripled this year, has slid 21% from its record high in early August. <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>, which has surged more than four-fold in 2021, has fallen almost as much over the past three weeks, while its U.S. partner, Pfizer Inc., is off more than 7% from its peak.</p>\n<p>The retreat comes as the pace of the American inoculation campaign slows, leaving investors divided over how much growth to expect from the manufacturers. That rift has only deepened after President Joe Biden administration promised that booster shots will be made available to most Americans, which would be a major source of demand if regulators endorse that step.</p>\n<p>The administration’s aim to push through new guidelines in late September, however, has been met with skepticism by some medical experts. The CDC as well as the U.S. Food and Drug Administration have to approve the plan before it can be implemented and that backing isn’t guaranteed.</p>\n<p>That uncertainty is likely to continue fueling volatility in the stocks. Options imply that Moderna and BioNTech could move roughly 7% in either direction over the next week while Pfizer’s stock may move about 3%.</p>\n<p><a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>’s Matthew Harrison is among Wall Street analysts who expect Biden’s plan to be backed by regulators. But but he remains equal weight on Moderna and Pfizer because he doesn’t expect any major new vaccine orders in the near future, with an estimated 630 million of unused shots from the companies already purchased through 2022.</p>\n<p>“We do not expect any supply constraints for booster doses and do not expect the U.S. government to purchase additional mRNA vaccine doses for 2022 based on current demand or booster dose need,” Harrison wrote in a research note, referring to the technology used in both Moderna and Pfizer’s shots.</p>\n<p>Analysts with Goldman Sachs Group Inc. are more bullish. The bank has a buy rating on Moderna, estimating that its shot could drive $36.2 billion of sales next year, some $15 billion more than Bloomberg’s consensus estimates. “We see upside to these numbers given supply and pricing dynamics,” said analyst Asad Haider.</p>\n<p>He sees new records for Moderna and Pfizer if U.S. and other global regulators endorse the receipt of a third dose. He estimates that Moderna shares -- which closed Friday a $382.22 -- could top $600 if boosters become the norm, while Pfizer could trade as high as $61, up from $46.58 at the end of last week. &nbsp;BioNTech already trades at best-case levels, he wrote.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, BioNTech Rally Stalls Ahead of CDC Meeting on Boosters</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, BioNTech Rally Stalls Ahead of CDC Meeting on Boosters\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-30 21:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-biontech-rally-stalls-ahead-103004269.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- The huge rally for Covid-19 vaccine makers has stalled as Wall Street waits for the U.S Centers for Disease Control and Prevention to weigh in on whether Americans should get a third ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-biontech-rally-stalls-ahead-103004269.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE","MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-biontech-rally-stalls-ahead-103004269.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2163885784","content_text":"(Bloomberg) -- The huge rally for Covid-19 vaccine makers has stalled as Wall Street waits for the U.S Centers for Disease Control and Prevention to weigh in on whether Americans should get a third shot.\nOn Monday, a meeting of outside advisers to the agency could finally give investors a sense of clarity.\nModerna Inc., which became the best performer in the S&P 500 Index after its stock price more than tripled this year, has slid 21% from its record high in early August. BioNTech SE, which has surged more than four-fold in 2021, has fallen almost as much over the past three weeks, while its U.S. partner, Pfizer Inc., is off more than 7% from its peak.\nThe retreat comes as the pace of the American inoculation campaign slows, leaving investors divided over how much growth to expect from the manufacturers. That rift has only deepened after President Joe Biden administration promised that booster shots will be made available to most Americans, which would be a major source of demand if regulators endorse that step.\nThe administration’s aim to push through new guidelines in late September, however, has been met with skepticism by some medical experts. The CDC as well as the U.S. Food and Drug Administration have to approve the plan before it can be implemented and that backing isn’t guaranteed.\nThat uncertainty is likely to continue fueling volatility in the stocks. Options imply that Moderna and BioNTech could move roughly 7% in either direction over the next week while Pfizer’s stock may move about 3%.\nMorgan Stanley’s Matthew Harrison is among Wall Street analysts who expect Biden’s plan to be backed by regulators. But but he remains equal weight on Moderna and Pfizer because he doesn’t expect any major new vaccine orders in the near future, with an estimated 630 million of unused shots from the companies already purchased through 2022.\n“We do not expect any supply constraints for booster doses and do not expect the U.S. government to purchase additional mRNA vaccine doses for 2022 based on current demand or booster dose need,” Harrison wrote in a research note, referring to the technology used in both Moderna and Pfizer’s shots.\nAnalysts with Goldman Sachs Group Inc. are more bullish. The bank has a buy rating on Moderna, estimating that its shot could drive $36.2 billion of sales next year, some $15 billion more than Bloomberg’s consensus estimates. “We see upside to these numbers given supply and pricing dynamics,” said analyst Asad Haider.\nHe sees new records for Moderna and Pfizer if U.S. and other global regulators endorse the receipt of a third dose. He estimates that Moderna shares -- which closed Friday a $382.22 -- could top $600 if boosters become the norm, while Pfizer could trade as high as $61, up from $46.58 at the end of last week.  BioNTech already trades at best-case levels, he wrote.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":579,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":811597743,"gmtCreate":1630331235682,"gmtModify":1676530271495,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/811597743","repostId":"2163885784","repostType":4,"repost":{"id":"2163885784","kind":"news","pubTimestamp":1630329604,"share":"https://ttm.financial/m/news/2163885784?lang=&edition=full_marsco","pubTime":"2021-08-30 21:20","market":"us","language":"en","title":"Moderna, BioNTech Rally Stalls Ahead of CDC Meeting on Boosters","url":"https://stock-news.laohu8.com/highlight/detail?id=2163885784","media":"Bloomberg","summary":"(Bloomberg) -- The huge rally for Covid-19 vaccine makers has stalled as Wall Street waits for the U","content":"<p>(Bloomberg) -- The huge rally for Covid-19 vaccine makers has stalled as Wall Street waits for the U.S Centers for Disease Control and Prevention to weigh in on whether Americans should get a third shot.</p>\n<p>On Monday, a meeting of outside advisers to the agency could finally give investors a sense of clarity.</p>\n<p>Moderna Inc., which became the best performer in the S&amp;P 500 Index after its stock price more than tripled this year, has slid 21% from its record high in early August. <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>, which has surged more than four-fold in 2021, has fallen almost as much over the past three weeks, while its U.S. partner, Pfizer Inc., is off more than 7% from its peak.</p>\n<p>The retreat comes as the pace of the American inoculation campaign slows, leaving investors divided over how much growth to expect from the manufacturers. That rift has only deepened after President Joe Biden administration promised that booster shots will be made available to most Americans, which would be a major source of demand if regulators endorse that step.</p>\n<p>The administration’s aim to push through new guidelines in late September, however, has been met with skepticism by some medical experts. The CDC as well as the U.S. Food and Drug Administration have to approve the plan before it can be implemented and that backing isn’t guaranteed.</p>\n<p>That uncertainty is likely to continue fueling volatility in the stocks. Options imply that Moderna and BioNTech could move roughly 7% in either direction over the next week while Pfizer’s stock may move about 3%.</p>\n<p><a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>’s Matthew Harrison is among Wall Street analysts who expect Biden’s plan to be backed by regulators. But but he remains equal weight on Moderna and Pfizer because he doesn’t expect any major new vaccine orders in the near future, with an estimated 630 million of unused shots from the companies already purchased through 2022.</p>\n<p>“We do not expect any supply constraints for booster doses and do not expect the U.S. government to purchase additional mRNA vaccine doses for 2022 based on current demand or booster dose need,” Harrison wrote in a research note, referring to the technology used in both Moderna and Pfizer’s shots.</p>\n<p>Analysts with Goldman Sachs Group Inc. are more bullish. The bank has a buy rating on Moderna, estimating that its shot could drive $36.2 billion of sales next year, some $15 billion more than Bloomberg’s consensus estimates. “We see upside to these numbers given supply and pricing dynamics,” said analyst Asad Haider.</p>\n<p>He sees new records for Moderna and Pfizer if U.S. and other global regulators endorse the receipt of a third dose. He estimates that Moderna shares -- which closed Friday a $382.22 -- could top $600 if boosters become the norm, while Pfizer could trade as high as $61, up from $46.58 at the end of last week. &nbsp;BioNTech already trades at best-case levels, he wrote.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, BioNTech Rally Stalls Ahead of CDC Meeting on Boosters</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, BioNTech Rally Stalls Ahead of CDC Meeting on Boosters\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-30 21:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-biontech-rally-stalls-ahead-103004269.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- The huge rally for Covid-19 vaccine makers has stalled as Wall Street waits for the U.S Centers for Disease Control and Prevention to weigh in on whether Americans should get a third ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-biontech-rally-stalls-ahead-103004269.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE","MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-biontech-rally-stalls-ahead-103004269.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2163885784","content_text":"(Bloomberg) -- The huge rally for Covid-19 vaccine makers has stalled as Wall Street waits for the U.S Centers for Disease Control and Prevention to weigh in on whether Americans should get a third shot.\nOn Monday, a meeting of outside advisers to the agency could finally give investors a sense of clarity.\nModerna Inc., which became the best performer in the S&P 500 Index after its stock price more than tripled this year, has slid 21% from its record high in early August. BioNTech SE, which has surged more than four-fold in 2021, has fallen almost as much over the past three weeks, while its U.S. partner, Pfizer Inc., is off more than 7% from its peak.\nThe retreat comes as the pace of the American inoculation campaign slows, leaving investors divided over how much growth to expect from the manufacturers. That rift has only deepened after President Joe Biden administration promised that booster shots will be made available to most Americans, which would be a major source of demand if regulators endorse that step.\nThe administration’s aim to push through new guidelines in late September, however, has been met with skepticism by some medical experts. The CDC as well as the U.S. Food and Drug Administration have to approve the plan before it can be implemented and that backing isn’t guaranteed.\nThat uncertainty is likely to continue fueling volatility in the stocks. Options imply that Moderna and BioNTech could move roughly 7% in either direction over the next week while Pfizer’s stock may move about 3%.\nMorgan Stanley’s Matthew Harrison is among Wall Street analysts who expect Biden’s plan to be backed by regulators. But but he remains equal weight on Moderna and Pfizer because he doesn’t expect any major new vaccine orders in the near future, with an estimated 630 million of unused shots from the companies already purchased through 2022.\n“We do not expect any supply constraints for booster doses and do not expect the U.S. government to purchase additional mRNA vaccine doses for 2022 based on current demand or booster dose need,” Harrison wrote in a research note, referring to the technology used in both Moderna and Pfizer’s shots.\nAnalysts with Goldman Sachs Group Inc. are more bullish. The bank has a buy rating on Moderna, estimating that its shot could drive $36.2 billion of sales next year, some $15 billion more than Bloomberg’s consensus estimates. “We see upside to these numbers given supply and pricing dynamics,” said analyst Asad Haider.\nHe sees new records for Moderna and Pfizer if U.S. and other global regulators endorse the receipt of a third dose. He estimates that Moderna shares -- which closed Friday a $382.22 -- could top $600 if boosters become the norm, while Pfizer could trade as high as $61, up from $46.58 at the end of last week.  BioNTech already trades at best-case levels, he wrote.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":530,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819234354,"gmtCreate":1630071830978,"gmtModify":1676530216530,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/819234354","repostId":"1177903834","repostType":4,"repost":{"id":"1177903834","kind":"news","pubTimestamp":1630070724,"share":"https://ttm.financial/m/news/1177903834?lang=&edition=full_marsco","pubTime":"2021-08-27 21:25","market":"us","language":"en","title":"Box: A Comfortable Investment At Tremendously Cheap Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=1177903834","media":"seekingalpha","summary":"Summary\n\nShares of Box have fallen ~5% after a strong Q2 earnings report.\nRevenue growth accelerated","content":"<p><b>Summary</b></p>\n<ul>\n <li>Shares of Box have fallen ~5% after a strong Q2 earnings report.</li>\n <li>Revenue growth accelerated to 12% y/y, and billings growth of 13% y/y indicates that revenue growth may even pick up slightly.</li>\n <li>The company also delivered significant margin expansion and expects to hit the \"Rule of 40\" on a free cash flow basis by FY24.</li>\n <li>Box is still a very cheap stock at &lt;4x forward revenue.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1670e3d657812cae8258809923793c19\" tg-width=\"1536\" tg-height=\"1026\" referrerpolicy=\"no-referrer\"><span>Noam Galai/Getty Images Entertainment</span></p>\n<p>So far, the year 2021 has been a promising one for Box(NYSE:BOX). The file storage and sharing service, one of the earlier SaaS companies to go public and gain a reputation for \"growth at all costs,\" has seen a 40% jump in its stock price year to date, more than doubling that of the S&amp;P 500 - though that hardly makes up for Box's years of disappointing returns. This is the year, however, that investors have seemed to favor positioning themselves defensively with value stocks over growth, even with the market counting to sit at all-time highs.</p>\n<p>A slight crack in this positive rebound showed after Box reported Q2 results, which resulted in a ~5% dip despite strong top and bottom-line results. In my view, the dip is a strong buying opportunity in a company that has repeatedly shown its capacity to scale profitably and to retain growth in a software category that is often described as overly competitive.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8e9c3ef144b8f48e4171067b3519dce8\" tg-width=\"635\" tg-height=\"417\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p>My main investing strategy over the past year has been to find stocks that I feel comfortable buying at all-time market tops. The basic question here is: \"what stock will be relatively immune to, say, a ~20% market correction, by gist of the fact that it's already currently cheap to begin with?\" Box has always retained a strong value element, and today, with strong forward-looking estimates plus a still-depressed share price, that value element has never been brighter.</p>\n<p>At current share prices near $25, Box trades at a market cap of $3.85 billion. After we net off the $829.4 million of cash and $366.5 million of debt on Box's most recent balance sheet, the company's resulting enterprise value is $3.39 billion.</p>\n<p>For the current fiscal year, Box has guided to revenue of $856-$860 million, representing 12% y/y growth. For the next fiscal year (FY22), Wall Street analysts have given a consensus revenue target of $942.5 million for Box, representing 11% y/y growth (data from Yahoo Finance). This puts Box's valuation multiples at an ultra-modest multiple of:</p>\n<ul>\n <li><b>4.0x EV/FY21 revenue</b></li>\n <li><b>3.6x EV/FY22 revenue</b></li>\n</ul>\n<p>Recall as well that Box has maintained its goal of hitting a \"Rule of 40\" profile by FY24, which it defines as revenue growth plus free cash flow margin (the latter standing in for how most companies calculate the Rule of 40, with pro forma operating margin instead of FCF).</p>\n<p>Figure 1. Box Rule of 40</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ffb5ce6e7901cd0b87e178d41c64b2ea\" tg-width=\"640\" tg-height=\"334\" width=\"100%\" height=\"auto\"><span>Source: BoxQ2 investor presentation</span></p>\n<p>Let's tease that out quickly. If Box hits 11% y/y growth in the two years after FY22, then its revenue in that year would be $1.16 billion. The lower point of its guidance would suggest a 29% FCF margin (though it really expects to be at 40%+ growth plus FCF margin in that year), which would imply $336.4 million in FCF. Its current valuation, then, stands at a ~10x multiple of future cash flow (an even lower multiple would result if Box outperforms the lower end of its Rule of 40 guidance).</p>\n<p>Aside from the free cash flow opportunity, here are the other reasons to be bullish on Box, as a refresher:</p>\n<ul>\n <li><b>Nearly pure recurring revenue business that has shown resilience during macroeconomic shocks.</b>Even amid the pandemic, Box has managed to retain its low double-digit/high single-digit revenue growth rates. Revenue growth in Q2 accelerated over Q1, showing sustained momentum.</li>\n <li><b>Enterprise orientation.</b>Of all of its well-known competitors, Box is the only company that is enterprise-focused. The company touts its security features plus advanced capabilities like Box Skills as key distinguishers versus the likes of Dropbox.</li>\n <li><b>Box's product portfolio expansion has led to a $55 billion market.</b>Despite competition, Box cites a massive $55 billion market across storage, content collaboration, and data security. That's a big enough space for multiple incumbents, and also suggests Box is only currently ~2% penetrated into this overall market. Recent portfolio additions like Box Sign have greatly expanded Box's potential.</li>\n</ul>\n<p>Stay long here and use the dip as a buying opportunity.</p>\n<p><b>Q2 download</b></p>\n<p>Let's now cover Box's latest second-quarter results in greater detail. There were no major red flags to be found, in my mind, that warrants Box's ~5% drop.</p>\n<p>Starting with revenue: Box saw its revenue growth accelerate two points in the quarter, growing 12% y/y to $214.5 million, edging out over Wall Street's $213.0 million (+11% y/y) expectations. We note as well that this is Box's strongest quarter for revenue growth over the past five.</p>\n<p>Figure 2. Box revenue growth trends</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3b477b6fd8ecc7c46b3fcce168903fcb\" tg-width=\"640\" tg-height=\"361\" width=\"100%\" height=\"auto\"><span>Source: Box Q2 investor presentation</span></p>\n<p>Box has also shown strong billings trends. Recall that in Q1, the company saw 24% y/y growth in billings, but against a very easy pandemic comp that saw deal signings materially slow down upon the immediate start of lockdowns. Yet billings were also strong in Q2 at 13% y/y growth, indicating that revenue growth may accelerate beyond 12% y/y growth in the near future. Note that Box's long-term operating plan calls for revenue growth between 12-16% y/y (so our expectations of 11% y/y are more on the conservative side). Box's deferred revenue is also up 16% y/y, indicating a strong \"pipeline\" of deals billed that are waiting to be recognized as revenue.</p>\n<p>Figure 3. Box billings trends</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3b81a48cf40f716a78b1cadfb79ae971\" tg-width=\"640\" tg-height=\"336\" width=\"100%\" height=\"auto\"><span>Source: Box Q2 investor presentation</span></p>\n<p>The company has noted that the rollout of the Box Sign product, Box's answer to the likes of DocuSign, has been a successful one. Here's some useful anecdotal commentary from founder and CEO Aaron Levie on the most recent Q2 earnings call detailing Box Sign traction and other go-to-market strengths:</p>\n<blockquote>\n Initial response from customers has been very positive and we're rolling out Box Sign to all business and enterprise customers throughout this fall with a significant roadmap of innovation ahead [...]\n</blockquote>\n<blockquote>\n Building on the success of suites, in late July, we also announced a new simplified product addition for our enterprise customers called Enterprise Plus, which includes shield governance, relay, platform, Box Sign, the ability for large file uploads and enhanced support and consulting credits. You can see the success of our go-to-market efforts most clearly when looking at our Q2 customer expansion. For instance, one of the largest banks in the world purchases seven figure deal with multiple products, including key safe governance, relay shield and platform to support new use cases for Box, including claims processing and loan origination and a more secure virtual environment.\"\n</blockquote>\n<p>To Levie's last point, multi-product customers have become a defining feature of Box's growth strategy. 73% of Box's &gt;$100k deals are now \"Box Suite\" deals, with custom pricing for a basket of Box services. Two years ago, when Box was still rolling out Suites, this rate stood closer to 10%.</p>\n<p>The trend toward more products per customer has helped bring up Box's net revenue retention rates as well, which you can see in the chart below has improved to 106%, from the low 100% range during the pandemic:</p>\n<p>Figure 4. Box net retention rates</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/04cfd569714ad97156280e851aa6abac\" tg-width=\"640\" tg-height=\"337\" width=\"100%\" height=\"auto\"><span>Source: Box Q2 investor presentation</span></p>\n<p>Box also managed to retain these strong top-line trends while delivering substantial profitability performance. The company's gross margins improved 100bps to 74.5%, while pro forma operating expenses fell 4% as a percentage of revenue, driven by a two-point reduction each in sales and marketing and R&amp;D expenses:</p>\n<p>Figure 5. Box gross margin trends</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/92552ec3249e1c378987e476b7ff4bb3\" tg-width=\"640\" tg-height=\"328\" width=\"100%\" height=\"auto\"><span>Source: Box Q2 investor presentation</span></p>\n<p>The company also delivered $29.8 million of free cash flow in the quarter, up more than 2x y/y. Year to date, Box's free cash flow of $105.7 million has also doubled y/y and is at a 25% FCF margin.</p>\n<p><b>Key takeaways</b></p>\n<p>Box falls into a category of stocks that I would consider \"guilt free.\" I don't need to feel anxious about buying this stock at market highs because I know its ultra-low valuation shields it from much further downside. On top of consistent low-teens growth, free cash flow expansion and ambitious long-term targets for continued FCF conversion, I'm staying long here.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Box: A Comfortable Investment At Tremendously Cheap Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBox: A Comfortable Investment At Tremendously Cheap Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 21:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4452035-box-guilt-free-stock-shielded-by-ultra-low-valuation><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nShares of Box have fallen ~5% after a strong Q2 earnings report.\nRevenue growth accelerated to 12% y/y, and billings growth of 13% y/y indicates that revenue growth may even pick up slightly....</p>\n\n<a href=\"https://seekingalpha.com/article/4452035-box-guilt-free-stock-shielded-by-ultra-low-valuation\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BOX":"Box Inc"},"source_url":"https://seekingalpha.com/article/4452035-box-guilt-free-stock-shielded-by-ultra-low-valuation","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1177903834","content_text":"Summary\n\nShares of Box have fallen ~5% after a strong Q2 earnings report.\nRevenue growth accelerated to 12% y/y, and billings growth of 13% y/y indicates that revenue growth may even pick up slightly.\nThe company also delivered significant margin expansion and expects to hit the \"Rule of 40\" on a free cash flow basis by FY24.\nBox is still a very cheap stock at <4x forward revenue.\n\nNoam Galai/Getty Images Entertainment\nSo far, the year 2021 has been a promising one for Box(NYSE:BOX). The file storage and sharing service, one of the earlier SaaS companies to go public and gain a reputation for \"growth at all costs,\" has seen a 40% jump in its stock price year to date, more than doubling that of the S&P 500 - though that hardly makes up for Box's years of disappointing returns. This is the year, however, that investors have seemed to favor positioning themselves defensively with value stocks over growth, even with the market counting to sit at all-time highs.\nA slight crack in this positive rebound showed after Box reported Q2 results, which resulted in a ~5% dip despite strong top and bottom-line results. In my view, the dip is a strong buying opportunity in a company that has repeatedly shown its capacity to scale profitably and to retain growth in a software category that is often described as overly competitive.\nData by YCharts\nMy main investing strategy over the past year has been to find stocks that I feel comfortable buying at all-time market tops. The basic question here is: \"what stock will be relatively immune to, say, a ~20% market correction, by gist of the fact that it's already currently cheap to begin with?\" Box has always retained a strong value element, and today, with strong forward-looking estimates plus a still-depressed share price, that value element has never been brighter.\nAt current share prices near $25, Box trades at a market cap of $3.85 billion. After we net off the $829.4 million of cash and $366.5 million of debt on Box's most recent balance sheet, the company's resulting enterprise value is $3.39 billion.\nFor the current fiscal year, Box has guided to revenue of $856-$860 million, representing 12% y/y growth. For the next fiscal year (FY22), Wall Street analysts have given a consensus revenue target of $942.5 million for Box, representing 11% y/y growth (data from Yahoo Finance). This puts Box's valuation multiples at an ultra-modest multiple of:\n\n4.0x EV/FY21 revenue\n3.6x EV/FY22 revenue\n\nRecall as well that Box has maintained its goal of hitting a \"Rule of 40\" profile by FY24, which it defines as revenue growth plus free cash flow margin (the latter standing in for how most companies calculate the Rule of 40, with pro forma operating margin instead of FCF).\nFigure 1. Box Rule of 40\nSource: BoxQ2 investor presentation\nLet's tease that out quickly. If Box hits 11% y/y growth in the two years after FY22, then its revenue in that year would be $1.16 billion. The lower point of its guidance would suggest a 29% FCF margin (though it really expects to be at 40%+ growth plus FCF margin in that year), which would imply $336.4 million in FCF. Its current valuation, then, stands at a ~10x multiple of future cash flow (an even lower multiple would result if Box outperforms the lower end of its Rule of 40 guidance).\nAside from the free cash flow opportunity, here are the other reasons to be bullish on Box, as a refresher:\n\nNearly pure recurring revenue business that has shown resilience during macroeconomic shocks.Even amid the pandemic, Box has managed to retain its low double-digit/high single-digit revenue growth rates. Revenue growth in Q2 accelerated over Q1, showing sustained momentum.\nEnterprise orientation.Of all of its well-known competitors, Box is the only company that is enterprise-focused. The company touts its security features plus advanced capabilities like Box Skills as key distinguishers versus the likes of Dropbox.\nBox's product portfolio expansion has led to a $55 billion market.Despite competition, Box cites a massive $55 billion market across storage, content collaboration, and data security. That's a big enough space for multiple incumbents, and also suggests Box is only currently ~2% penetrated into this overall market. Recent portfolio additions like Box Sign have greatly expanded Box's potential.\n\nStay long here and use the dip as a buying opportunity.\nQ2 download\nLet's now cover Box's latest second-quarter results in greater detail. There were no major red flags to be found, in my mind, that warrants Box's ~5% drop.\nStarting with revenue: Box saw its revenue growth accelerate two points in the quarter, growing 12% y/y to $214.5 million, edging out over Wall Street's $213.0 million (+11% y/y) expectations. We note as well that this is Box's strongest quarter for revenue growth over the past five.\nFigure 2. Box revenue growth trends\nSource: Box Q2 investor presentation\nBox has also shown strong billings trends. Recall that in Q1, the company saw 24% y/y growth in billings, but against a very easy pandemic comp that saw deal signings materially slow down upon the immediate start of lockdowns. Yet billings were also strong in Q2 at 13% y/y growth, indicating that revenue growth may accelerate beyond 12% y/y growth in the near future. Note that Box's long-term operating plan calls for revenue growth between 12-16% y/y (so our expectations of 11% y/y are more on the conservative side). Box's deferred revenue is also up 16% y/y, indicating a strong \"pipeline\" of deals billed that are waiting to be recognized as revenue.\nFigure 3. Box billings trends\nSource: Box Q2 investor presentation\nThe company has noted that the rollout of the Box Sign product, Box's answer to the likes of DocuSign, has been a successful one. Here's some useful anecdotal commentary from founder and CEO Aaron Levie on the most recent Q2 earnings call detailing Box Sign traction and other go-to-market strengths:\n\n Initial response from customers has been very positive and we're rolling out Box Sign to all business and enterprise customers throughout this fall with a significant roadmap of innovation ahead [...]\n\n\n Building on the success of suites, in late July, we also announced a new simplified product addition for our enterprise customers called Enterprise Plus, which includes shield governance, relay, platform, Box Sign, the ability for large file uploads and enhanced support and consulting credits. You can see the success of our go-to-market efforts most clearly when looking at our Q2 customer expansion. For instance, one of the largest banks in the world purchases seven figure deal with multiple products, including key safe governance, relay shield and platform to support new use cases for Box, including claims processing and loan origination and a more secure virtual environment.\"\n\nTo Levie's last point, multi-product customers have become a defining feature of Box's growth strategy. 73% of Box's >$100k deals are now \"Box Suite\" deals, with custom pricing for a basket of Box services. Two years ago, when Box was still rolling out Suites, this rate stood closer to 10%.\nThe trend toward more products per customer has helped bring up Box's net revenue retention rates as well, which you can see in the chart below has improved to 106%, from the low 100% range during the pandemic:\nFigure 4. Box net retention rates\nSource: Box Q2 investor presentation\nBox also managed to retain these strong top-line trends while delivering substantial profitability performance. The company's gross margins improved 100bps to 74.5%, while pro forma operating expenses fell 4% as a percentage of revenue, driven by a two-point reduction each in sales and marketing and R&D expenses:\nFigure 5. Box gross margin trends\nSource: Box Q2 investor presentation\nThe company also delivered $29.8 million of free cash flow in the quarter, up more than 2x y/y. Year to date, Box's free cash flow of $105.7 million has also doubled y/y and is at a 25% FCF margin.\nKey takeaways\nBox falls into a category of stocks that I would consider \"guilt free.\" I don't need to feel anxious about buying this stock at market highs because I know its ultra-low valuation shields it from much further downside. On top of consistent low-teens growth, free cash flow expansion and ambitious long-term targets for continued FCF conversion, I'm staying long here.","news_type":1,"symbols_score_info":{"BOX":0.9}},"isVote":1,"tweetType":1,"viewCount":515,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810118617,"gmtCreate":1629951532239,"gmtModify":1676530182398,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/810118617","repostId":"1197918153","repostType":4,"repost":{"id":"1197918153","kind":"news","pubTimestamp":1629948466,"share":"https://ttm.financial/m/news/1197918153?lang=&edition=full_marsco","pubTime":"2021-08-26 11:27","market":"us","language":"en","title":"AMC Stock: Running Of The Bulls Knocks Short Sellers Down","url":"https://stock-news.laohu8.com/highlight/detail?id=1197918153","media":"Thestreet","summary":"The August 24 trading session provided AMC stock (AMC) -Get Report owners with reasons to be optimis","content":"<p>The August 24 trading session provided AMC stock&nbsp;(<b>AMC</b>) -Get Report&nbsp;owners with reasons to be optimistic about a run towards new peaks. Possibly motivated by broad market movements that were also positive, AMC surged 20% and finally broke into the $40 levels once again.</p>\n<p>Not yet satisfied, ambitious apes still believe that the recent move in AMC is just the tip of the iceberg, and that the path to the moon is gradually being paved. Wall Street Memes reviews AMC stock’s recent performance.</p>\n<h3>Broad market strength</h3>\n<p>The US stock market had a record-breaking dayon August 24. In a week marked by chatter around monetary policy and the Jackson Hole symposium, vaccine approval news and the Chinese market’s retraction helped to fuel the market’s euphoria in the US.</p>\n<p>AMC trading volume reached about 220 million shares on August 24, more than double the average 10-day metric.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d1cc490ca24ca006f0cad2c9b785eb27\" tg-width=\"1200\" tg-height=\"595\" width=\"100%\" height=\"auto\"><span>Figure 1: AMC historical data and trading volume.</span></p>\n<h3>Bullish drivers</h3>\n<p>AMC’s popularity across the main online discussion boards remains at peak levels. The top meme stock’s performance mirrored WallStreetBets’ commentary volume, although correlation does not necessarily mean causation.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/81369ea6c61e3992aad71b0bb2d24e20\" tg-width=\"1200\" tg-height=\"609\" width=\"100%\" height=\"auto\"><span>Figure 2: WSB ticker sentiment - AMC.Swaggy Stocks</span></p>\n<p>Short interest remains elevated and on the rise, at around 18% according to&nbsp;Yahoo Finance.&nbsp;Also, Wall Street analysts' bearishness towards the stock has served as fuel for defying AMC apes in their quest to squeeze short sellers out.</p>\n<p>The company’s recent financial performance may also be playing a role in stock price action. The&nbsp;above-expectations Q2 earnings report, which pointed at a scenario of post-pandemic recovery for AMC, reinforces the fundamentalist thesis. Keep in mind, however, that meme mania has much more to do with momentum and market dynamics than with business fundamentals.</p>\n<h3>SEC looking closely at dark pools</h3>\n<p>One of the biggest complaints and concerns of AMC shareholders is the lack of transparency in the market. There seems to be a consensus among the ape community that dark pool activities and naked short selling could be hampering AMC's ride to new highs.</p>\n<p>Recently, SEC Chair Gay Genslerspoke directly on the matter, stating that the agency is looking closely at dark pool activities&nbsp;to protect investors. While no firm action has been taken yet, the SEC’s willingness to address the issue can be seen as positive news.</p>\n<h3>Short sellers get slapped</h3>\n<p>With over 92 million AMC shares currently shorted, sellers have racked up billions of dollars in losses since meme mania emerged. The latest data&nbsp;provided&nbsp;by third-party research reveals that, as of July 20, shorts had incurred year-to-date losses of $3.8 billion.</p>\n<p>Short seller losses are probably even higher now, since AMC stock has spiked 20% in August alone. Amid a new wave of optimism, bears might be playing with fire. How long will they withstand the upward pressures? Apes’ bet: not very long.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AMC Stock: Running Of The Bulls Knocks Short Sellers Down</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAMC Stock: Running Of The Bulls Knocks Short Sellers Down\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-26 11:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/memestocks/amc/amc-stock-running-of-the-bulls-knocks-short-sellers-down><strong>Thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The August 24 trading session provided AMC stock (AMC) -Get Report owners with reasons to be optimistic about a run towards new peaks. Possibly motivated by broad market movements that were also ...</p>\n\n<a href=\"https://www.thestreet.com/memestocks/amc/amc-stock-running-of-the-bulls-knocks-short-sellers-down\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"https://www.thestreet.com/memestocks/amc/amc-stock-running-of-the-bulls-knocks-short-sellers-down","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197918153","content_text":"The August 24 trading session provided AMC stock (AMC) -Get Report owners with reasons to be optimistic about a run towards new peaks. Possibly motivated by broad market movements that were also positive, AMC surged 20% and finally broke into the $40 levels once again.\nNot yet satisfied, ambitious apes still believe that the recent move in AMC is just the tip of the iceberg, and that the path to the moon is gradually being paved. Wall Street Memes reviews AMC stock’s recent performance.\nBroad market strength\nThe US stock market had a record-breaking dayon August 24. In a week marked by chatter around monetary policy and the Jackson Hole symposium, vaccine approval news and the Chinese market’s retraction helped to fuel the market’s euphoria in the US.\nAMC trading volume reached about 220 million shares on August 24, more than double the average 10-day metric.\nFigure 1: AMC historical data and trading volume.\nBullish drivers\nAMC’s popularity across the main online discussion boards remains at peak levels. The top meme stock’s performance mirrored WallStreetBets’ commentary volume, although correlation does not necessarily mean causation.\nFigure 2: WSB ticker sentiment - AMC.Swaggy Stocks\nShort interest remains elevated and on the rise, at around 18% according to Yahoo Finance. Also, Wall Street analysts' bearishness towards the stock has served as fuel for defying AMC apes in their quest to squeeze short sellers out.\nThe company’s recent financial performance may also be playing a role in stock price action. The above-expectations Q2 earnings report, which pointed at a scenario of post-pandemic recovery for AMC, reinforces the fundamentalist thesis. Keep in mind, however, that meme mania has much more to do with momentum and market dynamics than with business fundamentals.\nSEC looking closely at dark pools\nOne of the biggest complaints and concerns of AMC shareholders is the lack of transparency in the market. There seems to be a consensus among the ape community that dark pool activities and naked short selling could be hampering AMC's ride to new highs.\nRecently, SEC Chair Gay Genslerspoke directly on the matter, stating that the agency is looking closely at dark pool activities to protect investors. While no firm action has been taken yet, the SEC’s willingness to address the issue can be seen as positive news.\nShort sellers get slapped\nWith over 92 million AMC shares currently shorted, sellers have racked up billions of dollars in losses since meme mania emerged. The latest data provided by third-party research reveals that, as of July 20, shorts had incurred year-to-date losses of $3.8 billion.\nShort seller losses are probably even higher now, since AMC stock has spiked 20% in August alone. Amid a new wave of optimism, bears might be playing with fire. How long will they withstand the upward pressures? Apes’ bet: not very long.","news_type":1,"symbols_score_info":{"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":432,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837260667,"gmtCreate":1629894055159,"gmtModify":1676530164311,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/837260667","repostId":"1179982896","repostType":4,"isVote":1,"tweetType":1,"viewCount":375,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837260163,"gmtCreate":1629894049252,"gmtModify":1676530164319,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/837260163","repostId":"1179982896","repostType":4,"isVote":1,"tweetType":1,"viewCount":641,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834813532,"gmtCreate":1629788642426,"gmtModify":1676530131270,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/834813532","repostId":"1176455806","repostType":4,"repost":{"id":"1176455806","kind":"news","pubTimestamp":1629788575,"share":"https://ttm.financial/m/news/1176455806?lang=&edition=full_marsco","pubTime":"2021-08-24 15:02","market":"us","language":"en","title":"MSCI CEO Dismisses Concern Chinese Stocks Are ‘Uninvestable’","url":"https://stock-news.laohu8.com/highlight/detail?id=1176455806","media":"Bloomberg","summary":"Stocks have ‘very quickly’ recovered in past: CEO Fernandez\n‘Countries go through periods like this,","content":"<ul>\n <li>Stocks have ‘very quickly’ recovered in past: CEO Fernandez</li>\n <li>‘Countries go through periods like this,’ MSCI head says</li>\n</ul>\n<p>MSCI Inc., the world’s biggest index provider, shook off concerns about the “investability” of Chinese stocks following recent Beijing’s regulatory crackdown, citing previous instances where markets rebounded in the aftermath.</p>\n<p>Regulatory compliance has weighed on China “every three, four, five years and obviously the markets have sold off at the time. But very quickly afterwards, the markets have recovered and gone through to new heights,” MSCI Inc. Chairman and Chief Executive Officer Henry Fernandez told Bloomberg Television’s Haidi Lun and Shery Ahn in an interview.</p>\n<p>MSCI’s optimism on China stands in contrast to some investors who have called the nation’s stock market “uninvestable.” Regulatory uncertainty wiped off about $1 trillion from the market value of local stocks listed globally last month, with sharp declines in sectors including online gaming, live streaming and liquor.</p>\n<p>Every emerging market in the world has faced such criticism, Fernandez said, adding there were times markets in India and Mexico were also deemed uninvestable because of actions by their governments.</p>\n<p>“We have to look at this process that the Chinese regulators are going through in the prism of the last 10 years and also across other markets in the world,” he said.</p>\n<p>Stock benchmarks in Hong Kong and on the mainland are among the world’s worst-performing major equity gauges this year, at a time when U.S. benchmarks have been setting record highs. The Hang Seng Index dropped into a&nbsp;bear market&nbsp;last week.</p>\n<p><img src=\"https://static.tigerbbs.com/d1465635205eceae4d5d2c389ee91659\" tg-width=\"1200\" tg-height=\"675\" width=\"100%\" height=\"auto\"></p>\n<p>China’s regulatory campaign has come after a decade-plus boom in index investing that’s led to billions of dollars tracking Chinese stocks in gauges such as the MSCI Emerging Market Index and the MSCI Asia Pacific Index.</p>\n<p>MSCI, as well as rivals FTSE Russell and S&amp;P Dow Jones Indices LLC, have boosted their offerings of Chinese stocks over the years due to client demand for exposure to world’s second-biggest economy.</p>\n<p>So far there’s little sign that index providers are reversing course, with MSCI launching a futures contract based on the MSCI China A 50 Connect Index with Hong Kong’s bourse&nbsp;next month.</p>\n<p>“There is a lot of criticism on China in terms of lack of compliance” and the country is now going through a corrective phase, Fernandez said. “Countries go through periods like this.”</p>\n<p>Gabriela Santos, a global market strategist at JPMorgan Chase’s asset management unit, also disagrees with the view that China is now uninvestable.</p>\n<p>“We had this in 2018, 2015 and 2011 and it’s unrelated to the economic cycle -- it’s related to China’s regulatory and reform campaigns,” she said in an interview with Bloomberg Television on Saturday. “It takes time to rebuild confidence, but three months out Chinese equities tend to trend up.”</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MSCI CEO Dismisses Concern Chinese Stocks Are ‘Uninvestable’</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMSCI CEO Dismisses Concern Chinese Stocks Are ‘Uninvestable’\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-24 15:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-08-24/china-stocks-can-shrug-off-crackdown-to-reclaim-highs-msci-says?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks have ‘very quickly’ recovered in past: CEO Fernandez\n‘Countries go through periods like this,’ MSCI head says\n\nMSCI Inc., the world’s biggest index provider, shook off concerns about the “...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-08-24/china-stocks-can-shrug-off-crackdown-to-reclaim-highs-msci-says?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"399001":"深证成指","399006":"创业板指","HSTECH":"恒生科技指数","000001.SH":"上证指数","HSI":"恒生指数"},"source_url":"https://www.bloomberg.com/news/articles/2021-08-24/china-stocks-can-shrug-off-crackdown-to-reclaim-highs-msci-says?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176455806","content_text":"Stocks have ‘very quickly’ recovered in past: CEO Fernandez\n‘Countries go through periods like this,’ MSCI head says\n\nMSCI Inc., the world’s biggest index provider, shook off concerns about the “investability” of Chinese stocks following recent Beijing’s regulatory crackdown, citing previous instances where markets rebounded in the aftermath.\nRegulatory compliance has weighed on China “every three, four, five years and obviously the markets have sold off at the time. But very quickly afterwards, the markets have recovered and gone through to new heights,” MSCI Inc. Chairman and Chief Executive Officer Henry Fernandez told Bloomberg Television’s Haidi Lun and Shery Ahn in an interview.\nMSCI’s optimism on China stands in contrast to some investors who have called the nation’s stock market “uninvestable.” Regulatory uncertainty wiped off about $1 trillion from the market value of local stocks listed globally last month, with sharp declines in sectors including online gaming, live streaming and liquor.\nEvery emerging market in the world has faced such criticism, Fernandez said, adding there were times markets in India and Mexico were also deemed uninvestable because of actions by their governments.\n“We have to look at this process that the Chinese regulators are going through in the prism of the last 10 years and also across other markets in the world,” he said.\nStock benchmarks in Hong Kong and on the mainland are among the world’s worst-performing major equity gauges this year, at a time when U.S. benchmarks have been setting record highs. The Hang Seng Index dropped into a bear market last week.\n\nChina’s regulatory campaign has come after a decade-plus boom in index investing that’s led to billions of dollars tracking Chinese stocks in gauges such as the MSCI Emerging Market Index and the MSCI Asia Pacific Index.\nMSCI, as well as rivals FTSE Russell and S&P Dow Jones Indices LLC, have boosted their offerings of Chinese stocks over the years due to client demand for exposure to world’s second-biggest economy.\nSo far there’s little sign that index providers are reversing course, with MSCI launching a futures contract based on the MSCI China A 50 Connect Index with Hong Kong’s bourse next month.\n“There is a lot of criticism on China in terms of lack of compliance” and the country is now going through a corrective phase, Fernandez said. “Countries go through periods like this.”\nGabriela Santos, a global market strategist at JPMorgan Chase’s asset management unit, also disagrees with the view that China is now uninvestable.\n“We had this in 2018, 2015 and 2011 and it’s unrelated to the economic cycle -- it’s related to China’s regulatory and reform campaigns,” she said in an interview with Bloomberg Television on Saturday. “It takes time to rebuild confidence, but three months out Chinese equities tend to trend up.”","news_type":1,"symbols_score_info":{"399001":0.9,"399006":0.9,"000001.SH":0.9,"HSI":0.9,"HSTECH":0.9}},"isVote":1,"tweetType":1,"viewCount":529,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":890567148,"gmtCreate":1628124466684,"gmtModify":1703501605064,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/890567148","repostId":"1179402387","repostType":4,"isVote":1,"tweetType":1,"viewCount":446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":896617263,"gmtCreate":1628577463452,"gmtModify":1703508422823,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/896617263","repostId":"1127196790","repostType":4,"isVote":1,"tweetType":1,"viewCount":417,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":148375861,"gmtCreate":1625951138553,"gmtModify":1703751077981,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/148375861","repostId":"1177397700","repostType":4,"isVote":1,"tweetType":1,"viewCount":266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":133850113,"gmtCreate":1621736728832,"gmtModify":1704361880688,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Like and comment. thanks.","listText":"Like and comment. thanks.","text":"Like and comment. thanks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/133850113","repostId":"2137906121","repostType":4,"isVote":1,"tweetType":1,"viewCount":578,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3576796562001389","authorId":"3576796562001389","name":"JessFeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"idStr":"3576796562001389","authorIdStr":"3576796562001389"},"content":"reply my comment pls","text":"reply my comment pls","html":"reply my comment pls"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860341377,"gmtCreate":1632141101899,"gmtModify":1676530708683,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/860341377","repostId":"1130418583","repostType":4,"repost":{"id":"1130418583","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632138209,"share":"https://ttm.financial/m/news/1130418583?lang=&edition=full_marsco","pubTime":"2021-09-20 19:43","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1130418583","media":"Tiger Newspress","summary":"(Sept 20) U.S. stock futures sold off Monday morning, tracking declines in overseas equities as inve","content":"<p>(Sept 20)&nbsp;U.S. stock futures sold off Monday morning, tracking declines in overseas equities as investors nervously eyed the potential ripple effects of the default of a major Chinese real estate company and ongoing debates over the debt limit in Washington.</p>\n<p>At 07:47 a.m. ET,&nbsp;Dow futures sank by more than 600 points, or 1.79%, in early trading. S&amp;P 500 futures also dropped by more than 1%, adding to losses from last week. The CBOE Volatility Index, or Vix (^VIX), jumped by more than 30% as a confluence of concerns roiled markets.</p>\n<p><img src=\"https://static.tigerbbs.com/b8c25019026526b24ae7ba8fd17ac289\" tg-width=\"1242\" tg-height=\"503\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Stocks making the biggest moves premarket</b></p>\n<p>1)&nbsp;China Evergrande Group—&nbsp;Chinese property giant&nbsp;Evergrande tumbled more than 10% on Hong Kong Stock Exchange, spooking Asian markets.&nbsp;The company has been scrambling to pay its suppliers, and warned investors twice in as many weeks that it could default on its debts. Last week Evergrande said its property sales will likely continue to drop significantly in September after declining for months.</p>\n<p><b>2)&nbsp;<a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b> — The pharmaceutical giantsaid Mondaythat trials showed its Covid vaccine was safe and effective when used in children ages 5 to 11. Pfizer and partner BioNTech said they would submit the results for approval “as soon as possible.” Shares of Pfizer were down about 1% in premarket trading.</p>\n<p><b>3)&nbsp;<a href=\"https://laohu8.com/S/LPI\">Laredo</a> ,<a href=\"https://laohu8.com/S/OXY\">Occidental</a></b> — Oil and energy stocks dipped in premarket trading on Monday. The SPDR S&amp;P Oil &amp; Gas Exploration ETF is down more than 3% in early trading, on pace for its 3rd straight negative session. Laredo Petroleum is down more than 8%, Callon Petroleum is down roughly 6%, and Occidental Petroleum is down nearly 5%. The losses came as crude oil fell on fears of a global economic slowdown tied to the China property market.</p>\n<p><b>4)&nbsp;<a href=\"https://laohu8.com/S/CL\">Colgate-Palmolive</a></b> — The consumer staples stock wasupgradedto buy from hold by Deutsche Bank on Sunday. The investment firm said that Colgate’s difficulties with inflation and in some international markets was already priced in to its stock.</p>\n<p>5)&nbsp;JPMorgan,&nbsp;Bank of America— Bank stocks slid in unison amid a decline in bond yields on slowdown fears. Investors flocked to Treasurys for safety as the stock market is set for its biggest sell-off in months. Big bank stocks took a hit as the falling rates may crimp profits. Bank of America and JPMorgan Chase were each down more than 2% in premarket trading. Citizens Financial Group dropped 3%, while Citigroup declined 2.5%.</p>\n<p><b>6)&nbsp;<a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a></b> — The United Kingdom-based pharmaceutical company announced on Monday that its breast cancer drug Enhertu showed positive results in a phase-three trial. Shares of the company were up more than 1% in premarket trading.</p>\n<p><b>7)&nbsp;<a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a> </b>— Cathie Wood’s ARK Innovation ETF is down 2.75% in the premarket, on pace to snap a 3-day winning streak. Compugen, DraftKings, Coinbase and Square are so of the ETF’s biggest losers this morning.</p>\n<p>Some investors believe this is just normal market action that can occur in September.</p>\n<p>“The reasons for drop this morning are the same as last week: China concerns (Evergrande, regulation, COVID), Fed tapering and possible tax hikes, but nothing new occurred this weekend to justify this mornings’ declines,” Tom Essaye, founder of Sevens Report, said in a note.</p>\n<p>Other risky assets declined on Monday.Bitcoinlost 8% tobelow $44,000.</p>\n<p>Most commodities were in the red.Goldwas among the few assets in the green, adding 0.5% to $1,760.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-20 19:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Sept 20)&nbsp;U.S. stock futures sold off Monday morning, tracking declines in overseas equities as investors nervously eyed the potential ripple effects of the default of a major Chinese real estate company and ongoing debates over the debt limit in Washington.</p>\n<p>At 07:47 a.m. ET,&nbsp;Dow futures sank by more than 600 points, or 1.79%, in early trading. S&amp;P 500 futures also dropped by more than 1%, adding to losses from last week. The CBOE Volatility Index, or Vix (^VIX), jumped by more than 30% as a confluence of concerns roiled markets.</p>\n<p><img src=\"https://static.tigerbbs.com/b8c25019026526b24ae7ba8fd17ac289\" tg-width=\"1242\" tg-height=\"503\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Stocks making the biggest moves premarket</b></p>\n<p>1)&nbsp;China Evergrande Group—&nbsp;Chinese property giant&nbsp;Evergrande tumbled more than 10% on Hong Kong Stock Exchange, spooking Asian markets.&nbsp;The company has been scrambling to pay its suppliers, and warned investors twice in as many weeks that it could default on its debts. Last week Evergrande said its property sales will likely continue to drop significantly in September after declining for months.</p>\n<p><b>2)&nbsp;<a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b> — The pharmaceutical giantsaid Mondaythat trials showed its Covid vaccine was safe and effective when used in children ages 5 to 11. Pfizer and partner BioNTech said they would submit the results for approval “as soon as possible.” Shares of Pfizer were down about 1% in premarket trading.</p>\n<p><b>3)&nbsp;<a href=\"https://laohu8.com/S/LPI\">Laredo</a> ,<a href=\"https://laohu8.com/S/OXY\">Occidental</a></b> — Oil and energy stocks dipped in premarket trading on Monday. The SPDR S&amp;P Oil &amp; Gas Exploration ETF is down more than 3% in early trading, on pace for its 3rd straight negative session. Laredo Petroleum is down more than 8%, Callon Petroleum is down roughly 6%, and Occidental Petroleum is down nearly 5%. The losses came as crude oil fell on fears of a global economic slowdown tied to the China property market.</p>\n<p><b>4)&nbsp;<a href=\"https://laohu8.com/S/CL\">Colgate-Palmolive</a></b> — The consumer staples stock wasupgradedto buy from hold by Deutsche Bank on Sunday. The investment firm said that Colgate’s difficulties with inflation and in some international markets was already priced in to its stock.</p>\n<p>5)&nbsp;JPMorgan,&nbsp;Bank of America— Bank stocks slid in unison amid a decline in bond yields on slowdown fears. Investors flocked to Treasurys for safety as the stock market is set for its biggest sell-off in months. Big bank stocks took a hit as the falling rates may crimp profits. Bank of America and JPMorgan Chase were each down more than 2% in premarket trading. Citizens Financial Group dropped 3%, while Citigroup declined 2.5%.</p>\n<p><b>6)&nbsp;<a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a></b> — The United Kingdom-based pharmaceutical company announced on Monday that its breast cancer drug Enhertu showed positive results in a phase-three trial. Shares of the company were up more than 1% in premarket trading.</p>\n<p><b>7)&nbsp;<a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a> </b>— Cathie Wood’s ARK Innovation ETF is down 2.75% in the premarket, on pace to snap a 3-day winning streak. Compugen, DraftKings, Coinbase and Square are so of the ETF’s biggest losers this morning.</p>\n<p>Some investors believe this is just normal market action that can occur in September.</p>\n<p>“The reasons for drop this morning are the same as last week: China concerns (Evergrande, regulation, COVID), Fed tapering and possible tax hikes, but nothing new occurred this weekend to justify this mornings’ declines,” Tom Essaye, founder of Sevens Report, said in a note.</p>\n<p>Other risky assets declined on Monday.Bitcoinlost 8% tobelow $44,000.</p>\n<p>Most commodities were in the red.Goldwas among the few assets in the green, adding 0.5% to $1,760.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯","SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130418583","content_text":"(Sept 20) U.S. stock futures sold off Monday morning, tracking declines in overseas equities as investors nervously eyed the potential ripple effects of the default of a major Chinese real estate company and ongoing debates over the debt limit in Washington.\nAt 07:47 a.m. ET, Dow futures sank by more than 600 points, or 1.79%, in early trading. S&P 500 futures also dropped by more than 1%, adding to losses from last week. The CBOE Volatility Index, or Vix (^VIX), jumped by more than 30% as a confluence of concerns roiled markets.\n\nStocks making the biggest moves premarket\n1) China Evergrande Group— Chinese property giant Evergrande tumbled more than 10% on Hong Kong Stock Exchange, spooking Asian markets. The company has been scrambling to pay its suppliers, and warned investors twice in as many weeks that it could default on its debts. Last week Evergrande said its property sales will likely continue to drop significantly in September after declining for months.\n2) Pfizer — The pharmaceutical giantsaid Mondaythat trials showed its Covid vaccine was safe and effective when used in children ages 5 to 11. Pfizer and partner BioNTech said they would submit the results for approval “as soon as possible.” Shares of Pfizer were down about 1% in premarket trading.\n3) Laredo ,Occidental — Oil and energy stocks dipped in premarket trading on Monday. The SPDR S&P Oil & Gas Exploration ETF is down more than 3% in early trading, on pace for its 3rd straight negative session. Laredo Petroleum is down more than 8%, Callon Petroleum is down roughly 6%, and Occidental Petroleum is down nearly 5%. The losses came as crude oil fell on fears of a global economic slowdown tied to the China property market.\n4) Colgate-Palmolive — The consumer staples stock wasupgradedto buy from hold by Deutsche Bank on Sunday. The investment firm said that Colgate’s difficulties with inflation and in some international markets was already priced in to its stock.\n5) JPMorgan, Bank of America— Bank stocks slid in unison amid a decline in bond yields on slowdown fears. Investors flocked to Treasurys for safety as the stock market is set for its biggest sell-off in months. Big bank stocks took a hit as the falling rates may crimp profits. Bank of America and JPMorgan Chase were each down more than 2% in premarket trading. Citizens Financial Group dropped 3%, while Citigroup declined 2.5%.\n6) AstraZeneca Plc — The United Kingdom-based pharmaceutical company announced on Monday that its breast cancer drug Enhertu showed positive results in a phase-three trial. Shares of the company were up more than 1% in premarket trading.\n7) ARK Innovation ETF — Cathie Wood’s ARK Innovation ETF is down 2.75% in the premarket, on pace to snap a 3-day winning streak. Compugen, DraftKings, Coinbase and Square are so of the ETF’s biggest losers this morning.\nSome investors believe this is just normal market action that can occur in September.\n“The reasons for drop this morning are the same as last week: China concerns (Evergrande, regulation, COVID), Fed tapering and possible tax hikes, but nothing new occurred this weekend to justify this mornings’ declines,” Tom Essaye, founder of Sevens Report, said in a note.\nOther risky assets declined on Monday.Bitcoinlost 8% tobelow $44,000.\nMost commodities were in the red.Goldwas among the few assets in the green, adding 0.5% to $1,760.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":1870,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837260667,"gmtCreate":1629894055159,"gmtModify":1676530164311,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/837260667","repostId":"1179982896","repostType":4,"isVote":1,"tweetType":1,"viewCount":375,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838716794,"gmtCreate":1629429181618,"gmtModify":1676530038479,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"&nbsp;Hi","listText":"&nbsp;Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/838716794","repostId":"1190786418","repostType":4,"repost":{"id":"1190786418","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1629428881,"share":"https://ttm.financial/m/news/1190786418?lang=&edition=full_marsco","pubTime":"2021-08-20 11:08","market":"us","language":"en","title":"Musk says Tesla will launch prototype of humanoid robot next year","url":"https://stock-news.laohu8.com/highlight/detail?id=1190786418","media":"Reuters","summary":"SAN FRANCISCO, Aug 19 (Reuters) - Tesla Inc CEO Elon Musk on Thursday said it will probably launch t","content":"<p>SAN FRANCISCO, Aug 19 (Reuters) - Tesla Inc&nbsp;CEO Elon Musk on Thursday said it will probably launch the prototype of a humanoid robot called \"Tesla Bot\" next year, saying the robot would \"eliminate dangerous, repetitive, boring tasks.\"</p>\n<p>The robot with a human-like appearance would carry out the work people like to do least, with \"profound implications for the economy,\" Musk said at the company's AI Day event on Thursday.</p>\n<p>Tesla unveiled at the event&nbsp;chips it designed in-house&nbsp;for its fast computer, Dojo, to train its automated driving system.</p>\n<p>Musk said Dojo would be operational next year.</p>\n<p>A few years ago, Musk asked Tesla engineers \"to design a superfast training computer and that's how we started Project Dojo,\" Tesla director Ganesh Venkataramanan said at the AI Day event.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Musk says Tesla will launch prototype of humanoid robot next year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMusk says Tesla will launch prototype of humanoid robot next year\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-20 11:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SAN FRANCISCO, Aug 19 (Reuters) - Tesla Inc&nbsp;CEO Elon Musk on Thursday said it will probably launch the prototype of a humanoid robot called \"Tesla Bot\" next year, saying the robot would \"eliminate dangerous, repetitive, boring tasks.\"</p>\n<p>The robot with a human-like appearance would carry out the work people like to do least, with \"profound implications for the economy,\" Musk said at the company's AI Day event on Thursday.</p>\n<p>Tesla unveiled at the event&nbsp;chips it designed in-house&nbsp;for its fast computer, Dojo, to train its automated driving system.</p>\n<p>Musk said Dojo would be operational next year.</p>\n<p>A few years ago, Musk asked Tesla engineers \"to design a superfast training computer and that's how we started Project Dojo,\" Tesla director Ganesh Venkataramanan said at the AI Day event.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190786418","content_text":"SAN FRANCISCO, Aug 19 (Reuters) - Tesla Inc CEO Elon Musk on Thursday said it will probably launch the prototype of a humanoid robot called \"Tesla Bot\" next year, saying the robot would \"eliminate dangerous, repetitive, boring tasks.\"\nThe robot with a human-like appearance would carry out the work people like to do least, with \"profound implications for the economy,\" Musk said at the company's AI Day event on Thursday.\nTesla unveiled at the event chips it designed in-house for its fast computer, Dojo, to train its automated driving system.\nMusk said Dojo would be operational next year.\nA few years ago, Musk asked Tesla engineers \"to design a superfast training computer and that's how we started Project Dojo,\" Tesla director Ganesh Venkataramanan said at the AI Day event.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894707438,"gmtCreate":1628853844724,"gmtModify":1676529875317,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/894707438","repostId":"2159948482","repostType":4,"isVote":1,"tweetType":1,"viewCount":600,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":886038032,"gmtCreate":1631536981126,"gmtModify":1676530568891,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/886038032","repostId":"1129341543","repostType":4,"repost":{"id":"1129341543","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631534652,"share":"https://ttm.financial/m/news/1129341543?lang=&edition=full_marsco","pubTime":"2021-09-13 20:04","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1129341543","media":"Tiger Newspress","summary":"U.S. stock index futures rose on Monday after the S&P 500 logged its worst week in more than two mon","content":"<p>U.S. stock index futures rose on Monday after the S&amp;P 500 logged its worst week in more than two months, with investors keeping a close eye on inflation as well as monetary and tax policies.</p>\n<p>S&amp;P 500 E-minis were up 23.25 points, or 0.52% at 08:00 am ET. Dow E-minis were up 183 points, or 0.53%, while Nasdaq 100 E-minis were up 75 points, or 0.49%.</p>\n<p><img src=\"https://static.tigerbbs.com/2d51dd22d532e1b98f0ecae05c1f7a3e\" tg-width=\"1080\" tg-height=\"416\" width=\"100%\" height=\"auto\"></p>\n<p>Apple Inc rose 0.9% in premarket trading after a mixed court ruling in Epic Games’ antitrust case against the iPhone maker knocked nearly $90 billion off its market value on Friday.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Virgin Galactic(SPCE)</b> – Virgin Galactic is delaying its first commercial research space mission after a third-party supplier warned of a potential defect in a component of the flight control system. Virgin Galactic shares slid 3.3% in the premarket.</p>\n<p><b>Dell Technologies(DELL) </b>– Dell added 1.9% in premarket action after Goldman Sachs added the computer maker’s stock to its “Conviction Buy” list. Goldman cited strong cash flow generation and debt paydown plans, among other factors.</p>\n<p><b>TransUnion(TRU)</b> – TransUnion announced a deal to buy closely held information services company Neustar for $3.1 billion in cash. The credit reporting agency expects the deal to close during the fourth quarter.</p>\n<p><b>Viacom(VIAC) </b>– Viacom is planning a revamp of its Paramount Pictures unit, according to people familiar with the matter who spoke to The Wall Street Journal. The revamp, which would separate the TV and film operations, could be announced as soon as today. Viacom rose 1% in the premarket.</p>\n<p><b>Kansas City Southern(KSU)</b> – Kansas City Southern said&nbsp;the latest takeover bid&nbsp;from&nbsp;Canadian Pacific Railway(CP) is superior to the one it previously agreed to with&nbsp;Canadian National Railway(CNI). Canadian National now has five days to improve its offer, should it choose to do so. Canadian Pacific rallied 0.9% in premarket trading.</p>\n<p><b>Walt Disney(DIS)</b> – Disney will show the remainder of its 2021 movie releases exclusively in theaters, rather than making them simultaneously available on its Disney+ streaming service. Disney’s “Shang-Chi and the Legend of the 10 Rings” topped the weekend box office once again following its record Labor Day weekend performance, with that movie showing exclusively in theaters.</p>\n<p><b>Alibaba(BABA)</b> – Alibaba fell 1.7% in premarket action.</p>\n<p><b>Apple(AAPL)</b> – Epic Games will appeal Friday’s ruling that Apple’s app store was not an illegal monopoly. Epic did win a partial victory in the case, with the judge ruling that Apple must allow developers to include external payment links.</p>\n<p><b>Carlyle Group(CG)</b> – Carlyle is considering a $6 billion sale or initial public offering for packaging company Novolex, according to a Bloomberg report. The private-equity firm bought Novolex for an undisclosed amount in November 2016.</p>\n<p><b>MGM Resorts(MGM)</b> – MGM rose 1.5% in the premarket after Bernstein upgraded the resort operator’s stock to “outperform” from “market perform,” citing its strong presence in the gaming and sports betting industry as well as moves to divest the company’s real estate portfolio.</p>\n<p><b>Pfizer(PFE) </b>– Pfizer’s Covid-19 vaccine – developed in conjunction with German partner&nbsp;BioNTech(BNTX) – could be authorized for use in children aged 5-11 as soon as next month, according to two sources familiar with the situation who spoke to Reuters. Pfizer is expected to have enough study data by then to submit an application for emergency use authorization to the Food and Drug Administration. BioNTech added 1.1% in premarket trading.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-13 20:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures rose on Monday after the S&amp;P 500 logged its worst week in more than two months, with investors keeping a close eye on inflation as well as monetary and tax policies.</p>\n<p>S&amp;P 500 E-minis were up 23.25 points, or 0.52% at 08:00 am ET. Dow E-minis were up 183 points, or 0.53%, while Nasdaq 100 E-minis were up 75 points, or 0.49%.</p>\n<p><img src=\"https://static.tigerbbs.com/2d51dd22d532e1b98f0ecae05c1f7a3e\" tg-width=\"1080\" tg-height=\"416\" width=\"100%\" height=\"auto\"></p>\n<p>Apple Inc rose 0.9% in premarket trading after a mixed court ruling in Epic Games’ antitrust case against the iPhone maker knocked nearly $90 billion off its market value on Friday.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Virgin Galactic(SPCE)</b> – Virgin Galactic is delaying its first commercial research space mission after a third-party supplier warned of a potential defect in a component of the flight control system. Virgin Galactic shares slid 3.3% in the premarket.</p>\n<p><b>Dell Technologies(DELL) </b>– Dell added 1.9% in premarket action after Goldman Sachs added the computer maker’s stock to its “Conviction Buy” list. Goldman cited strong cash flow generation and debt paydown plans, among other factors.</p>\n<p><b>TransUnion(TRU)</b> – TransUnion announced a deal to buy closely held information services company Neustar for $3.1 billion in cash. The credit reporting agency expects the deal to close during the fourth quarter.</p>\n<p><b>Viacom(VIAC) </b>– Viacom is planning a revamp of its Paramount Pictures unit, according to people familiar with the matter who spoke to The Wall Street Journal. The revamp, which would separate the TV and film operations, could be announced as soon as today. Viacom rose 1% in the premarket.</p>\n<p><b>Kansas City Southern(KSU)</b> – Kansas City Southern said&nbsp;the latest takeover bid&nbsp;from&nbsp;Canadian Pacific Railway(CP) is superior to the one it previously agreed to with&nbsp;Canadian National Railway(CNI). Canadian National now has five days to improve its offer, should it choose to do so. Canadian Pacific rallied 0.9% in premarket trading.</p>\n<p><b>Walt Disney(DIS)</b> – Disney will show the remainder of its 2021 movie releases exclusively in theaters, rather than making them simultaneously available on its Disney+ streaming service. Disney’s “Shang-Chi and the Legend of the 10 Rings” topped the weekend box office once again following its record Labor Day weekend performance, with that movie showing exclusively in theaters.</p>\n<p><b>Alibaba(BABA)</b> – Alibaba fell 1.7% in premarket action.</p>\n<p><b>Apple(AAPL)</b> – Epic Games will appeal Friday’s ruling that Apple’s app store was not an illegal monopoly. Epic did win a partial victory in the case, with the judge ruling that Apple must allow developers to include external payment links.</p>\n<p><b>Carlyle Group(CG)</b> – Carlyle is considering a $6 billion sale or initial public offering for packaging company Novolex, according to a Bloomberg report. The private-equity firm bought Novolex for an undisclosed amount in November 2016.</p>\n<p><b>MGM Resorts(MGM)</b> – MGM rose 1.5% in the premarket after Bernstein upgraded the resort operator’s stock to “outperform” from “market perform,” citing its strong presence in the gaming and sports betting industry as well as moves to divest the company’s real estate portfolio.</p>\n<p><b>Pfizer(PFE) </b>– Pfizer’s Covid-19 vaccine – developed in conjunction with German partner&nbsp;BioNTech(BNTX) – could be authorized for use in children aged 5-11 as soon as next month, according to two sources familiar with the situation who spoke to Reuters. Pfizer is expected to have enough study data by then to submit an application for emergency use authorization to the Food and Drug Administration. BioNTech added 1.1% in premarket trading.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","DIS":"迪士尼","AAPL":"苹果",".IXIC":"NASDAQ Composite","BABA":"阿里巴巴","MGM":"美高梅","CG":"凯雷","TRU":"TransUnion","PFE":"辉瑞",".SPX":"S&P 500 Index",".DJI":"道琼斯","KSU":"堪萨斯南方铁路","DELL":"戴尔","SPCE":"维珍银河"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129341543","content_text":"U.S. stock index futures rose on Monday after the S&P 500 logged its worst week in more than two months, with investors keeping a close eye on inflation as well as monetary and tax policies.\nS&P 500 E-minis were up 23.25 points, or 0.52% at 08:00 am ET. Dow E-minis were up 183 points, or 0.53%, while Nasdaq 100 E-minis were up 75 points, or 0.49%.\n\nApple Inc rose 0.9% in premarket trading after a mixed court ruling in Epic Games’ antitrust case against the iPhone maker knocked nearly $90 billion off its market value on Friday.\nStocks making the biggest moves in the premarket:\nVirgin Galactic(SPCE) – Virgin Galactic is delaying its first commercial research space mission after a third-party supplier warned of a potential defect in a component of the flight control system. Virgin Galactic shares slid 3.3% in the premarket.\nDell Technologies(DELL) – Dell added 1.9% in premarket action after Goldman Sachs added the computer maker’s stock to its “Conviction Buy” list. Goldman cited strong cash flow generation and debt paydown plans, among other factors.\nTransUnion(TRU) – TransUnion announced a deal to buy closely held information services company Neustar for $3.1 billion in cash. The credit reporting agency expects the deal to close during the fourth quarter.\nViacom(VIAC) – Viacom is planning a revamp of its Paramount Pictures unit, according to people familiar with the matter who spoke to The Wall Street Journal. The revamp, which would separate the TV and film operations, could be announced as soon as today. Viacom rose 1% in the premarket.\nKansas City Southern(KSU) – Kansas City Southern said the latest takeover bid from Canadian Pacific Railway(CP) is superior to the one it previously agreed to with Canadian National Railway(CNI). Canadian National now has five days to improve its offer, should it choose to do so. Canadian Pacific rallied 0.9% in premarket trading.\nWalt Disney(DIS) – Disney will show the remainder of its 2021 movie releases exclusively in theaters, rather than making them simultaneously available on its Disney+ streaming service. Disney’s “Shang-Chi and the Legend of the 10 Rings” topped the weekend box office once again following its record Labor Day weekend performance, with that movie showing exclusively in theaters.\nAlibaba(BABA) – Alibaba fell 1.7% in premarket action.\nApple(AAPL) – Epic Games will appeal Friday’s ruling that Apple’s app store was not an illegal monopoly. Epic did win a partial victory in the case, with the judge ruling that Apple must allow developers to include external payment links.\nCarlyle Group(CG) – Carlyle is considering a $6 billion sale or initial public offering for packaging company Novolex, according to a Bloomberg report. The private-equity firm bought Novolex for an undisclosed amount in November 2016.\nMGM Resorts(MGM) – MGM rose 1.5% in the premarket after Bernstein upgraded the resort operator’s stock to “outperform” from “market perform,” citing its strong presence in the gaming and sports betting industry as well as moves to divest the company’s real estate portfolio.\nPfizer(PFE) – Pfizer’s Covid-19 vaccine – developed in conjunction with German partner BioNTech(BNTX) – could be authorized for use in children aged 5-11 as soon as next month, according to two sources familiar with the situation who spoke to Reuters. Pfizer is expected to have enough study data by then to submit an application for emergency use authorization to the Food and Drug Administration. BioNTech added 1.1% in premarket trading.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"AAPL":0.9,"BABA":0.9,"BNTX":0.9,"CG":0.9,"DELL":0.9,"DIS":0.9,"ESmain":0.9,"NQmain":0.9,"YMmain":0.9,"KSU":0.9,"MGM":0.9,"PFE":0.9,"SPCE":0.9,"TRU":0.9,"VIAC":0.9}},"isVote":1,"tweetType":1,"viewCount":1611,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832221723,"gmtCreate":1629642094962,"gmtModify":1676530084553,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/832221723","repostId":"1133515985","repostType":4,"isVote":1,"tweetType":1,"viewCount":488,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807042415,"gmtCreate":1627992316937,"gmtModify":1703499228958,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/807042415","repostId":"1109177267","repostType":4,"isVote":1,"tweetType":1,"viewCount":572,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806167518,"gmtCreate":1627642732834,"gmtModify":1703493924421,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/806167518","repostId":"2155134341","repostType":4,"isVote":1,"tweetType":1,"viewCount":338,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":881007403,"gmtCreate":1631279497902,"gmtModify":1676530517067,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/881007403","repostId":"1160544799","repostType":4,"isVote":1,"tweetType":1,"viewCount":1602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":811597743,"gmtCreate":1630331235682,"gmtModify":1676530271495,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/811597743","repostId":"2163885784","repostType":4,"repost":{"id":"2163885784","kind":"news","pubTimestamp":1630329604,"share":"https://ttm.financial/m/news/2163885784?lang=&edition=full_marsco","pubTime":"2021-08-30 21:20","market":"us","language":"en","title":"Moderna, BioNTech Rally Stalls Ahead of CDC Meeting on Boosters","url":"https://stock-news.laohu8.com/highlight/detail?id=2163885784","media":"Bloomberg","summary":"(Bloomberg) -- The huge rally for Covid-19 vaccine makers has stalled as Wall Street waits for the U","content":"<p>(Bloomberg) -- The huge rally for Covid-19 vaccine makers has stalled as Wall Street waits for the U.S Centers for Disease Control and Prevention to weigh in on whether Americans should get a third shot.</p>\n<p>On Monday, a meeting of outside advisers to the agency could finally give investors a sense of clarity.</p>\n<p>Moderna Inc., which became the best performer in the S&amp;P 500 Index after its stock price more than tripled this year, has slid 21% from its record high in early August. <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>, which has surged more than four-fold in 2021, has fallen almost as much over the past three weeks, while its U.S. partner, Pfizer Inc., is off more than 7% from its peak.</p>\n<p>The retreat comes as the pace of the American inoculation campaign slows, leaving investors divided over how much growth to expect from the manufacturers. That rift has only deepened after President Joe Biden administration promised that booster shots will be made available to most Americans, which would be a major source of demand if regulators endorse that step.</p>\n<p>The administration’s aim to push through new guidelines in late September, however, has been met with skepticism by some medical experts. The CDC as well as the U.S. Food and Drug Administration have to approve the plan before it can be implemented and that backing isn’t guaranteed.</p>\n<p>That uncertainty is likely to continue fueling volatility in the stocks. Options imply that Moderna and BioNTech could move roughly 7% in either direction over the next week while Pfizer’s stock may move about 3%.</p>\n<p><a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>’s Matthew Harrison is among Wall Street analysts who expect Biden’s plan to be backed by regulators. But but he remains equal weight on Moderna and Pfizer because he doesn’t expect any major new vaccine orders in the near future, with an estimated 630 million of unused shots from the companies already purchased through 2022.</p>\n<p>“We do not expect any supply constraints for booster doses and do not expect the U.S. government to purchase additional mRNA vaccine doses for 2022 based on current demand or booster dose need,” Harrison wrote in a research note, referring to the technology used in both Moderna and Pfizer’s shots.</p>\n<p>Analysts with Goldman Sachs Group Inc. are more bullish. The bank has a buy rating on Moderna, estimating that its shot could drive $36.2 billion of sales next year, some $15 billion more than Bloomberg’s consensus estimates. “We see upside to these numbers given supply and pricing dynamics,” said analyst Asad Haider.</p>\n<p>He sees new records for Moderna and Pfizer if U.S. and other global regulators endorse the receipt of a third dose. He estimates that Moderna shares -- which closed Friday a $382.22 -- could top $600 if boosters become the norm, while Pfizer could trade as high as $61, up from $46.58 at the end of last week. &nbsp;BioNTech already trades at best-case levels, he wrote.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, BioNTech Rally Stalls Ahead of CDC Meeting on Boosters</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, BioNTech Rally Stalls Ahead of CDC Meeting on Boosters\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-30 21:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-biontech-rally-stalls-ahead-103004269.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- The huge rally for Covid-19 vaccine makers has stalled as Wall Street waits for the U.S Centers for Disease Control and Prevention to weigh in on whether Americans should get a third ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-biontech-rally-stalls-ahead-103004269.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE","MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-biontech-rally-stalls-ahead-103004269.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2163885784","content_text":"(Bloomberg) -- The huge rally for Covid-19 vaccine makers has stalled as Wall Street waits for the U.S Centers for Disease Control and Prevention to weigh in on whether Americans should get a third shot.\nOn Monday, a meeting of outside advisers to the agency could finally give investors a sense of clarity.\nModerna Inc., which became the best performer in the S&P 500 Index after its stock price more than tripled this year, has slid 21% from its record high in early August. BioNTech SE, which has surged more than four-fold in 2021, has fallen almost as much over the past three weeks, while its U.S. partner, Pfizer Inc., is off more than 7% from its peak.\nThe retreat comes as the pace of the American inoculation campaign slows, leaving investors divided over how much growth to expect from the manufacturers. That rift has only deepened after President Joe Biden administration promised that booster shots will be made available to most Americans, which would be a major source of demand if regulators endorse that step.\nThe administration’s aim to push through new guidelines in late September, however, has been met with skepticism by some medical experts. The CDC as well as the U.S. Food and Drug Administration have to approve the plan before it can be implemented and that backing isn’t guaranteed.\nThat uncertainty is likely to continue fueling volatility in the stocks. Options imply that Moderna and BioNTech could move roughly 7% in either direction over the next week while Pfizer’s stock may move about 3%.\nMorgan Stanley’s Matthew Harrison is among Wall Street analysts who expect Biden’s plan to be backed by regulators. But but he remains equal weight on Moderna and Pfizer because he doesn’t expect any major new vaccine orders in the near future, with an estimated 630 million of unused shots from the companies already purchased through 2022.\n“We do not expect any supply constraints for booster doses and do not expect the U.S. government to purchase additional mRNA vaccine doses for 2022 based on current demand or booster dose need,” Harrison wrote in a research note, referring to the technology used in both Moderna and Pfizer’s shots.\nAnalysts with Goldman Sachs Group Inc. are more bullish. The bank has a buy rating on Moderna, estimating that its shot could drive $36.2 billion of sales next year, some $15 billion more than Bloomberg’s consensus estimates. “We see upside to these numbers given supply and pricing dynamics,” said analyst Asad Haider.\nHe sees new records for Moderna and Pfizer if U.S. and other global regulators endorse the receipt of a third dose. He estimates that Moderna shares -- which closed Friday a $382.22 -- could top $600 if boosters become the norm, while Pfizer could trade as high as $61, up from $46.58 at the end of last week.  BioNTech already trades at best-case levels, he wrote.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":530,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":808987621,"gmtCreate":1627551477963,"gmtModify":1703492182295,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/808987621","repostId":"2155990524","repostType":4,"isVote":1,"tweetType":1,"viewCount":466,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":142775404,"gmtCreate":1626180984008,"gmtModify":1703754915380,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/142775404","repostId":"1168255542","repostType":4,"isVote":1,"tweetType":1,"viewCount":527,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":880302223,"gmtCreate":1631016776762,"gmtModify":1676530442898,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/880302223","repostId":"1130130857","repostType":4,"repost":{"id":"1130130857","kind":"news","pubTimestamp":1631007146,"share":"https://ttm.financial/m/news/1130130857?lang=&edition=full_marsco","pubTime":"2021-09-07 17:32","market":"us","language":"en","title":"Strategists Say the Stock Market Could Struggle This Fall. What to Buy Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=1130130857","media":"Barron's","summary":"What a year this has been for the markets!Fueled by a torrent of monetary and fiscal stimulus, economic and earnings growth, and  a mostly receding pandemic, theS&P 500stock index has rallied 20%, notching seven straight months of gains and more than 50 highs along the way. And that’s on top of last year’s 68% rebound from the market’s March 2020 lows.Tailwinds remain in place, but headwinds now loom that could slow stocks’ advance. Stimulus spending has peaked, and economic and corporate-earnin","content":"<p>What a year this has been for the markets! Fueled by a torrent of monetary and fiscal stimulus, economic and earnings growth, and (until recently) a mostly receding pandemic, theS&amp;P 500stock index has rallied 20%, notching seven straight months of gains and more than 50 highs along the way. And that’s on top of last year’s 68% rebound from the market’s March 2020 lows.</p>\n<p>Tailwinds remain in place, but headwinds now loom that could slow stocks’ advance. Stimulus spending has peaked, and economic and corporate-earnings growth are likely to decelerate through the end of the year. What’s more, theFederal Reserve has all but promised to start tapering its bond buyingin coming months, and the Biden administration has proposed hiking corporate and personal tax rates. None of this is apt to sit well with holders of increasingly pricey shares.</p>\n<p>In other words,brace for a volatile fallin which conflicting forces buffet stocks, bonds, and investors. “The everything rally is behind us,” says Saira Malik, chief investment officer of global equities at Nuveen. “It’s not going to be a sharply rising economic tide that lifts all boats from here.”</p>\n<p>That’s the general consensus among the six market strategists and chief investment officers whom<i>Barron’s</i>recently consulted. All see the S&amp;P 500 ending the year near Thursday’s close of 4536. Their average target: 4585.</p>\n<p>Next year’s gains look muted, as well, relative to recent trends. The group expects the S&amp;P 500 to tack on another 6% in 2022, rising to about 4800.</p>\n<p><img src=\"https://static.tigerbbs.com/eb61c7b74b9b0f18a019afb4ac44ad59\" tg-width=\"300\" tg-height=\"645\" referrerpolicy=\"no-referrer\">With stocks trading for about 21 times the coming year’s expected earnings,bonds yielding little, and cash yielding less than nothing after accounting for inflation, investors face tough asset-allocation decisions. In place of the “everything rally,” which lifted fast-growing tech stocks, no-growth meme stocks, and the Dogecoins of the digital world, our market watchers recommend focusing on “quality” investments. In equities, that means shares of businesses with solid balance sheets, expanding profit margins, and ample and recurring free cash flow. Even if the averages do little in coming months, these stocks are likely to shine.</p>\n<p>The stock market’s massive rally in the past year was a gift of sorts from the Federal Reserve, which flooded the financial system with money to stave off theeconomic damage wrought by the Covid pandemic. Since March 2020, the U.S. central bank has been buying a combined $120 billion a month of U.S. Treasuries and mortgage-backed securities, while keeping its benchmark federal-funds rate target at 0% to 0.25%. These moves have depressed bond yields and pushed investors into riskier assets, including stocks.</p>\n<p>Fed Chairman Jerome <a href=\"https://laohu8.com/S/POWL\">Powell</a> has said that the central bank might begin to wind down, or taper, its emergency asset purchases sometime in the coming quarters, a move that could roil risk assets of all sorts. “For us, it’s very simple: Tapering is tightening,” says Mike Wilson, chief investment officer and chief U.S. equity strategist atMorgan Stanley.“It’s the first step away from maximum accommodation [by the Fed]. They’re being very calculated about it this time, but the bottom line is that it should have a negative effect on equity valuations.”</p>\n<p>The government’s stimulus spending, too, has peaked, the strategists note. Supplemental federal unemployment benefits of $300 a week expire as of Sept. 6. Although Congress seems likely to pass a bipartisan infrastructure bill this fall, the near-term economic impact will pale in comparison to the multiple rounds of stimulus introduced since March 2020.</p>\n<p><img src=\"https://static.tigerbbs.com/c2cb76c498c1c4c980139e3d0514c261\" tg-width=\"300\" tg-height=\"645\" referrerpolicy=\"no-referrer\">The bill includes about $550 billion in new spending—a fraction of the trillions authorized by previous laws—and it will be spread out over many years. The short-term boost that infrastructure stimulus will give to consumer spending, which accounts for almost 70% of U.S. growth domestic product, won’t come close to what the economy saw after millions of Americans received checks from the government this past year.</p>\n<p>A budget bill approved by Democrats only should follow the infrastructure bill, and include spending to support Medicare expansion, child-care funding, free community-college tuition, public housing, and climate-related measures, among other party priorities. Congress could vote to lift taxes on corporations and high-earning individuals to offset that spending—another near-term risk to the market.</p>\n<p><img src=\"https://static.tigerbbs.com/6693da658db16059fc99e08a7531675f\" tg-width=\"300\" tg-height=\"645\" referrerpolicy=\"no-referrer\">Other politically charged issues likewise could derail equities this fall. Congress needs to pass a debt-ceiling increase to fund the government, and a stop-gap spending bill later this month to avoid a <a href=\"https://laohu8.com/S/WASH\">Washington</a> shutdown in October.</p>\n<p>For now, our market experts are relatively sanguine about the economic impact of the Delta variant of Covid-19. As long as vaccines remain effective in minimizing severe infections that lead to hospitalizations and deaths, the negative effects of the current Covid wave will be limited largely to the travel industry and movie theaters, they say. Wall Street’s base case for the market doesn’t include a renewed wave of lockdowns that would undermine economic growth.</p>\n<p>Inflation has been a hot topic at the Fed and among investors, partly because it has been running so hot of late. The U.S. consumer price index rose at an annualized 5.4% in both June and July—a spike the Fed calls transitory, although others aren’t so sure. The strategists are taking Powell’s side of the argument; they expect inflation to fall significantly next year. Their forecasts fall between 2.5% and 3.5%, which they consider manageable for consumers and companies, and an acceptable side effect of rapid economic growth. An inflation rate above 2.5%, however, combined with Fed tapering, would mean that now ultralow bond yields should rise.</p>\n<p>“We think inflation will continue to run hotter than it has since the financial crisis, but it’s hard for us to see inflation much over 2.5% once many of the reopening-related pressures start to dissipate,” says Michael Fredericks, head of income investing for theBlackRockMulti-Asset Strategies Group. “So bond yields do need to move up, but that will happen gradually.”</p>\n<p>The strategists see the yield on the 10-year U.S. Treasury note climbing to around 1.65% by year end. That’s about 35 basis points—or hundredths of a percentage point—above current levels, but below the 1.75% that the yield reached at its March 2021 highs. By next year, the 10-year Treasury could yield 2%, the group says. Those aren’t big moves in absolute terms, but they’re meaningful for&nbsp;the bond market—and could be even more so for stocks.</p>\n<p>Rising yields tend to weigh on stock valuations for two reasons. Higher-yielding bonds offer competition to stocks, and companies’ future earnings are worthless in the present when discounting them at a higher rate. Still, a 10-year yield around 2% won’t be enough to knock stock valuations down to pre-Covid levels. Even if yields climb, market strategists see the price/earnings multiple of the S&amp;P 500 holding well above its 30-year average of 16 times forward earnings. The index’s forward P/E topped 23 last fall.</p>\n<p><img src=\"https://static.tigerbbs.com/e08d24cb421d7cc13debd76a9c6fea01\" tg-width=\"660\" tg-height=\"434\" referrerpolicy=\"no-referrer\"></p>\n<p>As long as 10-year Treasury yields stay in the 2% range, the S&amp;P 500 should be able to command a forward P/E in the high teens, strategists say. A return to the 16-times long-term average isn’t in the cards until there is more pressure from much higher yields—or something else that causes stocks to fall.</p>\n<p>If yields surge past 2% or 2.25%, investors could start to question equity valuations more seriously, says&nbsp;<a href=\"https://laohu8.com/S/STT\">State</a> Street’schief portfolio strategist, Gaurav Mallik: “We haven’t seen [the 10-year yield] above 2% for some time now, so that’s an important sentiment level for investors.”</p>\n<p><img src=\"https://static.tigerbbs.com/93ff6490069ab5dc1b4057f1ff7966f3\" tg-width=\"664\" tg-height=\"441\" referrerpolicy=\"no-referrer\"></p>\n<p>Wilson is more concerned, noting that the stock market’s valuation risk is asymmetric: “It’s very unlikely that multiples are going to go up, and there’s a good chance that they go down more than 10% given the deceleration in growth and where we are in the cycle,” he says</p>\n<p>If 16 to 23 times forward earnings is the range, he adds, “you’re already at the very high end of that. There’s more potential risk than reward.”</p>\n<p>Some P/E-multiple compression is baked into all six strategists’ forecasts, heaping greater importance on the path of profit growth. On average, the strategists expect S&amp;P 500 earnings to jump 46% this year, to about $204, after last year’s earnings depression. That could be followed by a more normalized gain of 9% in 2022, to about $222.50.</p>\n<p>A potential headwind would be a higher federal corporate-tax rate in 2022. The details of Democrats’ spending and taxation plans will be worked out in the coming weeks, and investors can expect to hear a lot more about potential tax increases. Several strategists see a 25% federal rate on corporate profits as a likely compromise figure, above the 21% in place since 2018, but below the 28% sought by the Biden administration.</p>\n<p>An increase of that magnitude would shave about 5% off S&amp;P 500 earnings next year. The index could drop by a similar amount as the passage of the Democrats’ reconciliation bill nears this fall, but the impact should be limited to that initial correction. As with the tax cuts in December 2017, the change should be a <a href=\"https://laohu8.com/S/AONE.U\">one</a>-time event for the market, some strategists predict.</p>\n<p>These concerns aside, investors shouldn’t miss the bigger picture: The U.S. economy is in good shape and growing robustly. The strategists expect gross domestic product to rise 6.3% this year and about 4% in 2022. “The cyclical uplift and above-trend growth will continue at least through 2022, and we want to be biased toward assets that have that exposure,” says Mallik.</p>\n<blockquote>\n “We’re going to have a hot economy this year and next. When GDP growth is above average, value beats growth and cyclicals beat defensives.”— Lori Calvasina, RBC Capital Markets\n</blockquote>\n<p>The State Street strategist recommends overweighting materials, financials, and technology in investment portfolios. That approach includes both economically sensitive companies, such as banks and miners, and steady growers in the tech sector.</p>\n<p>RBC Capital Markets’ head of U.S. equity strategy, Lori Calvasina, likewise takes a barbell approach, with both cyclical and growth exposure. Her preferred sectors are energy, financials, and technology.</p>\n<p>“Valuations are still a lot more attractive in financials and energy than growth [sectors such as technology or consumer discretionary,]” Calvasina says. “The catalyst in the near term is getting out of the current Covid wave... We’re going to have a hot economy this year and next, and traditionally when GDP growth is above average, value beats growth and cyclicals beat defensives.”</p>\n<p>But the focus on quality will be pivotal, especially moving into the second half of 2022. That’s when the Fed is likely to hike interest rates for the first time in this cycle. By 2023, the economy could return to pre-Covid growth on the order of 2%.</p>\n<p>“The historical playbook is that coming out of a recession, you tend to see low-quality outperformance that lasts about a year, then leadership flips back to high quality,” Calvasina says. “But that transition from low quality back to high quality tends to be very bumpy.”</p>\n<p><b>A Shopping List for Fall</b></p>\n<p>Most strategists favor a combination of economically sensitive stocks and steady growers, including tech shares. Financials should do well, particularly if bond yields rise.</p>\n<p><img src=\"https://static.tigerbbs.com/a54c4bd114c1a5f7f700d1fc14d30d8e\" tg-width=\"970\" tg-height=\"230\" referrerpolicy=\"no-referrer\"></p>\n<p>Although stocks with quality attributes have outperformed the market this summer, according to a <a href=\"https://laohu8.com/S/BLK\">BlackRock</a> analysis, the quality factor has lagged since positive vaccine news was first reported last November.</p>\n<p>“We’re moving into a mid-cycle environment, when underlying economic growth remains strong but momentum begins to decelerate,” BlackRock’s Fredericks says. “Our research shows that quality stocks perform particularly well in such a period.”</p>\n<p>He recommends overweighting profitable technology companies; financials, including banks, and consumer staples and industrials with those quality characteristics.</p>\n<p>For <a href=\"https://laohu8.com/S/WFC\">Wells Fargo</a>’s head of equity strategy, Christopher Harvey, a mix of post-pandemic beneficiaries and defensive exposure is the way to go. He constructed a basket of stocks with lower-than-average volatility—which should outperform during periods of market uncertainty or stress this fall—and high “Covid beta,” or sensitivity to good or bad news about the pandemic. One requirement; The stocks had to be rated the equivalent of Buy by Wells Fargo’s equity analysts.</p>\n<p>“There’s near-term economic uncertainty, interest-rate uncertainty, and Covid risk, and generally we’re in a seasonally weaker part of the year around September,” says Harvey. “If we can balance low vol and high Covid beta, we can mitigate a lot of the upcoming uncertainty and volatility around timing of several of those catalysts. Longer-term, though, we still want to have that [reopening exposure.]”</p>\n<p>Harvey’s list of low-volatility stocks with high Covid beta includesApple(AAPL),<a href=\"https://laohu8.com/S/BAC\">Bank of America</a>(BAC),<a href=\"https://laohu8.com/S/NTRSP\">Northern</a> Trust(NTRS),Lowe’s(LOW),<a href=\"https://laohu8.com/S/IQV\">IQVIA</a> Holdings(IQV), andMasco(MAS).</p>\n<p>Overall, banks are the most frequently recommended group for the months ahead. TheInvesco KBW Bankexchange-traded fund (KBWB) provides broad exposure to the sector in the U.S.</p>\n<p>“We like the valuations [and] credit quality; they are now allowed to buy back shares and increase dividends, and there’s higher Covid beta,” says Harvey.</p>\n<p>Cheaper valuations mean less potential downside in a market correction. And, contrary to much of the rest of the stock market, higher interest rates would be a tailwind for the banks, which could then charge more for loans.</p>\n<p><a href=\"https://laohu8.com/S/HCSG\">Healthcare</a> stocks also have some fans. “<a href=\"https://laohu8.com/S/HR\">Healthcare</a> has both defensive and growth attributes to it,” Wilson says. “You’re paying a lot less per unit of growth in healthcare today than you are in other sectors. So we think it provides good balance in this market when we’re worried about valuation.” Health insurerHumana(HUM) makes Wilson’s “Fresh Money Buy List” of stocks Buy-rated by <a href=\"https://laohu8.com/S/MS\">Morgan Stanley</a> analysts and fitting his macro views.</p>\n<p>Nuveen’s Malik is also looking toward health care for relatively underpriced growth exposure, namely in the pharmaceuticals and biotechnology groups. She points toSeagen(SGEN), which is focused on oncology drugs and could be an attractive acquisition target for a pharma giant.</p>\n<p>Malik also likesAbbVie(ABBV) which trades at an undemanding eight times forward earnings and sports a 4.7% dividend yield. The coming expiration of patents on its blockbuster anti-inflammatory drug Humira has kept some investors away, but Malik is confident that management can limit the damage and sees promising drugs in development at the $200 billion company.</p>\n<p>Both stocks have had a tough time in recent days. Seagen fell more than 8% last week, to around $152, on news that its co-founder and CEO sold a large number of shares recently. AndAbbVietanked 7% Wednesday, to $112.27, after the Food and Drug Administration required new warning labels for JAK inhibitors, a type of anti-rheumatoid drug that includes one of <a href=\"https://laohu8.com/S/ABBV\">AbbVie</a>’s most promising post-Humira products.</p>\n<p><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>(PFE),<a href=\"https://laohu8.com/S/AXP\">American Express</a>(AXP),Johnson &amp; Johnson(JNJ), andCisco Systems(CSCO) are other S&amp;P 500 members that pass a<i>Barron’s</i>screen for quality attributes.</p>\n<p>After a year of steady gains, investors might be reminded this fall that stocks can also decline, as growth momentum and policy support begin to fade. But underlying economic strength supports buying the dip, should the market drop from its highs. <a href=\"https://laohu8.com/S/JE\">Just</a> be more selective. And go with quality.</p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Strategists Say the Stock Market Could Struggle This Fall. What to Buy Now?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStrategists Say the Stock Market Could Struggle This Fall. What to Buy Now?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 17:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/stocks-could-struggle-this-fall-market-strategists-say-stick-with-quality-companies-51630699840?siteid=yhoof2><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What a year this has been for the markets! Fueled by a torrent of monetary and fiscal stimulus, economic and earnings growth, and (until recently) a mostly receding pandemic, theS&P 500stock index has...</p>\n\n<a href=\"https://www.barrons.com/articles/stocks-could-struggle-this-fall-market-strategists-say-stick-with-quality-companies-51630699840?siteid=yhoof2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://www.barrons.com/articles/stocks-could-struggle-this-fall-market-strategists-say-stick-with-quality-companies-51630699840?siteid=yhoof2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130130857","content_text":"What a year this has been for the markets! Fueled by a torrent of monetary and fiscal stimulus, economic and earnings growth, and (until recently) a mostly receding pandemic, theS&P 500stock index has rallied 20%, notching seven straight months of gains and more than 50 highs along the way. And that’s on top of last year’s 68% rebound from the market’s March 2020 lows.\nTailwinds remain in place, but headwinds now loom that could slow stocks’ advance. Stimulus spending has peaked, and economic and corporate-earnings growth are likely to decelerate through the end of the year. What’s more, theFederal Reserve has all but promised to start tapering its bond buyingin coming months, and the Biden administration has proposed hiking corporate and personal tax rates. None of this is apt to sit well with holders of increasingly pricey shares.\nIn other words,brace for a volatile fallin which conflicting forces buffet stocks, bonds, and investors. “The everything rally is behind us,” says Saira Malik, chief investment officer of global equities at Nuveen. “It’s not going to be a sharply rising economic tide that lifts all boats from here.”\nThat’s the general consensus among the six market strategists and chief investment officers whomBarron’srecently consulted. All see the S&P 500 ending the year near Thursday’s close of 4536. Their average target: 4585.\nNext year’s gains look muted, as well, relative to recent trends. The group expects the S&P 500 to tack on another 6% in 2022, rising to about 4800.\nWith stocks trading for about 21 times the coming year’s expected earnings,bonds yielding little, and cash yielding less than nothing after accounting for inflation, investors face tough asset-allocation decisions. In place of the “everything rally,” which lifted fast-growing tech stocks, no-growth meme stocks, and the Dogecoins of the digital world, our market watchers recommend focusing on “quality” investments. In equities, that means shares of businesses with solid balance sheets, expanding profit margins, and ample and recurring free cash flow. Even if the averages do little in coming months, these stocks are likely to shine.\nThe stock market’s massive rally in the past year was a gift of sorts from the Federal Reserve, which flooded the financial system with money to stave off theeconomic damage wrought by the Covid pandemic. Since March 2020, the U.S. central bank has been buying a combined $120 billion a month of U.S. Treasuries and mortgage-backed securities, while keeping its benchmark federal-funds rate target at 0% to 0.25%. These moves have depressed bond yields and pushed investors into riskier assets, including stocks.\nFed Chairman Jerome Powell has said that the central bank might begin to wind down, or taper, its emergency asset purchases sometime in the coming quarters, a move that could roil risk assets of all sorts. “For us, it’s very simple: Tapering is tightening,” says Mike Wilson, chief investment officer and chief U.S. equity strategist atMorgan Stanley.“It’s the first step away from maximum accommodation [by the Fed]. They’re being very calculated about it this time, but the bottom line is that it should have a negative effect on equity valuations.”\nThe government’s stimulus spending, too, has peaked, the strategists note. Supplemental federal unemployment benefits of $300 a week expire as of Sept. 6. Although Congress seems likely to pass a bipartisan infrastructure bill this fall, the near-term economic impact will pale in comparison to the multiple rounds of stimulus introduced since March 2020.\nThe bill includes about $550 billion in new spending—a fraction of the trillions authorized by previous laws—and it will be spread out over many years. The short-term boost that infrastructure stimulus will give to consumer spending, which accounts for almost 70% of U.S. growth domestic product, won’t come close to what the economy saw after millions of Americans received checks from the government this past year.\nA budget bill approved by Democrats only should follow the infrastructure bill, and include spending to support Medicare expansion, child-care funding, free community-college tuition, public housing, and climate-related measures, among other party priorities. Congress could vote to lift taxes on corporations and high-earning individuals to offset that spending—another near-term risk to the market.\nOther politically charged issues likewise could derail equities this fall. Congress needs to pass a debt-ceiling increase to fund the government, and a stop-gap spending bill later this month to avoid a Washington shutdown in October.\nFor now, our market experts are relatively sanguine about the economic impact of the Delta variant of Covid-19. As long as vaccines remain effective in minimizing severe infections that lead to hospitalizations and deaths, the negative effects of the current Covid wave will be limited largely to the travel industry and movie theaters, they say. Wall Street’s base case for the market doesn’t include a renewed wave of lockdowns that would undermine economic growth.\nInflation has been a hot topic at the Fed and among investors, partly because it has been running so hot of late. The U.S. consumer price index rose at an annualized 5.4% in both June and July—a spike the Fed calls transitory, although others aren’t so sure. The strategists are taking Powell’s side of the argument; they expect inflation to fall significantly next year. Their forecasts fall between 2.5% and 3.5%, which they consider manageable for consumers and companies, and an acceptable side effect of rapid economic growth. An inflation rate above 2.5%, however, combined with Fed tapering, would mean that now ultralow bond yields should rise.\n“We think inflation will continue to run hotter than it has since the financial crisis, but it’s hard for us to see inflation much over 2.5% once many of the reopening-related pressures start to dissipate,” says Michael Fredericks, head of income investing for theBlackRockMulti-Asset Strategies Group. “So bond yields do need to move up, but that will happen gradually.”\nThe strategists see the yield on the 10-year U.S. Treasury note climbing to around 1.65% by year end. That’s about 35 basis points—or hundredths of a percentage point—above current levels, but below the 1.75% that the yield reached at its March 2021 highs. By next year, the 10-year Treasury could yield 2%, the group says. Those aren’t big moves in absolute terms, but they’re meaningful for the bond market—and could be even more so for stocks.\nRising yields tend to weigh on stock valuations for two reasons. Higher-yielding bonds offer competition to stocks, and companies’ future earnings are worthless in the present when discounting them at a higher rate. Still, a 10-year yield around 2% won’t be enough to knock stock valuations down to pre-Covid levels. Even if yields climb, market strategists see the price/earnings multiple of the S&P 500 holding well above its 30-year average of 16 times forward earnings. The index’s forward P/E topped 23 last fall.\n\nAs long as 10-year Treasury yields stay in the 2% range, the S&P 500 should be able to command a forward P/E in the high teens, strategists say. A return to the 16-times long-term average isn’t in the cards until there is more pressure from much higher yields—or something else that causes stocks to fall.\nIf yields surge past 2% or 2.25%, investors could start to question equity valuations more seriously, says State Street’schief portfolio strategist, Gaurav Mallik: “We haven’t seen [the 10-year yield] above 2% for some time now, so that’s an important sentiment level for investors.”\n\nWilson is more concerned, noting that the stock market’s valuation risk is asymmetric: “It’s very unlikely that multiples are going to go up, and there’s a good chance that they go down more than 10% given the deceleration in growth and where we are in the cycle,” he says\nIf 16 to 23 times forward earnings is the range, he adds, “you’re already at the very high end of that. There’s more potential risk than reward.”\nSome P/E-multiple compression is baked into all six strategists’ forecasts, heaping greater importance on the path of profit growth. On average, the strategists expect S&P 500 earnings to jump 46% this year, to about $204, after last year’s earnings depression. That could be followed by a more normalized gain of 9% in 2022, to about $222.50.\nA potential headwind would be a higher federal corporate-tax rate in 2022. The details of Democrats’ spending and taxation plans will be worked out in the coming weeks, and investors can expect to hear a lot more about potential tax increases. Several strategists see a 25% federal rate on corporate profits as a likely compromise figure, above the 21% in place since 2018, but below the 28% sought by the Biden administration.\nAn increase of that magnitude would shave about 5% off S&P 500 earnings next year. The index could drop by a similar amount as the passage of the Democrats’ reconciliation bill nears this fall, but the impact should be limited to that initial correction. As with the tax cuts in December 2017, the change should be a one-time event for the market, some strategists predict.\nThese concerns aside, investors shouldn’t miss the bigger picture: The U.S. economy is in good shape and growing robustly. The strategists expect gross domestic product to rise 6.3% this year and about 4% in 2022. “The cyclical uplift and above-trend growth will continue at least through 2022, and we want to be biased toward assets that have that exposure,” says Mallik.\n\n “We’re going to have a hot economy this year and next. When GDP growth is above average, value beats growth and cyclicals beat defensives.”— Lori Calvasina, RBC Capital Markets\n\nThe State Street strategist recommends overweighting materials, financials, and technology in investment portfolios. That approach includes both economically sensitive companies, such as banks and miners, and steady growers in the tech sector.\nRBC Capital Markets’ head of U.S. equity strategy, Lori Calvasina, likewise takes a barbell approach, with both cyclical and growth exposure. Her preferred sectors are energy, financials, and technology.\n“Valuations are still a lot more attractive in financials and energy than growth [sectors such as technology or consumer discretionary,]” Calvasina says. “The catalyst in the near term is getting out of the current Covid wave... We’re going to have a hot economy this year and next, and traditionally when GDP growth is above average, value beats growth and cyclicals beat defensives.”\nBut the focus on quality will be pivotal, especially moving into the second half of 2022. That’s when the Fed is likely to hike interest rates for the first time in this cycle. By 2023, the economy could return to pre-Covid growth on the order of 2%.\n“The historical playbook is that coming out of a recession, you tend to see low-quality outperformance that lasts about a year, then leadership flips back to high quality,” Calvasina says. “But that transition from low quality back to high quality tends to be very bumpy.”\nA Shopping List for Fall\nMost strategists favor a combination of economically sensitive stocks and steady growers, including tech shares. Financials should do well, particularly if bond yields rise.\n\nAlthough stocks with quality attributes have outperformed the market this summer, according to a BlackRock analysis, the quality factor has lagged since positive vaccine news was first reported last November.\n“We’re moving into a mid-cycle environment, when underlying economic growth remains strong but momentum begins to decelerate,” BlackRock’s Fredericks says. “Our research shows that quality stocks perform particularly well in such a period.”\nHe recommends overweighting profitable technology companies; financials, including banks, and consumer staples and industrials with those quality characteristics.\nFor Wells Fargo’s head of equity strategy, Christopher Harvey, a mix of post-pandemic beneficiaries and defensive exposure is the way to go. He constructed a basket of stocks with lower-than-average volatility—which should outperform during periods of market uncertainty or stress this fall—and high “Covid beta,” or sensitivity to good or bad news about the pandemic. One requirement; The stocks had to be rated the equivalent of Buy by Wells Fargo’s equity analysts.\n“There’s near-term economic uncertainty, interest-rate uncertainty, and Covid risk, and generally we’re in a seasonally weaker part of the year around September,” says Harvey. “If we can balance low vol and high Covid beta, we can mitigate a lot of the upcoming uncertainty and volatility around timing of several of those catalysts. Longer-term, though, we still want to have that [reopening exposure.]”\nHarvey’s list of low-volatility stocks with high Covid beta includesApple(AAPL),Bank of America(BAC),Northern Trust(NTRS),Lowe’s(LOW),IQVIA Holdings(IQV), andMasco(MAS).\nOverall, banks are the most frequently recommended group for the months ahead. TheInvesco KBW Bankexchange-traded fund (KBWB) provides broad exposure to the sector in the U.S.\n“We like the valuations [and] credit quality; they are now allowed to buy back shares and increase dividends, and there’s higher Covid beta,” says Harvey.\nCheaper valuations mean less potential downside in a market correction. And, contrary to much of the rest of the stock market, higher interest rates would be a tailwind for the banks, which could then charge more for loans.\nHealthcare stocks also have some fans. “Healthcare has both defensive and growth attributes to it,” Wilson says. “You’re paying a lot less per unit of growth in healthcare today than you are in other sectors. So we think it provides good balance in this market when we’re worried about valuation.” Health insurerHumana(HUM) makes Wilson’s “Fresh Money Buy List” of stocks Buy-rated by Morgan Stanley analysts and fitting his macro views.\nNuveen’s Malik is also looking toward health care for relatively underpriced growth exposure, namely in the pharmaceuticals and biotechnology groups. She points toSeagen(SGEN), which is focused on oncology drugs and could be an attractive acquisition target for a pharma giant.\nMalik also likesAbbVie(ABBV) which trades at an undemanding eight times forward earnings and sports a 4.7% dividend yield. The coming expiration of patents on its blockbuster anti-inflammatory drug Humira has kept some investors away, but Malik is confident that management can limit the damage and sees promising drugs in development at the $200 billion company.\nBoth stocks have had a tough time in recent days. Seagen fell more than 8% last week, to around $152, on news that its co-founder and CEO sold a large number of shares recently. AndAbbVietanked 7% Wednesday, to $112.27, after the Food and Drug Administration required new warning labels for JAK inhibitors, a type of anti-rheumatoid drug that includes one of AbbVie’s most promising post-Humira products.\nPfizer(PFE),American Express(AXP),Johnson & Johnson(JNJ), andCisco Systems(CSCO) are other S&P 500 members that pass aBarron’sscreen for quality attributes.\nAfter a year of steady gains, investors might be reminded this fall that stocks can also decline, as growth momentum and policy support begin to fade. But underlying economic strength supports buying the dip, should the market drop from its highs. Just be more selective. And go with quality.","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9,"SPY":0.9}},"isVote":1,"tweetType":1,"viewCount":613,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835220807,"gmtCreate":1629721967709,"gmtModify":1676530110932,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"H","listText":"H","text":"H","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/835220807","repostId":"1132832038","repostType":4,"isVote":1,"tweetType":1,"viewCount":295,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171026979,"gmtCreate":1626697897191,"gmtModify":1703763518256,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/171026979","repostId":"1135910714","repostType":4,"isVote":1,"tweetType":1,"viewCount":324,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":149736391,"gmtCreate":1625748103113,"gmtModify":1703747682375,"author":{"id":"3578668729356671","authorId":"3578668729356671","name":"ssw04104","avatar":"https://community-static.tradeup.com/news/e055e9b6e2b600c2b058d79546a7deb4","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578668729356671","authorIdStr":"3578668729356671"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/149736391","repostId":"1169470367","repostType":4,"isVote":1,"tweetType":1,"viewCount":308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}